activity_comment	activity_id	assay_chembl_id	assay_description	assay_type	canonical_smiles	data_validity_comment	molecule_chembl_id	relation	standard_type	standard_units	standard_value	target_chembl_id	target_organism	type	units	value
	1459898	CHEMBL828513	Inhibitory activity against Fgr kinase	B	Cc1cc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)nc(C)n1		CHEMBL364623	<	IC50	nM	1.0	CHEMBL4454	Homo sapiens	IC50	uM	0.001
	1459898	CHEMBL828513	Inhibitory activity against Fgr kinase	B	Cc1cc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)nc(C)n1		CHEMBL364623	<	IC50	nM	1.0	CHEMBL4454	Homo sapiens	IC50	uM	0.001
	1466802	CHEMBL830879	Inhibition of Fgr protein kinase	B	Cc1cccc(Cl)c1Nc1nc2ccc(N3CCN[C@@H](C)C3)nc2n2cncc12		CHEMBL189338	>	IC50	nM	2.8	CHEMBL4454	Homo sapiens	IC50	nM	2.8
Not Active	1650729	CHEMBL860637	Average Binding Constant for FGR; NA=Not Active at 10 uM	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554		Kd			CHEMBL4454	Homo sapiens	Kd		
Not Active	1650730	CHEMBL860637	Average Binding Constant for FGR; NA=Not Active at 10 uM	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707		Kd			CHEMBL4454	Homo sapiens	Kd		
Not Active	1650731	CHEMBL860637	Average Binding Constant for FGR; NA=Not Active at 10 uM	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253		Kd			CHEMBL4454	Homo sapiens	Kd		
	1650732	CHEMBL860637	Average Binding Constant for FGR; NA=Not Active at 10 uM	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	290.0	CHEMBL4454	Homo sapiens	Kd	uM	0.29
Not Active	1650733	CHEMBL860637	Average Binding Constant for FGR; NA=Not Active at 10 uM	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660		Kd			CHEMBL4454	Homo sapiens	Kd		
Not Active	1650734	CHEMBL860637	Average Binding Constant for FGR; NA=Not Active at 10 uM	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829		Kd			CHEMBL4454	Homo sapiens	Kd		
Not Active	1650735	CHEMBL860637	Average Binding Constant for FGR; NA=Not Active at 10 uM	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336		Kd			CHEMBL4454	Homo sapiens	Kd		
Not Active	1650736	CHEMBL860637	Average Binding Constant for FGR; NA=Not Active at 10 uM	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762		Kd			CHEMBL4454	Homo sapiens	Kd		
Not Active	1650737	CHEMBL860637	Average Binding Constant for FGR; NA=Not Active at 10 uM	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690		Kd			CHEMBL4454	Homo sapiens	Kd		
	1651192	CHEMBL860637	Average Binding Constant for FGR; NA=Not Active at 10 uM	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	30.0	CHEMBL4454	Homo sapiens	Kd	uM	0.03
Not Active	1651193	CHEMBL860637	Average Binding Constant for FGR; NA=Not Active at 10 uM	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041		Kd			CHEMBL4454	Homo sapiens	Kd		
Not Active	1651194	CHEMBL860637	Average Binding Constant for FGR; NA=Not Active at 10 uM	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10		Kd			CHEMBL4454	Homo sapiens	Kd		
	1651195	CHEMBL860637	Average Binding Constant for FGR; NA=Not Active at 10 uM	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	=	Kd	nM	1200.0	CHEMBL4454	Homo sapiens	Kd	uM	1.2
Not Active	1651196	CHEMBL860637	Average Binding Constant for FGR; NA=Not Active at 10 uM	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667		Kd			CHEMBL4454	Homo sapiens	Kd		
Not Active	1651197	CHEMBL860637	Average Binding Constant for FGR; NA=Not Active at 10 uM	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279		Kd			CHEMBL4454	Homo sapiens	Kd		
Not Active	1651198	CHEMBL860637	Average Binding Constant for FGR; NA=Not Active at 10 uM	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941		Kd			CHEMBL4454	Homo sapiens	Kd		
Not Active	1651199	CHEMBL860637	Average Binding Constant for FGR; NA=Not Active at 10 uM	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939		Kd			CHEMBL4454	Homo sapiens	Kd		
Not Active	1651200	CHEMBL860637	Average Binding Constant for FGR; NA=Not Active at 10 uM	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553		Kd			CHEMBL4454	Homo sapiens	Kd		
	1651201	CHEMBL860637	Average Binding Constant for FGR; NA=Not Active at 10 uM	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	=	Kd	nM	2200.0	CHEMBL4454	Homo sapiens	Kd	uM	2.2
	1651202	CHEMBL860637	Average Binding Constant for FGR; NA=Not Active at 10 uM	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	=	Kd	nM	1700.0	CHEMBL4454	Homo sapiens	Kd	uM	1.7
	1663200	CHEMBL863883	Inhibitory activity against fgr	B	COc1cc(-c2nn([C@H]3CC[C@H](N4CCN(C(C)=O)CC4)CC3)c3ncnc(N)c23)ccc1NC(=O)c1cc2ccccc2n1C		CHEMBL197603	=	IC50	nM	14100.0	CHEMBL4454	Homo sapiens	IC50	uM	14.1
	1778594	CHEMBL910566	Inhibition of Fgr	B	Cc1cc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)nc(C)n1		CHEMBL364623	=	IC50	nM	0.8	CHEMBL4454	Homo sapiens	IC50	nM	0.8
	1815213	CHEMBL908523	Inhibition of Fgr	B	CNc1ncnc(-c2cccnc2Oc2ccc(F)c(C(=O)Nc3cc(C(F)(F)F)ccc3N(C)CCCN(C)C)c2)n1		CHEMBL373882	=	IC50	nM	8300.0	CHEMBL4454	Homo sapiens	IC50	nM	8300.0
	1815343	CHEMBL910176	Inhibition of FGR	B	CN(C)[C@H]1CCCN(c2ccc(C(F)(F)F)cc2NC(=O)c2cc(C#Cc3cnc(N)nc3)ccc2F)C1		CHEMBL386637	=	IC50	nM	43.0	CHEMBL4454	Homo sapiens	IC50	nM	43.0
	1826442	CHEMBL919918	Inhibition of FGR	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1	Outside typical range	CHEMBL223360	=	IC50	nM	500000.0	CHEMBL4454	Homo sapiens	IC50	nM	500000.0
	1837925	CHEMBL920477	Inhibition of c-Fgr at 10 uM relative to control	B	CN(C)c1nc2c(Br)c(Br)c(Br)c(Br)c2[nH]1		CHEMBL376505	=	Inhibition	%	94.0	CHEMBL4454	Homo sapiens	Inhibition	%	94.0
	1837964	CHEMBL920477	Inhibition of c-Fgr at 10 uM relative to control	B	Brc1c(Br)c(Br)c2[nH]nnc2c1Br		CHEMBL177820	=	Inhibition	%	98.0	CHEMBL4454	Homo sapiens	Inhibition	%	98.0
Not Active	1912284	CHEMBL889661	Binding affinity to Fgr	B	CCOC(=O)c1cnn(CC(O)c2ccccc2)c1NC(=O)NC(C)C		CHEMBL450013		Activity			CHEMBL4454	Homo sapiens	Activity		
Not Active	1912298	CHEMBL889661	Binding affinity to Fgr	B	CCOC(=O)c1cnn(CC(O)c2ccccc2)c1NC(=O)Nc1ccccc1		CHEMBL226939		Activity			CHEMBL4454	Homo sapiens	Activity		
Not Active	1912299	CHEMBL889661	Binding affinity to Fgr	B	CCOC(=O)c1cnn(CC(O)c2ccccc2)c1NC(=O)NCc1ccccc1		CHEMBL226836		Activity			CHEMBL4454	Homo sapiens	Activity		
	1964484	CHEMBL897110	Inhibition of Fgr	B	CCN(CC)C/C=C/c1cnc(N)c2c(-c3ccc(NC(=O)c4cc5ccccc5n4C)c(OC)c3)csc12		CHEMBL232542	=	IC50	nM	14100.0	CHEMBL4454	Homo sapiens	IC50	uM	14.1
	1964493	CHEMBL897110	Inhibition of Fgr	B	COc1cc(-c2csc3c(/C=C/CNC4CCNCC4)cnc(N)c23)ccc1NC(=O)c1cc2ccccc2n1C		CHEMBL395664	=	IC50	nM	26500.0	CHEMBL4454	Homo sapiens	IC50	uM	26.5
	1964498	CHEMBL897110	Inhibition of Fgr	B	COc1cc(-c2csc3c(/C=C/CN[C@H]4CC[C@H](N)CC4)cnc(N)c23)ccc1NC(=O)c1cc2ccccc2n1C		CHEMBL395665	=	IC50	nM	17900.0	CHEMBL4454	Homo sapiens	IC50	uM	17.9
	1964503	CHEMBL897110	Inhibition of Fgr	B	COc1cc(-c2csc3c(/C=C/CN[C@H]4CC[C@@H](N)CC4)cnc(N)c23)ccc1NC(=O)c1cc2ccccc2n1C		CHEMBL395666	=	IC50	nM	21700.0	CHEMBL4454	Homo sapiens	IC50	uM	21.7
	1964508	CHEMBL897110	Inhibition of Fgr	B	COc1cc(-c2csc3c(/C=C/CN4CCC(O)CC4)cnc(N)c23)ccc1NC(=O)c1cc2ccccc2n1C		CHEMBL233958	=	IC50	nM	37900.0	CHEMBL4454	Homo sapiens	IC50	uM	37.9
	2050270	CHEMBL925568	Inhibition of Fgr at 1 uM	B	CC1CCN(c2ccc(CO)cc2NC(=O)c2ccc(C#N)o2)CC1		CHEMBL400754	=	Inhibition	%	2.0	CHEMBL4454	Homo sapiens	Inhibition	%	2.0
	2081818	CHEMBL929858	Inhibition of Fgr at 10 uM	B	CC[C@@H](C)Nc1nc2ccc(-c3c(-c4ccccc4F)n[nH]c3N)cc2s1		CHEMBL404115	=	Inhibition	%	54.0	CHEMBL4454	Homo sapiens	Inhibition	%	54.0
	2120852	CHEMBL950239	Inhibition of FGR	B	COc1cc2nccc(Oc3ccc4c(C(=O)NC5CC5)cccc4c3)c2cc1OC		CHEMBL272198	=	IC50	nM	396.0	CHEMBL4454	Homo sapiens	IC50	nM	396.0
	2147265	CHEMBL921855	Activity of human FGR kinase at 1 uM	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	=	Activity	%	36.0	CHEMBL4454	Homo sapiens	Activity	%	36.0
	2206822	CHEMBL990524	Inhibition of FGR	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	290.0	CHEMBL4454	Homo sapiens	Kd	nM	290.0
	2206984	CHEMBL990524	Inhibition of FGR	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	>	IC50	nM	10000.0	CHEMBL4454	Homo sapiens	IC50	uM	10.0
	2449123	CHEMBL985576	Inhibition of FGR	B	COc1ccc2c(Oc3ccc(NC(=O)c4c(C)n(CC(C)(C)O)n(-c5ccccc5)c4=O)nc3)ccnc2c1		CHEMBL460472	=	IC50	nM	328.0	CHEMBL4454	Homo sapiens	IC50	nM	328.0
	2470224	CHEMBL983626	Inhibition of FGR at 3 uM	B	CN(C)CCOc1cc(-c2cn[nH]c2)ccc1NC(=O)C1COc2ccccc2O1		CHEMBL521179	<	Inhibition	%	10.0	CHEMBL4454	Homo sapiens	INH	%	10.0
	2476614	CHEMBL1035878	Binding affinity to human FGR at 10 uM relative to control	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Activity	%	10.4	CHEMBL4454	Homo sapiens	Activity	%	10.4
Not Evaluated	2476817	CHEMBL1035878	Binding affinity to human FGR at 10 uM relative to control	B	NC(=O)c1ccc(-c2cc(C(N)=O)c(N)c(-c3ccc(S(N)(=O)=O)cc3)c2)cc1		CHEMBL514582		Activity			CHEMBL4454	Homo sapiens	Activity		
Not Evaluated	2478656	CHEMBL1035878	Binding affinity to human FGR at 10 uM relative to control	B	N#Cc1c(NC(=O)c2ccccc2)sc2c1CCCC2		CHEMBL233000		Activity			CHEMBL4454	Homo sapiens	Activity		
Not Evaluated	2478859	CHEMBL1035878	Binding affinity to human FGR at 10 uM relative to control	B	O=C1Nc2ccccc2/C1=C/c1ccc[nH]1		CHEMBL86755		Activity			CHEMBL4454	Homo sapiens	Activity		
	2479534	CHEMBL988928	Binding affinity to human FGR	B	Cc1ccc(O)cc1Nc1ccnc(Nc2cccc(C(N)=O)c2)n1		CHEMBL249097	=	Kd	nM	0.3	CHEMBL4454	Homo sapiens	Kd	nM	0.3
	2479568	CHEMBL988928	Binding affinity to human FGR	B	Nc1ncnc2c1c(-c1cccc(O)c1)cn2C1CCNCC1		CHEMBL450519	=	Kd	nM	7.0	CHEMBL4454	Homo sapiens	Kd	nM	7.0
Not Evaluated	2479714	CHEMBL1035878	Binding affinity to human FGR at 10 uM relative to control	B	N#Cc1ccc(-c2cnc3[nH]cc(NC(=O)c4cccnc4)c3c2)cc1		CHEMBL516312		Activity			CHEMBL4454	Homo sapiens	Activity		
	2480713	CHEMBL1035878	Binding affinity to human FGR at 10 uM relative to control	B	CCS(=O)(=O)Nc1ccc2c(c1)/C(=C(/Nc1ccc(CN3CCCCC3)cc1)c1ccccc1)C(=O)N2		CHEMBL514409	=	Activity	%	0.1	CHEMBL4454	Homo sapiens	Activity	%	0.1
	2482700	CHEMBL987151	Inhibition of Fgr	B	Nc1ccc(N)c2c1C(=O)c1ccccc1C2=O		CHEMBL86771	=	IC50	nM	24000.0	CHEMBL4454	Homo sapiens	IC50	uM	24.0
Not Evaluated	2577335	CHEMBL1035878	Binding affinity to human FGR at 10 uM relative to control	B	CC(=O)c1c(-c2ccncc2)[nH]c(-c2ccncc2)c1C		CHEMBL526901		Activity			CHEMBL4454	Homo sapiens	Activity		
Not Evaluated	2577538	CHEMBL1035878	Binding affinity to human FGR at 10 uM relative to control	B	NC(=O)c1ccc(Nc2cc(-c3ccc(F)cc3)[nH]n2)cc1		CHEMBL511337		Activity			CHEMBL4454	Homo sapiens	Activity		
	2593540	CHEMBL1035878	Binding affinity to human FGR at 10 uM relative to control	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Activity	%	6.8	CHEMBL4454	Homo sapiens	Activity	%	6.8
Active	2593743	CHEMBL1035878	Binding affinity to human FGR at 10 uM relative to control	B	Cc1ccc(O)cc1Nc1ccnc(Nc2cccc(C(N)=O)c2)n1		CHEMBL249097		Activity			CHEMBL4454	Homo sapiens	Activity		
	2594009	CHEMBL1035878	Binding affinity to human FGR at 10 uM relative to control	B	Nc1ncnc2c1c(-c1cccc(O)c1)cn2C1CCNCC1		CHEMBL450519	=	Activity	%	0.7	CHEMBL4454	Homo sapiens	Activity	%	0.7
Not Evaluated	2594952	CHEMBL1035878	Binding affinity to human FGR at 10 uM relative to control	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL478649		Activity			CHEMBL4454	Homo sapiens	Activity		
Not Evaluated	2595155	CHEMBL1035878	Binding affinity to human FGR at 10 uM relative to control	B	Cc1ccc(NC(=O)c2cccc(N3CCCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL1964275		Activity			CHEMBL4454	Homo sapiens	Activity		
Not Evaluated	2595221	CHEMBL1035878	Binding affinity to human FGR at 10 uM relative to control	B	Cc1ccc(C(=O)Nc2cccc(C(C)(C)C)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL515466		Activity			CHEMBL4454	Homo sapiens	Activity		
	2596352	CHEMBL1035878	Binding affinity to human FGR at 10 uM relative to control	B	CN(C)c1ccc(-c2cc3ncccc3c(NCCCCN)n2)cc1		CHEMBL282342	=	Activity	%	2.7	CHEMBL4454	Homo sapiens	Activity	%	2.7
	2597621	CHEMBL1035878	Binding affinity to human FGR at 10 uM relative to control	B	O=C(Nc1n[nH]c2nc(-c3cccc(O)c3)ccc12)C1CC1		CHEMBL408019	=	Activity	%	20.7	CHEMBL4454	Homo sapiens	Activity	%	20.7
Not Evaluated	2597824	CHEMBL1035878	Binding affinity to human FGR at 10 uM relative to control	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454		Activity			CHEMBL4454	Homo sapiens	Activity		
	2704633	CHEMBL1054868	Inhibition of FGR at 10 uM by HotSpot assay relative to control	B	Cc1cc(O)cc(-c2nn(CC#N)cc2-c2cc(NC[C@H](C)O)nc(-c3cccnc3)n2)c1		CHEMBL560733	=	Inhibition	%	3.34	CHEMBL4454	Homo sapiens	INH	%	3.34
	2719529	CHEMBL1059979	Inhibition of Tel fused FGR expressed in mouse BA/F3 cells	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(NC(=O)c4cncc(-c5cccs5)c4)c3)cc2C(F)(F)F)CC1		CHEMBL556140	<	EC50	nM	500.0	CHEMBL4454	Homo sapiens	EC50	nM	500.0
	2721610	CHEMBL1057439	Inhibition of Fgr at 1 uM	B	C[C@@H](Oc1cc(-c2cnc3ccccn23)sc1C(N)=O)c1ccc(CNC(C)(C)C)cc1OC(F)F		CHEMBL551079	<	Inhibition	%	50.0	CHEMBL4454	Homo sapiens	INH	%	50.0
	2897222	CHEMBL1051346	Percent residual c-Fgr activity in the presence of 10uM inhibitor	B	O=C(O)Cc1c2ccccc2n2c1[nH]c(=O)c1ccccc12		CHEMBL92361	=	Activity	%	91.0	CHEMBL4454	Homo sapiens	Activity	%	91.0
	2897223	CHEMBL1051346	Percent residual c-Fgr activity in the presence of 10uM inhibitor	B	O=c1cc(-c2ccc(O)cc2)oc2cc(O)cc(O)c12		CHEMBL28	=	Activity	%	48.0	CHEMBL4454	Homo sapiens	Activity	%	48.0
	2897224	CHEMBL1051346	Percent residual c-Fgr activity in the presence of 10uM inhibitor	B	Cc1cc(O)c2c(c1)C(=O)c1cc(O)cc(O)c1C2=O		CHEMBL289277	=	Activity	%	99.0	CHEMBL4454	Homo sapiens	Activity	%	99.0
	2907301	CHEMBL1050840	Binding constant for FGR kinase domain	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	10000.0	CHEMBL4454	Homo sapiens	Kd	uM	10.0
	2907302	CHEMBL1050840	Binding constant for FGR kinase domain	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	=	Kd	nM	6900.0	CHEMBL4454	Homo sapiens	Kd	nM	6900.0
	2907303	CHEMBL1050840	Binding constant for FGR kinase domain	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	=	Kd	nM	190.0	CHEMBL4454	Homo sapiens	Kd	nM	190.0
	2907304	CHEMBL1050840	Binding constant for FGR kinase domain	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	10000.0	CHEMBL4454	Homo sapiens	Kd	uM	10.0
	2907305	CHEMBL1050840	Binding constant for FGR kinase domain	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	>	Kd	nM	10000.0	CHEMBL4454	Homo sapiens	Kd	uM	10.0
	2907306	CHEMBL1050840	Binding constant for FGR kinase domain	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	10000.0	CHEMBL4454	Homo sapiens	Kd	uM	10.0
	2907307	CHEMBL1050840	Binding constant for FGR kinase domain	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	=	Kd	nM	190.0	CHEMBL4454	Homo sapiens	Kd	nM	190.0
	2907308	CHEMBL1050840	Binding constant for FGR kinase domain	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	10000.0	CHEMBL4454	Homo sapiens	Kd	uM	10.0
	2907309	CHEMBL1050840	Binding constant for FGR kinase domain	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	=	Kd	nM	2800.0	CHEMBL4454	Homo sapiens	Kd	nM	2800.0
	2907310	CHEMBL1050840	Binding constant for FGR kinase domain	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	10000.0	CHEMBL4454	Homo sapiens	Kd	uM	10.0
	2907311	CHEMBL1050840	Binding constant for FGR kinase domain	B	COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1		CHEMBL483321	>	Kd	nM	10000.0	CHEMBL4454	Homo sapiens	Kd	uM	10.0
	2907312	CHEMBL1050840	Binding constant for FGR kinase domain	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Kd	nM	0.5	CHEMBL4454	Homo sapiens	Kd	nM	0.5
	2907313	CHEMBL1050840	Binding constant for FGR kinase domain	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	=	Kd	nM	950.0	CHEMBL4454	Homo sapiens	Kd	nM	950.0
	2907314	CHEMBL1050840	Binding constant for FGR kinase domain	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	=	Kd	nM	1100.0	CHEMBL4454	Homo sapiens	Kd	nM	1100.0
	2907315	CHEMBL1050840	Binding constant for FGR kinase domain	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	10000.0	CHEMBL4454	Homo sapiens	Kd	uM	10.0
	2907316	CHEMBL1050840	Binding constant for FGR kinase domain	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	10000.0	CHEMBL4454	Homo sapiens	Kd	uM	10.0
	2907317	CHEMBL1050840	Binding constant for FGR kinase domain	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL4454	Homo sapiens	Kd	uM	10.0
	2907318	CHEMBL1050840	Binding constant for FGR kinase domain	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	=	Kd	nM	1600.0	CHEMBL4454	Homo sapiens	Kd	nM	1600.0
	2907319	CHEMBL1050840	Binding constant for FGR kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	=	Kd	nM	2400.0	CHEMBL4454	Homo sapiens	Kd	nM	2400.0
	2907320	CHEMBL1050840	Binding constant for FGR kinase domain	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Kd	nM	2000.0	CHEMBL4454	Homo sapiens	Kd	nM	2000.0
	2907321	CHEMBL1050840	Binding constant for FGR kinase domain	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL4454	Homo sapiens	Kd	uM	10.0
	2907322	CHEMBL1050840	Binding constant for FGR kinase domain	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	10000.0	CHEMBL4454	Homo sapiens	Kd	uM	10.0
	2907323	CHEMBL1050840	Binding constant for FGR kinase domain	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL4454	Homo sapiens	Kd	uM	10.0
	2907324	CHEMBL1050840	Binding constant for FGR kinase domain	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	=	Kd	nM	220.0	CHEMBL4454	Homo sapiens	Kd	nM	220.0
	2907325	CHEMBL1050840	Binding constant for FGR kinase domain	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	>	Kd	nM	10000.0	CHEMBL4454	Homo sapiens	Kd	uM	10.0
	2907326	CHEMBL1050840	Binding constant for FGR kinase domain	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Kd	nM	730.0	CHEMBL4454	Homo sapiens	Kd	nM	730.0
	2907327	CHEMBL1050840	Binding constant for FGR kinase domain	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	10000.0	CHEMBL4454	Homo sapiens	Kd	uM	10.0
	2907328	CHEMBL1050840	Binding constant for FGR kinase domain	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	>	Kd	nM	10000.0	CHEMBL4454	Homo sapiens	Kd	uM	10.0
	2907329	CHEMBL1050840	Binding constant for FGR kinase domain	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	>	Kd	nM	10000.0	CHEMBL4454	Homo sapiens	Kd	uM	10.0
	2907330	CHEMBL1050840	Binding constant for FGR kinase domain	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	>	Kd	nM	10000.0	CHEMBL4454	Homo sapiens	Kd	uM	10.0
	2907331	CHEMBL1050840	Binding constant for FGR kinase domain	B	NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL440084	>	Kd	nM	10000.0	CHEMBL4454	Homo sapiens	Kd	uM	10.0
	2907332	CHEMBL1050840	Binding constant for FGR kinase domain	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL4454	Homo sapiens	Kd	uM	10.0
	2907333	CHEMBL1050840	Binding constant for FGR kinase domain	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	17.0	CHEMBL4454	Homo sapiens	Kd	nM	17.0
	2907334	CHEMBL1050840	Binding constant for FGR kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	=	Kd	nM	390.0	CHEMBL4454	Homo sapiens	Kd	nM	390.0
	2907335	CHEMBL1050840	Binding constant for FGR kinase domain	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	270.0	CHEMBL4454	Homo sapiens	Kd	nM	270.0
	2907336	CHEMBL1050840	Binding constant for FGR kinase domain	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Kd	nM	790.0	CHEMBL4454	Homo sapiens	Kd	nM	790.0
	2907337	CHEMBL1050840	Binding constant for FGR kinase domain	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	=	Kd	nM	1300.0	CHEMBL4454	Homo sapiens	Kd	nM	1300.0
	2907338	CHEMBL1050840	Binding constant for FGR kinase domain	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	=	Kd	nM	270.0	CHEMBL4454	Homo sapiens	Kd	nM	270.0
	2921333	CHEMBL1053732	Inhibition of FGR assessed as enzyme activity at 1 uM relative to untreated control	B	Cc1ccc2c(Nc3ccc(Cl)cc3)nccc2c1Nc1ncccc1-c1ncnc2[nH]cnc12.Cl.Cl.Cl		CHEMBL3215582	=	Activity	%	100.0	CHEMBL4454	Homo sapiens	Activity	%	100.0
	3052613	CHEMBL1037589	Residual activity of FGR at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	91.0	CHEMBL4454	Homo sapiens	Residual activity	%	91.0
	3053922	CHEMBL1045132	Residual activity of FGR at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	24.0	CHEMBL4454	Homo sapiens	Residual activity	%	24.0
	3054174	CHEMBL1040642	Residual activity of FGR at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	103.0	CHEMBL4454	Homo sapiens	Residual activity	%	103.0
	3055461	CHEMBL1037589	Residual activity of FGR at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	101.0	CHEMBL4454	Homo sapiens	Residual activity	%	101.0
	3056766	CHEMBL1045132	Residual activity of FGR at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	82.0	CHEMBL4454	Homo sapiens	Residual activity	%	82.0
	3057018	CHEMBL1040642	Residual activity of FGR at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	96.0	CHEMBL4454	Homo sapiens	Residual activity	%	96.0
	3058338	CHEMBL1037589	Residual activity of FGR at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	94.0	CHEMBL4454	Homo sapiens	Residual activity	%	94.0
	3058590	CHEMBL1045132	Residual activity of FGR at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	90.0	CHEMBL4454	Homo sapiens	Residual activity	%	90.0
	3072936	CHEMBL1040642	Residual activity of FGR at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	103.0	CHEMBL4454	Homo sapiens	Residual activity	%	103.0
	3213816	CHEMBL1108403	Inhibition of FGR at 5 uM	B	O=C(Nc1ccccc1Cl)c1cnc2ccc(C3CCNCC3)cn12.O=C(O)C(=O)O		CHEMBL1077739	=	Inhibition	%	104.0	CHEMBL4454	Homo sapiens	INH	%	104.0
	3224824	CHEMBL1099661	Inhibition of FGR at 10 uM	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1-c1cnc(CO)cn1		CHEMBL1081678	<	Inhibition	%	50.0	CHEMBL4454	Homo sapiens	INH	%	50.0
	3225074	CHEMBL1099661	Inhibition of FGR at 10 uM	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1Cc1ccc(CN(C)C)cc1		CHEMBL1078665	<	Inhibition	%	50.0	CHEMBL4454	Homo sapiens	INH	%	50.0
	3331946	CHEMBL1169236	Inhibition of FGR at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(F)ccc3F)CCN4)cn2)CC1		CHEMBL1165499	<	Inhibition	%	50.0	CHEMBL4454	Homo sapiens	INH	%	50.0
	3333361	CHEMBL1169236	Inhibition of FGR at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cn2)CC1		CHEMBL1164180	<	Inhibition	%	50.0	CHEMBL4454	Homo sapiens	INH	%	50.0
	3334766	CHEMBL1169236	Inhibition of FGR at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3Cl)CCN4)cn2)CC1		CHEMBL1164181	<	Inhibition	%	50.0	CHEMBL4454	Homo sapiens	INH	%	50.0
	3336186	CHEMBL1169236	Inhibition of FGR at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3c(F)ccc(F)c3Cl)CCN4)cn2)CC1		CHEMBL1164265	<	Inhibition	%	50.0	CHEMBL4454	Homo sapiens	INH	%	50.0
	3337533	CHEMBL1169236	Inhibition of FGR at 1 uM	B	O=C(O)c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1		CHEMBL1163510	<	Inhibition	%	50.0	CHEMBL4454	Homo sapiens	INH	%	50.0
	3337783	CHEMBL1169236	Inhibition of FGR at 1 uM	B	O=C(c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1)N1CCCCC1		CHEMBL1163518	<	Inhibition	%	50.0	CHEMBL4454	Homo sapiens	INH	%	50.0
	3339117	CHEMBL1169236	Inhibition of FGR at 1 uM	B	COC1CCN(C(=O)c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cc2)CC1		CHEMBL1163567	<	Inhibition	%	50.0	CHEMBL4454	Homo sapiens	INH	%	50.0
	3340419	CHEMBL1169236	Inhibition of FGR at 1 uM	B	O=C(c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1)N1CCC(N2CCCC2)CC1		CHEMBL1163559	<	Inhibition	%	50.0	CHEMBL4454	Homo sapiens	INH	%	50.0
	3340714	CHEMBL1169236	Inhibition of FGR at 1 uM	B	FC(F)(F)c1ccc(Cl)cc1CN1CCNc2ncc(-c3ccnc(N4CCNCC4)c3)cc21		CHEMBL1163566	<	Inhibition	%	50.0	CHEMBL4454	Homo sapiens	INH	%	50.0
	3342130	CHEMBL1169236	Inhibition of FGR at 1 uM	B	CC(=O)N1CCN(c2cc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)ccn2)CC1		CHEMBL1163565	<	Inhibition	%	50.0	CHEMBL4454	Homo sapiens	INH	%	50.0
	3344687	CHEMBL1168108	Inhibition of FGR assessed as residual activity at 10 uM after 80 mins by microplate scintillation counting	B	CN1CCN(c2ccc(NC(=O)c3ccc4c(c3)/C(=C3/Nc5ccccc5C3=O)C(=O)N4)cc2)CC1		CHEMBL1164526	=	Activity	%	59.0	CHEMBL4454	Homo sapiens	Activity	%	59.0
	3344688	CHEMBL1168109	Inhibition of FGR assessed as residual activity at 1 uM after 80 mins by microplate scintillation counting	B	CN1CCN(c2ccc(NC(=O)c3ccc4c(c3)/C(=C3/Nc5ccccc5C3=O)C(=O)N4)cc2)CC1		CHEMBL1164526	=	Activity	%	99.0	CHEMBL4454	Homo sapiens	Activity	%	99.0
	3358581	CHEMBL1174426	Inhibition of FGR at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cccnc4)c3)cc2C(F)(F)F)CC1		CHEMBL1171523	=	Inhibition	%	0.0	CHEMBL4454	Homo sapiens	INH	%	0.0
	3359023	CHEMBL1174426	Inhibition of FGR at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cnc5[nH]ccc5c4)c3)cc2C(F)(F)F)CC1		CHEMBL1170139	=	Inhibition	%	0.15	CHEMBL4454	Homo sapiens	INH	%	0.15
	3443401	CHEMBL1244434	Inhibition of FGR at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc(Br)c(O)c2)c2c(N)ncnc21		CHEMBL1241578	=	Inhibition	%	101.0	CHEMBL4454	Homo sapiens	INH	%	101.0
	3443618	CHEMBL1244434	Inhibition of FGR at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1cnc3[nH]ccc3c1)nn2C1CCCC1		CHEMBL1081312	=	Inhibition	%	100.0	CHEMBL4454	Homo sapiens	INH	%	100.0
	3444773	CHEMBL1244434	Inhibition of FGR at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3ncccc3c2)c2c(N)ncnc21		CHEMBL1233882	=	Inhibition	%	90.0	CHEMBL4454	Homo sapiens	INH	%	90.0
	3445121	CHEMBL1244843	Binding affinity to FGR	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	52.0	CHEMBL4454	Homo sapiens	Kd	nM	52.0
	3445397	CHEMBL1244434	Inhibition of FGR at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	COc1ccc(-c2nn(C3CCC3)c3ncnc(N)c23)cc1OC		CHEMBL1233881	=	Inhibition	%	86.0	CHEMBL4454	Homo sapiens	INH	%	86.0
	3445614	CHEMBL1244434	Inhibition of FGR at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21		CHEMBL1241674	=	Inhibition	%	51.0	CHEMBL4454	Homo sapiens	INH	%	51.0
	3445822	CHEMBL1244434	Inhibition of FGR at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cccc(O)c2)c2c(N)ncnc21		CHEMBL1230790	=	Inhibition	%	99.0	CHEMBL4454	Homo sapiens	INH	%	99.0
	3446012	CHEMBL1244434	Inhibition of FGR at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	Cn1nc(-c2ccc3ccccc3c2)c2c(N)ncnc21		CHEMBL1234815	=	Inhibition	%	81.0	CHEMBL4454	Homo sapiens	INH	%	81.0
	3446184	CHEMBL1244326	Inhibition of FGR	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	=	IC50	nM	1.1	CHEMBL4454	Homo sapiens	IC50	nM	1.1
	3448439	CHEMBL1244843	Binding affinity to FGR	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL4454	Homo sapiens	Kd	uM	10.0
	3448929	CHEMBL1244843	Binding affinity to FGR	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Kd	nM	730.0	CHEMBL4454	Homo sapiens	Kd	nM	730.0
	3449175	CHEMBL1244843	Binding affinity to FGR	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL1240703	=	Kd	nM	140.0	CHEMBL4454	Homo sapiens	Kd	nM	140.0
	3449176	CHEMBL1244843	Binding affinity to FGR	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	270.0	CHEMBL4454	Homo sapiens	Kd	nM	270.0
	3449674	CHEMBL1244843	Binding affinity to FGR	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	10000.0	CHEMBL4454	Homo sapiens	Kd	uM	10.0
	3450084	CHEMBL1244843	Binding affinity to FGR	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL4454	Homo sapiens	Kd	uM	10.0
	3463234	CHEMBL1252422	Inhibition of FGR at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4c[nH]c5ccccc45)c3)cc12		CHEMBL379300	=	Inhibition	%	36.0	CHEMBL4454	Homo sapiens	INH	%	36.0
	3463453	CHEMBL1252422	Inhibition of FGR at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control	B	COc1ccccc1N1CCN(c2ncnc3[nH]nc(Br)c23)CC1		CHEMBL1254209	=	Inhibition	%	8.0	CHEMBL4454	Homo sapiens	INH	%	8.0
	3463997	CHEMBL1252422	Inhibition of FGR at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control	B	O=C(NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1I)c1cccs1		CHEMBL577784	=	Inhibition	%	29.0	CHEMBL4454	Homo sapiens	INH	%	29.0
	5120310	CHEMBL1645968	Inhibition of human Fgr at 10 uM after 60 mins by TR-FRET assay	B	S=c1[nH]nc(-c2ccncc2)n1-c1ccc2ccccc2c1		CHEMBL1644616	=	Inhibition	%	99.0	CHEMBL4454	Homo sapiens	INH	%	99.0
	5123797	CHEMBL1649037	Inhibition of FGR at 1 uM	B	CCN1C(=O)CCC(C)(C)c2ccc(Nc3ncc(Cl)c(Nc4c(F)cccc4C(=O)NC)n3)cc21		CHEMBL1644812	=	Inhibition	%	91.0	CHEMBL4454	Homo sapiens	INH	%	91.0
	5243709	CHEMBL1685672	Inhibition of Fgr at 0.1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NC5CCN(Cc6ccccc6)CC5)cc34)[nH]c2c1		CHEMBL1684543	=	Inhibition	%	2.0	CHEMBL4454	Homo sapiens	INH	%	2.0
	5243817	CHEMBL1685921	Inhibition of Fgr at 1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NC5CCN(Cc6ccccc6)CC5)cc34)[nH]c2c1		CHEMBL1684543	=	Inhibition	%	0.0	CHEMBL4454	Homo sapiens	INH	%	0.0
	5243930	CHEMBL1685672	Inhibition of Fgr at 0.1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NC5CCNC5)cc34)[nH]c2c1		CHEMBL1684654	=	Inhibition	%	0.0	CHEMBL4454	Homo sapiens	INH	%	0.0
	5244038	CHEMBL1685921	Inhibition of Fgr at 1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NC5CCNC5)cc34)[nH]c2c1		CHEMBL1684654	=	Inhibition	%	-1.0	CHEMBL4454	Homo sapiens	INH	%	-1.0
	5244911	CHEMBL1685672	Inhibition of Fgr at 0.1 uM	B	O=C(Cc1ccc2cc(-c3n[nH]c4cccnc34)[nH]c2c1)c1ccccc1		CHEMBL1684662	=	Inhibition	%	38.0	CHEMBL4454	Homo sapiens	INH	%	38.0
	5245019	CHEMBL1685921	Inhibition of Fgr at 1 uM	B	O=C(Cc1ccc2cc(-c3n[nH]c4cccnc34)[nH]c2c1)c1ccccc1		CHEMBL1684662	=	Inhibition	%	6.0	CHEMBL4454	Homo sapiens	INH	%	6.0
	5245170	CHEMBL1685672	Inhibition of Fgr at 0.1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NS(=O)(=O)c5ncn(C)c5C)cc34)[nH]c2c1		CHEMBL1684525	=	Inhibition	%	66.0	CHEMBL4454	Homo sapiens	INH	%	66.0
	5246000	CHEMBL1685921	Inhibition of Fgr at 1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NS(=O)(=O)c5ncn(C)c5C)cc34)[nH]c2c1		CHEMBL1684525	=	Inhibition	%	13.0	CHEMBL4454	Homo sapiens	INH	%	13.0
	6340222	CHEMBL1827043	Inhibition of FGR at 1 uM	B	COc1n[nH]c2ncc(NC(=O)c3c(F)ccc(NS(=O)(=O)c4cccc(F)c4)c3F)cc12		CHEMBL1822258	=	Inhibition	%	98.0	CHEMBL4454	Homo sapiens	INH	%	98.0
	6340223	CHEMBL1827043	Inhibition of FGR at 1 uM	B	COc1n[nH]c2ncc(NC(=O)c3c(F)ccc(NS(=O)(=O)N4CCCC4)c3F)cc12		CHEMBL1822099	=	Inhibition	%	101.0	CHEMBL4454	Homo sapiens	INH	%	101.0
	6340224	CHEMBL1827043	Inhibition of FGR at 1 uM	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)Nc2cnc3[nH]nc(OC)c3c2)c1F		CHEMBL1822067	=	Inhibition	%	88.0	CHEMBL4454	Homo sapiens	INH	%	88.0
	6341062	CHEMBL1828231	Activity of FGR kinase at 1 uM	B	CC(=O)Nc1cn2nc(-c3cnc(Cl)c(NS(=O)(=O)c4ccc(F)cc4)c3)ccc2n1		CHEMBL1822054	=	Activity	%	100.0	CHEMBL4454	Homo sapiens	Activity	%	100.0
	6385808	CHEMBL1838329	Inhibition of human FGR in HL60 cells lysate at 10 uM using post probe-labeling by LC-MS/MS analysis relative to control	B	Nc1c(F)c(NCCCc2ccccc2)c(F)c2c1c(=O)c(C(=O)O)cn2C1CC1		CHEMBL1834114	<	Inhibition	%	35.0	CHEMBL4454	Homo sapiens	INH	%	35.0
	6385809	CHEMBL1838329	Inhibition of human FGR in HL60 cells lysate at 10 uM using post probe-labeling by LC-MS/MS analysis relative to control	B	Nc1c(F)c(NCCNc2ccccn2)c(F)c2c1c(=O)c(C(=O)O)cn2C1CCCC1		CHEMBL1834318	<	Inhibition	%	35.0	CHEMBL4454	Homo sapiens	INH	%	35.0
	6385810	CHEMBL1838329	Inhibition of human FGR in HL60 cells lysate at 10 uM using post probe-labeling by LC-MS/MS analysis relative to control	B	C[C@H]1COc2c(NCCNc3ccccn3)c(F)c(N)c3c(=O)c(C(=O)O)cn1c23		CHEMBL1834323	<	Inhibition	%	35.0	CHEMBL4454	Homo sapiens	INH	%	35.0
	6385811	CHEMBL1838329	Inhibition of human FGR in HL60 cells lysate at 10 uM using post probe-labeling by LC-MS/MS analysis relative to control	B	CC(C)[C@@H]1COc2c(NCCNc3ccccn3)c(F)c(N)c3c(=O)c(C(=O)O)cn1c23		CHEMBL1834324	<	Inhibition	%	35.0	CHEMBL4454	Homo sapiens	INH	%	35.0
	6385812	CHEMBL1838329	Inhibition of human FGR in HL60 cells lysate at 10 uM using post probe-labeling by LC-MS/MS analysis relative to control	B	Nc1c(F)c(NCCNc2ccccn2)c2c3c1c(=O)c(C(=O)O)cn3C1(CCCC1)CO2		CHEMBL1834330	<	Inhibition	%	35.0	CHEMBL4454	Homo sapiens	INH	%	35.0
	7567409	CHEMBL1908708	Binding constant for FGR kinase domain	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	=	Kd	nM	1100.0	CHEMBL4454	Homo sapiens	Kd	nM	1100.0
	7567897	CHEMBL1908708	Binding constant for FGR kinase domain	B	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL180022	=	Kd	nM	1900.0	CHEMBL4454	Homo sapiens	Kd	nM	1900.0
	7568365	CHEMBL1908708	Binding constant for FGR kinase domain	B	CSc1cccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)c1		CHEMBL386051	=	Kd	nM	2.4	CHEMBL4454	Homo sapiens	Kd	nM	2.4
	7568797	CHEMBL1908708	Binding constant for FGR kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	=	Kd	nM	390.0	CHEMBL4454	Homo sapiens	Kd	nM	390.0
	7569382	CHEMBL1908708	Binding constant for FGR kinase domain	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	>	Kd	nM	10000.0	CHEMBL4454	Homo sapiens	Kd	nM	10000.0
	7569400	CHEMBL1908708	Binding constant for FGR kinase domain	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	10000.0	CHEMBL4454	Homo sapiens	Kd	nM	10000.0
	7569872	CHEMBL1908708	Binding constant for FGR kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	=	Kd	nM	2400.0	CHEMBL4454	Homo sapiens	Kd	nM	2400.0
	7570335	CHEMBL1908708	Binding constant for FGR kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1		CHEMBL450786	=	Kd	nM	1900.0	CHEMBL4454	Homo sapiens	Kd	nM	1900.0
	7570762	CHEMBL1908708	Binding constant for FGR kinase domain	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	270.0	CHEMBL4454	Homo sapiens	Kd	nM	270.0
	7571373	CHEMBL1908708	Binding constant for FGR kinase domain	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	=	Kd	nM	670.0	CHEMBL4454	Homo sapiens	Kd	nM	670.0
	7571849	CHEMBL1908708	Binding constant for FGR kinase domain	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	>	Kd	nM	10000.0	CHEMBL4454	Homo sapiens	Kd	nM	10000.0
	7572312	CHEMBL1908708	Binding constant for FGR kinase domain	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	>	Kd	nM	10000.0	CHEMBL4454	Homo sapiens	Kd	nM	10000.0
	7572728	CHEMBL1908708	Binding constant for FGR kinase domain	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Kd	nM	120.0	CHEMBL4454	Homo sapiens	Kd	nM	120.0
	7572897	CHEMBL1908708	Binding constant for FGR kinase domain	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	>	Kd	nM	10000.0	CHEMBL4454	Homo sapiens	Kd	nM	10000.0
	7573354	CHEMBL1908708	Binding constant for FGR kinase domain	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Kd	nM	0.5	CHEMBL4454	Homo sapiens	Kd	nM	0.5
	7573830	CHEMBL1908708	Binding constant for FGR kinase domain	B	CN(C)CC(=O)N1CCC(c2ccc(NC(=O)c3nc(C#N)c[nH]3)c(C3=CCCCC3)c2)CC1.Cl		CHEMBL1908395	=	Kd	nM	220.0	CHEMBL4454	Homo sapiens	Kd	nM	220.0
	7574299	CHEMBL1908708	Binding constant for FGR kinase domain	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Kd	nM	730.0	CHEMBL4454	Homo sapiens	Kd	nM	730.0
	7574707	CHEMBL1908708	Binding constant for FGR kinase domain	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	>	Kd	nM	10000.0	CHEMBL4454	Homo sapiens	Kd	nM	10000.0
	7574875	CHEMBL1908708	Binding constant for FGR kinase domain	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	=	Kd	nM	300.0	CHEMBL4454	Homo sapiens	Kd	nM	300.0
	7575336	CHEMBL1908708	Binding constant for FGR kinase domain	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	=	Kd	nM	1100.0	CHEMBL4454	Homo sapiens	Kd	nM	1100.0
	7575807	CHEMBL1908708	Binding constant for FGR kinase domain	B	COc1cc(Oc2ccnc3cc(OC)c(OC)cc23)ccc1NC(=O)NC(C)c1nccs1		CHEMBL1908396	=	Kd	nM	1800.0	CHEMBL4454	Homo sapiens	Kd	nM	1800.0
	7576272	CHEMBL1908708	Binding constant for FGR kinase domain	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F		CHEMBL1230020	=	Kd	nM	62.0	CHEMBL4454	Homo sapiens	Kd	nM	62.0
	7576680	CHEMBL1908708	Binding constant for FGR kinase domain	B	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1		CHEMBL1287853	=	Kd	nM	82.0	CHEMBL4454	Homo sapiens	Kd	nM	82.0
	7576849	CHEMBL1908708	Binding constant for FGR kinase domain	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	>	Kd	nM	10000.0	CHEMBL4454	Homo sapiens	Kd	nM	10000.0
	7577308	CHEMBL1908708	Binding constant for FGR kinase domain	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	=	Kd	nM	40.0	CHEMBL4454	Homo sapiens	Kd	nM	40.0
	7577786	CHEMBL1908708	Binding constant for FGR kinase domain	B	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1		CHEMBL1908397	=	Kd	nM	440.0	CHEMBL4454	Homo sapiens	Kd	nM	440.0
	7578857	CHEMBL1908708	Binding constant for FGR kinase domain	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4ccccc4)c3)cc12		CHEMBL379218	>	Kd	nM	10000.0	CHEMBL4454	Homo sapiens	Kd	nM	10000.0
	7579231	CHEMBL1908708	Binding constant for FGR kinase domain	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	>	Kd	nM	10000.0	CHEMBL4454	Homo sapiens	Kd	nM	10000.0
	7579681	CHEMBL1908708	Binding constant for FGR kinase domain	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	10000.0	CHEMBL4454	Homo sapiens	Kd	nM	10000.0
	7580182	CHEMBL1908708	Binding constant for FGR kinase domain	B	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21		CHEMBL1241674	=	Kd	nM	160.0	CHEMBL4454	Homo sapiens	Kd	nM	160.0
	7580585	CHEMBL1908708	Binding constant for FGR kinase domain	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	=	Kd	nM	270.0	CHEMBL4454	Homo sapiens	Kd	nM	270.0
	7581215	CHEMBL1908708	Binding constant for FGR kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1908391	=	Kd	nM	640.0	CHEMBL4454	Homo sapiens	Kd	nM	640.0
	7581600	CHEMBL1908708	Binding constant for FGR kinase domain	B	Cc1ccc2nc(NCCN)c3ncc(C)n3c2c1		CHEMBL249697	>	Kd	nM	10000.0	CHEMBL4454	Homo sapiens	Kd	nM	10000.0
	7582045	CHEMBL1908708	Binding constant for FGR kinase domain	B	OCCn1cc(-c2ccc3c(c2)CC/C3=N\O)c(-c2ccncc2)n1		CHEMBL525191	>	Kd	nM	10000.0	CHEMBL4454	Homo sapiens	Kd	nM	10000.0
	7582074	CHEMBL1908708	Binding constant for FGR kinase domain	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL4454	Homo sapiens	Kd	nM	10000.0
	7582538	CHEMBL1908708	Binding constant for FGR kinase domain	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	10000.0	CHEMBL4454	Homo sapiens	Kd	nM	10000.0
	7582938	CHEMBL1908708	Binding constant for FGR kinase domain	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Kd	nM	790.0	CHEMBL4454	Homo sapiens	Kd	nM	790.0
	7583561	CHEMBL1908708	Binding constant for FGR kinase domain	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	10000.0	CHEMBL4454	Homo sapiens	Kd	nM	10000.0
	7583958	CHEMBL1908708	Binding constant for FGR kinase domain	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	10000.0	CHEMBL4454	Homo sapiens	Kd	nM	10000.0
	7584432	CHEMBL1908708	Binding constant for FGR kinase domain	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300138	>	Kd	nM	10000.0	CHEMBL4454	Homo sapiens	Kd	nM	10000.0
	7584894	CHEMBL1908708	Binding constant for FGR kinase domain	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	=	Kd	nM	33.0	CHEMBL4454	Homo sapiens	Kd	nM	33.0
	7585298	CHEMBL1908708	Binding constant for FGR kinase domain	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	=	Kd	nM	1300.0	CHEMBL4454	Homo sapiens	Kd	nM	1300.0
	7586303	CHEMBL1908708	Binding constant for FGR kinase domain	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	>	Kd	nM	10000.0	CHEMBL4454	Homo sapiens	Kd	nM	10000.0
	7586774	CHEMBL1908708	Binding constant for FGR kinase domain	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	10000.0	CHEMBL4454	Homo sapiens	Kd	nM	10000.0
	7587228	CHEMBL1908708	Binding constant for FGR kinase domain	B	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL384304	>	Kd	nM	10000.0	CHEMBL4454	Homo sapiens	Kd	nM	10000.0
	7587410	CHEMBL1908708	Binding constant for FGR kinase domain	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	10000.0	CHEMBL4454	Homo sapiens	Kd	nM	10000.0
	7587829	CHEMBL1908708	Binding constant for FGR kinase domain	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	>	Kd	nM	10000.0	CHEMBL4454	Homo sapiens	Kd	nM	10000.0
	7588282	CHEMBL1908708	Binding constant for FGR kinase domain	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	=	Kd	nM	2600.0	CHEMBL4454	Homo sapiens	Kd	nM	2600.0
	7588753	CHEMBL1908708	Binding constant for FGR kinase domain	B	COc1c(Cl)cc2c([nH]c3cnccc32)c1NC(=O)c1cccnc1C		CHEMBL608154	>	Kd	nM	10000.0	CHEMBL4454	Homo sapiens	Kd	nM	10000.0
	7589204	CHEMBL1908708	Binding constant for FGR kinase domain	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	>	Kd	nM	10000.0	CHEMBL4454	Homo sapiens	Kd	nM	10000.0
	7589375	CHEMBL1908708	Binding constant for FGR kinase domain	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	=	Kd	nM	1800.0	CHEMBL4454	Homo sapiens	Kd	nM	1800.0
	7589799	CHEMBL1908708	Binding constant for FGR kinase domain	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	52.0	CHEMBL4454	Homo sapiens	Kd	nM	52.0
	7590266	CHEMBL1908708	Binding constant for FGR kinase domain	B	CNC(=O)c1c(F)cccc1Nc1nc(Nc2cc3c(cc2OC)CCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL464552	>	Kd	nM	10000.0	CHEMBL4454	Homo sapiens	Kd	nM	10000.0
	7590740	CHEMBL1908708	Binding constant for FGR kinase domain	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL4454	Homo sapiens	Kd	nM	10000.0
	7591191	CHEMBL1908708	Binding constant for FGR kinase domain	B	Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1		CHEMBL1236107	>	Kd	nM	10000.0	CHEMBL4454	Homo sapiens	Kd	nM	10000.0
	7591348	CHEMBL1908708	Binding constant for FGR kinase domain	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	=	Kd	nM	6900.0	CHEMBL4454	Homo sapiens	Kd	nM	6900.0
	7591770	CHEMBL1908708	Binding constant for FGR kinase domain	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	=	Kd	nM	190.0	CHEMBL4454	Homo sapiens	Kd	nM	190.0
	7592242	CHEMBL1908708	Binding constant for FGR kinase domain	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	>	Kd	nM	10000.0	CHEMBL4454	Homo sapiens	Kd	nM	10000.0
	7592715	CHEMBL1908708	Binding constant for FGR kinase domain	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	=	Kd	nM	220.0	CHEMBL4454	Homo sapiens	Kd	nM	220.0
	7593315	CHEMBL1908708	Binding constant for FGR kinase domain	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	=	Kd	nM	190.0	CHEMBL4454	Homo sapiens	Kd	nM	190.0
	7593750	CHEMBL1908708	Binding constant for FGR kinase domain	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	10000.0	CHEMBL4454	Homo sapiens	Kd	nM	10000.0
	7594222	CHEMBL1908708	Binding constant for FGR kinase domain	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21		CHEMBL494089	>	Kd	nM	10000.0	CHEMBL4454	Homo sapiens	Kd	nM	10000.0
	7594705	CHEMBL1908708	Binding constant for FGR kinase domain	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	=	Kd	nM	6.3	CHEMBL4454	Homo sapiens	Kd	nM	6.3
	7595283	CHEMBL1908708	Binding constant for FGR kinase domain	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	>	Kd	nM	10000.0	CHEMBL4454	Homo sapiens	Kd	nM	10000.0
	7595727	CHEMBL1908708	Binding constant for FGR kinase domain	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	=	Kd	nM	2800.0	CHEMBL4454	Homo sapiens	Kd	nM	2800.0
	7596201	CHEMBL1908708	Binding constant for FGR kinase domain	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL4454	Homo sapiens	Kd	nM	10000.0
	7596230	CHEMBL1908708	Binding constant for FGR kinase domain	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	=	Kd	nM	320.0	CHEMBL4454	Homo sapiens	Kd	nM	320.0
	7596677	CHEMBL1908708	Binding constant for FGR kinase domain	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	Kd	nM	7800.0	CHEMBL4454	Homo sapiens	Kd	nM	7800.0
	7597255	CHEMBL1908708	Binding constant for FGR kinase domain	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	10000.0	CHEMBL4454	Homo sapiens	Kd	nM	10000.0
	7597708	CHEMBL1908708	Binding constant for FGR kinase domain	B	O=C(NOCC1CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl		CHEMBL105442	>	Kd	nM	10000.0	CHEMBL4454	Homo sapiens	Kd	nM	10000.0
	7598209	CHEMBL1908708	Binding constant for FGR kinase domain	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	=	Kd	nM	1600.0	CHEMBL4454	Homo sapiens	Kd	nM	1600.0
	7598651	CHEMBL1908708	Binding constant for FGR kinase domain	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	17.0	CHEMBL4454	Homo sapiens	Kd	nM	17.0
	7931085	CHEMBL1919262	Inhibition of FGR relative to control	B	Cc1ccccc1Nc1nc2cc(F)c(N(C)C(=O)/C=C/CN(C)C)cc2n2cncc12		CHEMBL1916891	=	Inhibition	%	15.0	CHEMBL4454	Homo sapiens	INH	%	15.0
	7947904	CHEMBL1925479	Inhibition of Fgr at 1 uM	B	Cc1c(CN2CCN(C(=O)[C@H](C)O)CC2)sc2c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12		CHEMBL1922094	>	Inhibition	%	60.0	CHEMBL4454	Homo sapiens	INH	%	60.0
	7947909	CHEMBL1925484	Inhibition of Fgr	B	Cc1c(CN2CCN(C(=O)[C@H](C)O)CC2)sc2c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12		CHEMBL1922094	=	IC50	nM	697.0	CHEMBL4454	Homo sapiens	IC50	nM	697.0
	7959773	CHEMBL1932861	Inhibition of FGR	B	CN(C)CCN1CCN(C(=O)c2cc(C(C)(C)C)sc2NC(=O)Nc2cccc(Cl)c2Cl)CCC1=O		CHEMBL1929238	>	IC50	nM	30000.0	CHEMBL4454	Homo sapiens	IC50	uM	30.0
	7959774	CHEMBL1932861	Inhibition of FGR	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	=	IC50	nM	8500.0	CHEMBL4454	Homo sapiens	IC50	uM	8.5
	7996690	CHEMBL1944021	Inhibition of FGR at 1 uM	B	CNC(=O)c1cccc(F)c1Nc1nc(Nc2ccc3c(c2)NC(=O)[C@H](NC(=O)N2CCCC2)CC3(C)C)ncc1Cl		CHEMBL1939491	=	Inhibition	%	97.0	CHEMBL4454	Homo sapiens	INH	%	97.0
	8004392	CHEMBL1943594	Inhibition of human FGR in HL-60 cells lysate assessed as reduction of labeling of acyl-phosphate ATP probe at 100 nM	B	C[C@H]1COc2c(NCCCn3cccn3)c(F)c(N)c3c(=O)c(C(=O)O)cn1c23		CHEMBL1940980	<	Inhibition	%	35.0	CHEMBL4454	Homo sapiens	INH	%	35.0
	8004393	CHEMBL1943594	Inhibition of human FGR in HL-60 cells lysate assessed as reduction of labeling of acyl-phosphate ATP probe at 100 nM	B	C[C@H]1COc2c(NCCCn3cccn3)c(F)c(N)c3c(=O)c(C#N)cn1c23		CHEMBL1940981	<	Inhibition	%	35.0	CHEMBL4454	Homo sapiens	INH	%	35.0
	8004394	CHEMBL1943594	Inhibition of human FGR in HL-60 cells lysate assessed as reduction of labeling of acyl-phosphate ATP probe at 100 nM	B	C[C@H]1COc2c(NCCCc3ccccn3)c(F)c(N)c3c(=O)c(C(=O)O)cn1c23		CHEMBL1940987	<	Inhibition	%	35.0	CHEMBL4454	Homo sapiens	INH	%	35.0
	8004395	CHEMBL1943594	Inhibition of human FGR in HL-60 cells lysate assessed as reduction of labeling of acyl-phosphate ATP probe at 100 nM	B	C[C@H]1COc2c(NCCCc3ccccn3)c(F)c(N)c3c(=O)c(C#N)cn1c23		CHEMBL1940990	<	Inhibition	%	35.0	CHEMBL4454	Homo sapiens	INH	%	35.0
	8047120	CHEMBL1958946	Inhibition of FGR at 1 uM	B	CN1CCN(c2ccc(Nc3nc(N)c(C(=O)c4ccc5c(c4)OCCO5)s3)cc2)CC1		CHEMBL1956070	<	Inhibition	%	50.0	CHEMBL4454	Homo sapiens	INH	%	50.0
	8061559	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3Cc2ccccc2)ccc1O		CHEMBL1789962	=	Inhibition	%	52.13	CHEMBL4454	Homo sapiens	Inhibition	%	52.13
	8061666	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(Nc3ccccc3)n2)CC1		CHEMBL318892	=	Inhibition	%	11.52	CHEMBL4454	Homo sapiens	Inhibition	%	11.52
	8061890	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(Nc3ccccc3)n2)CC1		CHEMBL318892	=	Inhibition	%	33.72	CHEMBL4454	Homo sapiens	Inhibition	%	33.72
	8062081	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	=	Inhibition	%	7.5	CHEMBL4454	Homo sapiens	Inhibition	%	7.5
	8062421	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	Cn1c(-c2nonc2N)nc2cnccc21		CHEMBL188048	=	Inhibition	%	2.79	CHEMBL4454	Homo sapiens	Inhibition	%	2.79
	8062583	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1		CHEMBL261129	=	Inhibition	%	4.79	CHEMBL4454	Homo sapiens	Inhibition	%	4.79
	8062905	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccncc21		CHEMBL185710	=	Inhibition	%	1.16	CHEMBL4454	Homo sapiens	Inhibition	%	1.16
	8063037	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NCc1ccc(-c2nc(-c3ccc(Cl)c(O)c3)c(-c3ccncc3)[nH]2)cc1		CHEMBL1909412	=	Inhibition	%	4.3	CHEMBL4454	Homo sapiens	Inhibition	%	4.3
	8063261	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	Cl.NCc1ccc(-c2nc(-c3ccc(Cl)c(O)c3)c(-c3ccncc3)[nH]2)cc1		CHEMBL1909412	=	Inhibition	%	32.79	CHEMBL4454	Homo sapiens	Inhibition	%	32.79
	8063428	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(Cl)c(C(F)(F)F)c3)n2)cc1		CHEMBL188794	=	Inhibition	%	5.75	CHEMBL4454	Homo sapiens	Inhibition	%	5.75
	8063760	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL1909378	=	Inhibition	%	3.69	CHEMBL4454	Homo sapiens	Inhibition	%	3.69
	8063942	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	=	Inhibition	%	43.99	CHEMBL4454	Homo sapiens	Inhibition	%	43.99
	8064281	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	Cn1c(-c2nonc2N)nc2cnccc21		CHEMBL188048	=	Inhibition	%	3.33	CHEMBL4454	Homo sapiens	Inhibition	%	3.33
	8064491	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)C(=O)O[C@@H]1CN[C@@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL466412	=	Inhibition	%	4.03	CHEMBL4454	Homo sapiens	Inhibition	%	4.03
	8064853	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(Nc2ncc(-c3ccccc3)o2)cc1OC.Cl		CHEMBL1794060	=	Inhibition	%	3.96	CHEMBL4454	Homo sapiens	Inhibition	%	3.96
	8065019	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(Cl)c(C(F)(F)F)c3)n2)cc1		CHEMBL188794	=	Inhibition	%	16.85	CHEMBL4454	Homo sapiens	Inhibition	%	16.85
	8065359	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	Cl.NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL1909378	=	Inhibition	%	5.27	CHEMBL4454	Homo sapiens	Inhibition	%	5.27
	8065534	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1cccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)c1		CHEMBL362155	=	Inhibition	%	32.54	CHEMBL4454	Homo sapiens	Inhibition	%	32.54
	8065758	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1cccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)c1		CHEMBL362155	=	Inhibition	%	75.29	CHEMBL4454	Homo sapiens	Inhibition	%	75.29
	8065873	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(N(C)C)cc4)c3)cc21		CHEMBL220465	=	Inhibition	%	0.55	CHEMBL4454	Homo sapiens	Inhibition	%	0.55
	8066083	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	CN(C)C(=O)O[C@@H]1CN[C@@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL466412	=	Inhibition	%	8.75	CHEMBL4454	Homo sapiens	Inhibition	%	8.75
	8066443	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(Nc2ncc(-c3ccccc3)o2)cc1OC.Cl		CHEMBL1794060	=	Inhibition	%	31.43	CHEMBL4454	Homo sapiens	Inhibition	%	31.43
	8066609	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3n2)cc1		CHEMBL408732	=	Inhibition	%	3.05	CHEMBL4454	Homo sapiens	Inhibition	%	3.05
	8066833	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3n2)cc1		CHEMBL408732	=	Inhibition	%	6.74	CHEMBL4454	Homo sapiens	Inhibition	%	6.74
	8066957	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909370	=	Inhibition	%	4.68	CHEMBL4454	Homo sapiens	Inhibition	%	4.68
	8067356	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(S(=O)(=O)c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.Cl		CHEMBL1909367	=	Inhibition	%	0.25	CHEMBL4454	Homo sapiens	Inhibition	%	0.25
	8067477	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(N(C)C)cc4)c3)cc21	Outside typical range	CHEMBL220465	=	Inhibition	%	-22.97	CHEMBL4454	Homo sapiens	Inhibition	%	-22.97
	8067687	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	CCc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL365072	=	Inhibition	%	-0.77	CHEMBL4454	Homo sapiens	Inhibition	%	-0.77
	8067911	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	CCc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL365072	=	Inhibition	%	3.85	CHEMBL4454	Homo sapiens	Inhibition	%	3.85
	8068046	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2nccc(-c3cnn4ncccc34)n2)cc(OC)c1		CHEMBL359999	=	Inhibition	%	6.85	CHEMBL4454	Homo sapiens	Inhibition	%	6.85
	8068434	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	Cl.N#Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL1794061	=	Inhibition	%	5.47	CHEMBL4454	Homo sapiens	Inhibition	%	5.47
	8068559	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909370	=	Inhibition	%	2.98	CHEMBL4454	Homo sapiens	Inhibition	%	2.98
	8068783	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)cc2)sc2c1CCCC2		CHEMBL397570	=	Inhibition	%	2.11	CHEMBL4454	Homo sapiens	Inhibition	%	2.11
	8068957	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(S(=O)(=O)c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.Cl		CHEMBL1909367	=	Inhibition	%	6.79	CHEMBL4454	Homo sapiens	Inhibition	%	6.79
	8069082	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ccccc3c2-c2ccncc2)cc1		CHEMBL485745	=	Inhibition	%	-0.1	CHEMBL4454	Homo sapiens	Inhibition	%	-0.1
	8069306	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ccccc3c2-c2ccncc2)cc1		CHEMBL485745	=	Inhibition	%	6.02	CHEMBL4454	Homo sapiens	Inhibition	%	6.02
	8069377	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2nccc(-c3cnn4ncccc34)n2)cc(OC)c1		CHEMBL359999	=	Inhibition	%	36.9	CHEMBL4454	Homo sapiens	Inhibition	%	36.9
	8069601	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(c2ccc(Nc3nccc(-c4cnn5ncccc45)n3)cc2C(F)(F)F)CC1		CHEMBL468963	=	Inhibition	%	11.21	CHEMBL4454	Homo sapiens	Inhibition	%	11.21
	8069762	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	Cl.N#Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL1794061	=	Inhibition	%	13.46	CHEMBL4454	Homo sapiens	Inhibition	%	13.46
	8070112	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)cc2)sc2c1CCCC2		CHEMBL397570	=	Inhibition	%	1.83	CHEMBL4454	Homo sapiens	Inhibition	%	1.83
	8070284	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4)n3C)ccc2c1		CHEMBL399410	=	Inhibition	%	1.14	CHEMBL4454	Homo sapiens	Inhibition	%	1.14
	8070633	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL206544	=	Inhibition	%	0.18	CHEMBL4454	Homo sapiens	Inhibition	%	0.18
	8070931	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(c2ccc(Nc3nccc(-c4cnn5ncccc45)n3)cc2C(F)(F)F)CC1		CHEMBL468963	=	Inhibition	%	47.52	CHEMBL4454	Homo sapiens	Inhibition	%	47.52
	8071088	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(Cl)cc2c1NC(=O)C2=NNc1ccc(S(N)(=O)=O)cc1		CHEMBL1909397	=	Inhibition	%	4.99	CHEMBL4454	Homo sapiens	Inhibition	%	4.99
	8071438	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1		CHEMBL185238	=	Inhibition	%	2.06	CHEMBL4454	Homo sapiens	Inhibition	%	2.06
	8071611	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4)n3C)ccc2c1		CHEMBL399410	=	Inhibition	%	6.14	CHEMBL4454	Homo sapiens	Inhibition	%	6.14
	8071960	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL206544	=	Inhibition	%	1.8	CHEMBL4454	Homo sapiens	Inhibition	%	1.8
	8072274	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)c3)ccc2[nH]1.Cl		CHEMBL1909366	=	Inhibition	%	1.17	CHEMBL4454	Homo sapiens	Inhibition	%	1.17
	8072431	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(Cl)cc2c1NC(=O)C2=NNc1ccc(S(N)(=O)=O)cc1		CHEMBL1909397	=	Inhibition	%	2.96	CHEMBL4454	Homo sapiens	Inhibition	%	2.96
	8072655	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ccc2[nH]1.Cl		CHEMBL1909371	=	Inhibition	%	4.41	CHEMBL4454	Homo sapiens	Inhibition	%	4.41
	8072780	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1		CHEMBL185238	=	Inhibition	%	4.41	CHEMBL4454	Homo sapiens	Inhibition	%	4.41
	8072947	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CC1		CHEMBL408564	=	Inhibition	%	2.88	CHEMBL4454	Homo sapiens	Inhibition	%	2.88
	8073171	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CC1		CHEMBL408564	=	Inhibition	%	11.35	CHEMBL4454	Homo sapiens	Inhibition	%	11.35
	8073296	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2s1.Cl		CHEMBL1909369	=	Inhibition	%	1.85	CHEMBL4454	Homo sapiens	Inhibition	%	1.85
	8073639	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL271843	=	Inhibition	%	-0.72	CHEMBL4454	Homo sapiens	Inhibition	%	-0.72
	8073872	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)c3)ccc2[nH]1.Cl		CHEMBL1909366	=	Inhibition	%	3.3	CHEMBL4454	Homo sapiens	Inhibition	%	3.3
	8074248	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ccc2[nH]1.Cl		CHEMBL1909371	=	Inhibition	%	3.18	CHEMBL4454	Homo sapiens	Inhibition	%	3.18
	8074378	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)N(C)C)s3)c2cc1OC		CHEMBL482326	=	Inhibition	%	0.95	CHEMBL4454	Homo sapiens	Inhibition	%	0.95
	8074759	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)Cc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785002	=	Inhibition	%	0.84	CHEMBL4454	Homo sapiens	Inhibition	%	0.84
	8074886	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2s1.Cl		CHEMBL1909369	=	Inhibition	%	9.94	CHEMBL4454	Homo sapiens	Inhibition	%	9.94
	8075110	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc3ncccc23)c2cc[nH]c2n1		CHEMBL458438	=	Inhibition	%	-0.04	CHEMBL4454	Homo sapiens	Inhibition	%	-0.04
	8075221	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL271843	=	Inhibition	%	9.99	CHEMBL4454	Homo sapiens	Inhibition	%	9.99
	8075458	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(CN3CCCC3)cc21		CHEMBL1096290	=	Inhibition	%	-1.03	CHEMBL4454	Homo sapiens	Inhibition	%	-1.03
	8075823	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL156987	=	Inhibition	%	5.15	CHEMBL4454	Homo sapiens	Inhibition	%	5.15
	8075965	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)N(C)C)s3)c2cc1OC		CHEMBL482326	=	Inhibition	%	6.42	CHEMBL4454	Homo sapiens	Inhibition	%	6.42
	8076189	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4C(F)(F)F)c(C(N)=O)s3)c2c1		CHEMBL522709	=	Inhibition	%	0.34	CHEMBL4454	Homo sapiens	Inhibition	%	0.34
	8076337	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	NC(=O)Cc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785002	=	Inhibition	%	2.97	CHEMBL4454	Homo sapiens	Inhibition	%	2.97
	8076695	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc3ncccc23)c2cc[nH]c2n1		CHEMBL458438	=	Inhibition	%	3.16	CHEMBL4454	Homo sapiens	Inhibition	%	3.16
	8076797	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(CCCN3CCOCC3)c2-c2ccncc2)cc1		CHEMBL14112	=	Inhibition	%	-2.23	CHEMBL4454	Homo sapiens	Inhibition	%	-2.23
	8077021	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(CCCN3CCOCC3)c2-c2ccncc2)cc1		CHEMBL14112	=	Inhibition	%	3.21	CHEMBL4454	Homo sapiens	Inhibition	%	3.21
	8077044	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(CN3CCCC3)cc21		CHEMBL1096290	=	Inhibition	%	3.81	CHEMBL4454	Homo sapiens	Inhibition	%	3.81
	8077268	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(O[C@@H](CN)c3ccccc3)cc21.O=C(O)C(F)(F)F		CHEMBL1909349	=	Inhibition	%	3.54	CHEMBL4454	Homo sapiens	Inhibition	%	3.54
	8077396	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL156987	=	Inhibition	%	1.19	CHEMBL4454	Homo sapiens	Inhibition	%	1.19
	8077771	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4C(F)(F)F)c(C(N)=O)s3)c2c1		CHEMBL522709	=	Inhibition	%	1.98	CHEMBL4454	Homo sapiens	Inhibition	%	1.98
	8077914	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCCc4ccccc4)c(C(N)=O)s3)c2cc1OC		CHEMBL473629	=	Inhibition	%	-0.62	CHEMBL4454	Homo sapiens	Inhibition	%	-0.62
	8078277	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3ccc(O)c(F)c3)n[nH]2)cc1		CHEMBL103115	=	Inhibition	%	0.78	CHEMBL4454	Homo sapiens	Inhibition	%	0.78
	8078603	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	Cl.ON=C1CCc2cc(-c3nc(C4CCNCC4)[nH]c3-c3ccncc3)ccc21		CHEMBL1794071	=	Inhibition	%	-1.48	CHEMBL4454	Homo sapiens	Inhibition	%	-1.48
	8078853	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(O[C@@H](CN)c3ccccc3)cc21.O=C(O)C(F)(F)F		CHEMBL1909349	=	Inhibition	%	28.63	CHEMBL4454	Homo sapiens	Inhibition	%	28.63
	8078969	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)Nc4cccc(C#N)c4)cc3)c2)o1		CHEMBL270164	=	Inhibition	%	4.67	CHEMBL4454	Homo sapiens	Inhibition	%	4.67
	8079351	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC[C@@H](O)CO)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794067	=	Inhibition	%	0.03	CHEMBL4454	Homo sapiens	Inhibition	%	0.03
	8079493	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCCc4ccccc4)c(C(N)=O)s3)c2cc1OC		CHEMBL473629	=	Inhibition	%	7.7	CHEMBL4454	Homo sapiens	Inhibition	%	7.7
	8079717	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(F)c5)c4c3)o2)CC1		CHEMBL1909391	=	Inhibition	%	0.4	CHEMBL4454	Homo sapiens	Inhibition	%	0.4
	8079856	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3ccc(O)c(F)c3)n[nH]2)cc1		CHEMBL103115	=	Inhibition	%	13.71	CHEMBL4454	Homo sapiens	Inhibition	%	13.71
	8080185	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	Cl.ON=C1CCc2cc(-c3nc(C4CCNCC4)[nH]c3-c3ccncc3)ccc21		CHEMBL1794071	=	Inhibition	%	2.99	CHEMBL4454	Homo sapiens	Inhibition	%	2.99
	8080437	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)COC(=O)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL269883	=	Inhibition	%	4.59	CHEMBL4454	Homo sapiens	Inhibition	%	4.59
	8080552	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)Nc4cccc(C#N)c4)cc3)c2)o1		CHEMBL270164	=	Inhibition	%	5.11	CHEMBL4454	Homo sapiens	Inhibition	%	5.11
	8080776	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909411	=	Inhibition	%	3.7	CHEMBL4454	Homo sapiens	Inhibition	%	3.7
	8080940	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC[C@@H](O)CO)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794067	=	Inhibition	%	4.04	CHEMBL4454	Homo sapiens	Inhibition	%	4.04
	8081299	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(F)c5)c4c3)o2)CC1		CHEMBL1909391	=	Inhibition	%	9.74	CHEMBL4454	Homo sapiens	Inhibition	%	9.74
	8081443	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)CC1		CHEMBL476259	=	Inhibition	%	6.28	CHEMBL4454	Homo sapiens	Inhibition	%	6.28
	8081770	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(O)c(Cl)c1		CHEMBL160333	=	Inhibition	%	-2.2	CHEMBL4454	Homo sapiens	Inhibition	%	-2.2
	8082022	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	CC(C)COC(=O)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL269883	=	Inhibition	%	31.96	CHEMBL4454	Homo sapiens	Inhibition	%	31.96
	8082359	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909411	=	Inhibition	%	15.45	CHEMBL4454	Homo sapiens	Inhibition	%	15.45
	8082532	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	-0.15	CHEMBL4454	Homo sapiens	Inhibition	%	-0.15
	8082879	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL517507	=	Inhibition	%	0.84	CHEMBL4454	Homo sapiens	Inhibition	%	0.84
	8083035	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)CC1		CHEMBL476259	=	Inhibition	%	7.49	CHEMBL4454	Homo sapiens	Inhibition	%	7.49
	8083259	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCCn4ccnc4)cc32)cc1		CHEMBL272026	=	Inhibition	%	5.97	CHEMBL4454	Homo sapiens	Inhibition	%	5.97
	8083358	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(O)c(Cl)c1		CHEMBL160333	=	Inhibition	%	3.74	CHEMBL4454	Homo sapiens	Inhibition	%	3.74
	8083612	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CCCCC1		CHEMBL189231	=	Inhibition	%	-0.56	CHEMBL4454	Homo sapiens	Inhibition	%	-0.56
	8083946	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC1		CHEMBL95207	=	Inhibition	%	4.22	CHEMBL4454	Homo sapiens	Inhibition	%	4.22
	8084131	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	4.65	CHEMBL4454	Homo sapiens	Inhibition	%	4.65
	8084355	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc4ncccc4c32)cc1		CHEMBL409892	=	Inhibition	%	8.01	CHEMBL4454	Homo sapiens	Inhibition	%	8.01
	8084473	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL517507	=	Inhibition	%	4.82	CHEMBL4454	Homo sapiens	Inhibition	%	4.82
	8084858	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCCn4ccnc4)cc32)cc1		CHEMBL272026	=	Inhibition	%	13.41	CHEMBL4454	Homo sapiens	Inhibition	%	13.41
	8084956	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL103080	=	Inhibition	%	-0.31	CHEMBL4454	Homo sapiens	Inhibition	%	-0.31
	8085180	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL103080	=	Inhibition	%	4.5	CHEMBL4454	Homo sapiens	Inhibition	%	4.5
	8085212	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CCCCC1		CHEMBL189231	=	Inhibition	%	6.63	CHEMBL4454	Homo sapiens	Inhibition	%	6.63
	8085436	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3Cc2ccccc2)ccc1O		CHEMBL1789962	=	Inhibition	%	11.84	CHEMBL4454	Homo sapiens	Inhibition	%	11.84
	8085544	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC1		CHEMBL95207	=	Inhibition	%	8.36	CHEMBL4454	Homo sapiens	Inhibition	%	8.36
	8085957	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc4ncccc4c32)cc1		CHEMBL409892	=	Inhibition	%	42.35	CHEMBL4454	Homo sapiens	Inhibition	%	42.35
	8086072	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cn1		CHEMBL30432	=	Inhibition	%	9.23	CHEMBL4454	Homo sapiens	Inhibition	%	9.23
	8086296	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cn1		CHEMBL30432	=	Inhibition	%	33.25	CHEMBL4454	Homo sapiens	Inhibition	%	33.25
	8086458	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1		CHEMBL261129	=	Inhibition	%	4.74	CHEMBL4454	Homo sapiens	Inhibition	%	4.74
	8086781	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccncc21		CHEMBL185710	=	Inhibition	%	0.66	CHEMBL4454	Homo sapiens	Inhibition	%	0.66
	8086992	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(Cl)cccc2Cl)c1		CHEMBL263796	=	Inhibition	%	3.11	CHEMBL4454	Homo sapiens	Inhibition	%	3.11
	8087150	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL318728	=	Inhibition	%	14.99	CHEMBL4454	Homo sapiens	Inhibition	%	14.99
	8087374	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	CCC(=O)Nc1ccc(C)c(-c2ccc(C(=O)NCC3CC3)cc2)c1		CHEMBL517666	=	Inhibition	%	1.7	CHEMBL4454	Homo sapiens	Inhibition	%	1.7
	8087488	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2nccc(N(C)c3ccc4c(C)n[nH]c4c3)n2)c1.Cl		CHEMBL1909358	=	Inhibition	%	61.58	CHEMBL4454	Homo sapiens	Inhibition	%	61.58
	8087850	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	30.29	CHEMBL4454	Homo sapiens	Inhibition	%	30.29
	8087992	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCNCC3)c21.Cl		CHEMBL1909376	=	Inhibition	%	1.29	CHEMBL4454	Homo sapiens	Inhibition	%	1.29
	8088216	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCNCC3)c21.Cl		CHEMBL1909376	=	Inhibition	%	2.57	CHEMBL4454	Homo sapiens	Inhibition	%	2.57
	8088364	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2cc(-c3ccccc3)cc(C(N)=O)c2N)cc1		CHEMBL230597	=	Inhibition	%	-1.31	CHEMBL4454	Homo sapiens	Inhibition	%	-1.31
	8088716	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL521806	=	Inhibition	%	5.04	CHEMBL4454	Homo sapiens	Inhibition	%	5.04
	8088809	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccccc21		CHEMBL365286	=	Inhibition	%	2.86	CHEMBL4454	Homo sapiens	Inhibition	%	2.86
	8089033	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccccc21		CHEMBL365286	=	Inhibition	%	4.31	CHEMBL4454	Homo sapiens	Inhibition	%	4.31
	8089161	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC(Oc2cc(Nc3nc(Nc4cccc(F)c4C(N)=O)c4cc[nH]c4n3)c(OC)cc2Cl)CC1		CHEMBL517171	=	Inhibition	%	0.61	CHEMBL4454	Homo sapiens	Inhibition	%	0.61
	8089309	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207410	=	Inhibition	%	6.13	CHEMBL4454	Homo sapiens	Inhibition	%	6.13
	8089533	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)=Cc1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL270544	=	Inhibition	%	5.76	CHEMBL4454	Homo sapiens	Inhibition	%	5.76
	8089653	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476351	=	Inhibition	%	1.66	CHEMBL4454	Homo sapiens	Inhibition	%	1.66
	8090057	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909402	=	Inhibition	%	4.08	CHEMBL4454	Homo sapiens	Inhibition	%	4.08
	8090222	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN1CCN(C(C)C)CC1)CC2		CHEMBL505915	=	Inhibition	%	0.5	CHEMBL4454	Homo sapiens	Inhibition	%	0.5
	8090613	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nc(-c2ccccc2)n2nc(NCCCN3CCOCC3)ncc12		CHEMBL486124	=	Inhibition	%	2.33	CHEMBL4454	Homo sapiens	Inhibition	%	2.33
	8090752	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL183993	=	Inhibition	%	5.2	CHEMBL4454	Homo sapiens	Inhibition	%	5.2
	8090957	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL186213	=	Inhibition	%	42.11	CHEMBL4454	Homo sapiens	Inhibition	%	42.11
	8091181	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)o1.Cl		CHEMBL1909385	=	Inhibition	%	5.33	CHEMBL4454	Homo sapiens	Inhibition	%	5.33
	8091318	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(Cl)cccc2Cl)c1		CHEMBL263796	=	Inhibition	%	21.31	CHEMBL4454	Homo sapiens	Inhibition	%	21.31
	8091697	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	CCC(=O)Nc1ccc(C)c(-c2ccc(C(=O)NCC3CC3)cc2)c1		CHEMBL517666	=	Inhibition	%	4.31	CHEMBL4454	Homo sapiens	Inhibition	%	4.31
	8091813	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1Nc1ncc(-c2ccccc2)o1.Cl		CHEMBL1794062	=	Inhibition	%	5.21	CHEMBL4454	Homo sapiens	Inhibition	%	5.21
	8092037	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1Nc1ncc(-c2ccccc2)o1.Cl		CHEMBL1794062	=	Inhibition	%	12.1	CHEMBL4454	Homo sapiens	Inhibition	%	12.1
	8092174	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccccc3)n2)cc1		CHEMBL275798	=	Inhibition	%	1.86	CHEMBL4454	Homo sapiens	Inhibition	%	1.86
	8092549	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1cc(-c2cc3c(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)ncnc3s2)cs1		CHEMBL475599	=	Inhibition	%	2.51	CHEMBL4454	Homo sapiens	Inhibition	%	2.51
	8092697	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2cc(-c3ccccc3)cc(C(N)=O)c2N)cc1		CHEMBL230597	=	Inhibition	%	1.01	CHEMBL4454	Homo sapiens	Inhibition	%	1.01
	8093050	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL521806	=	Inhibition	%	32.17	CHEMBL4454	Homo sapiens	Inhibition	%	32.17
	8093362	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)/C=C/C(=O)O.OCCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909403	=	Inhibition	%	2.9	CHEMBL4454	Homo sapiens	Inhibition	%	2.9
	8093502	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC(Oc2cc(Nc3nc(Nc4cccc(F)c4C(N)=O)c4cc[nH]c4n3)c(OC)cc2Cl)CC1		CHEMBL517171	=	Inhibition	%	4.19	CHEMBL4454	Homo sapiens	Inhibition	%	4.19
	8093865	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	CC(C)=Cc1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL270544	=	Inhibition	%	25.29	CHEMBL4454	Homo sapiens	Inhibition	%	25.29
	8093985	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3Cl)o2)c1		CHEMBL179453	=	Inhibition	%	3.37	CHEMBL4454	Homo sapiens	Inhibition	%	3.37
	8094209	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3Cl)o2)c1		CHEMBL179453	=	Inhibition	%	17.02	CHEMBL4454	Homo sapiens	Inhibition	%	17.02
	8094389	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(-c2ccco2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909353	=	Inhibition	%	3.13	CHEMBL4454	Homo sapiens	Inhibition	%	3.13
	8094564	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN1CCN(C(C)C)CC1)CC2		CHEMBL505915	=	Inhibition	%	0.3	CHEMBL4454	Homo sapiens	Inhibition	%	0.3
	8094944	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	Cc1nc(-c2ccccc2)n2nc(NCCCN3CCOCC3)ncc12		CHEMBL486124	=	Inhibition	%	4.11	CHEMBL4454	Homo sapiens	Inhibition	%	4.11
	8095084	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)cc1)c1ccnc(Nc2cccc(S(N)(=O)=O)c2)n1		CHEMBL188381	=	Inhibition	%	13.84	CHEMBL4454	Homo sapiens	Inhibition	%	13.84
	8095308	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)cc1)c1ccnc(Nc2cccc(S(N)(=O)=O)c2)n1		CHEMBL188381	=	Inhibition	%	57.18	CHEMBL4454	Homo sapiens	Inhibition	%	57.18
	8095511	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)o1.Cl		CHEMBL1909385	=	Inhibition	%	20.15	CHEMBL4454	Homo sapiens	Inhibition	%	20.15
	8095652	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC=C(c2ccc(Nc3nc(Nc4ccccc4C(N)=O)c4cc[nH]c4n3)c(C)c2)C1		CHEMBL513897	=	Inhibition	%	-0.56	CHEMBL4454	Homo sapiens	Inhibition	%	-0.56
	8095876	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC=C(c2ccc(Nc3nc(Nc4ccccc4C(N)=O)c4cc[nH]c4n3)c(C)c2)C1		CHEMBL513897	=	Inhibition	%	4.71	CHEMBL4454	Homo sapiens	Inhibition	%	4.71
	8096024	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1OC.Cl		CHEMBL1909380	=	Inhibition	%	18.35	CHEMBL4454	Homo sapiens	Inhibition	%	18.35
	8096365	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL275666	=	Inhibition	%	4.09	CHEMBL4454	Homo sapiens	Inhibition	%	4.09
	8096504	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccccc3)n2)cc1		CHEMBL275798	=	Inhibition	%	4.87	CHEMBL4454	Homo sapiens	Inhibition	%	4.87
	8096884	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1cc(-c2cc3c(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)ncnc3s2)cs1		CHEMBL475599	=	Inhibition	%	4.32	CHEMBL4454	Homo sapiens	Inhibition	%	4.32
	8097031	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5cccs5)cc34)cc2Cl)c1		CHEMBL506414	=	Inhibition	%	1.43	CHEMBL4454	Homo sapiens	Inhibition	%	1.43
	8097255	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5cccs5)cc34)cc2Cl)c1		CHEMBL506414	=	Inhibition	%	3.69	CHEMBL4454	Homo sapiens	Inhibition	%	3.69
	8097342	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2c1		CHEMBL493326	=	Inhibition	%	3.06	CHEMBL4454	Homo sapiens	Inhibition	%	3.06
	8097562	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	O=C(O)/C=C/C(=O)O.OCCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909403	=	Inhibition	%	8.24	CHEMBL4454	Homo sapiens	Inhibition	%	8.24
	8097712	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@@H](N)c3ccccc3)cc21		CHEMBL1096626	=	Inhibition	%	5.0	CHEMBL4454	Homo sapiens	Inhibition	%	5.0
	8097936	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@@H](N)c3ccccc3)cc21		CHEMBL1096626	=	Inhibition	%	10.15	CHEMBL4454	Homo sapiens	Inhibition	%	10.15
	8098069	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(C(=O)O)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909373	=	Inhibition	%	3.78	CHEMBL4454	Homo sapiens	Inhibition	%	3.78
	8098413	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(COc2cc(-n3cnc4ccccc43)sc2C(N)=O)c1		CHEMBL516248	=	Inhibition	%	1.93	CHEMBL4454	Homo sapiens	Inhibition	%	1.93
	8098593	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(-c2ccco2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909353	=	Inhibition	%	6.29	CHEMBL4454	Homo sapiens	Inhibition	%	6.29
	8098778	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(N)=O)c2cc[nH]c2n1		CHEMBL458865	=	Inhibition	%	0.9	CHEMBL4454	Homo sapiens	Inhibition	%	0.9
	8099002	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(N)=O)c2cc[nH]c2n1		CHEMBL458865	=	Inhibition	%	5.03	CHEMBL4454	Homo sapiens	Inhibition	%	5.03
	8099146	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1coc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)c1.Cl		CHEMBL1909386	=	Inhibition	%	3.94	CHEMBL4454	Homo sapiens	Inhibition	%	3.94
	8099512	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(C)=O)s3)c2cc1OC		CHEMBL471789	=	Inhibition	%	3.6	CHEMBL4454	Homo sapiens	Inhibition	%	3.6
	8099706	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1ccc2c(-c3ccnc(NC4CC4)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1885746	=	Inhibition	%	1.68	CHEMBL4454	Homo sapiens	Inhibition	%	1.68
	8100077	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C)cc4)ncnc32)c1		CHEMBL303687	=	Inhibition	%	3.81	CHEMBL4454	Homo sapiens	Inhibition	%	3.81
	8100223	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1OC.Cl		CHEMBL1909380	=	Inhibition	%	44.2	CHEMBL4454	Homo sapiens	Inhibition	%	44.2
	8100563	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL275666	=	Inhibition	%	6.39	CHEMBL4454	Homo sapiens	Inhibition	%	6.39
	8100703	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909393	=	Inhibition	%	-0.44	CHEMBL4454	Homo sapiens	Inhibition	%	-0.44
	8100927	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909393	=	Inhibition	%	8.63	CHEMBL4454	Homo sapiens	Inhibition	%	8.63
	8101087	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2ccncc2)cc1C(N)=O		CHEMBL231013	=	Inhibition	%	3.69	CHEMBL4454	Homo sapiens	Inhibition	%	3.69
	8101453	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1OC		CHEMBL443563	=	Inhibition	%	3.9	CHEMBL4454	Homo sapiens	Inhibition	%	3.9
	8101638	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2c1		CHEMBL493326	=	Inhibition	%	2.3	CHEMBL4454	Homo sapiens	Inhibition	%	2.3
	8101891	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-c2c[nH]c3c(N/N=C/c4ccncc4)ncnc23)c1		CHEMBL206010	=	Inhibition	%	14.15	CHEMBL4454	Homo sapiens	Inhibition	%	14.15
	8102270	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cccc(Nc2nccc(Nc3cccc4[nH]ncc34)n2)c1		CHEMBL251549	=	Inhibition	%	53.58	CHEMBL4454	Homo sapiens	Inhibition	%	53.58
	8102401	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(C(=O)O)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909373	=	Inhibition	%	6.34	CHEMBL4454	Homo sapiens	Inhibition	%	6.34
	8102745	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(COc2cc(-n3cnc4ccccc43)sc2C(N)=O)c1		CHEMBL516248	=	Inhibition	%	1.54	CHEMBL4454	Homo sapiens	Inhibition	%	1.54
	8102923	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(COc2ccc(Nc3ncnc4ccc(-c5ccco5)cc34)cc2)cc1		CHEMBL215993	=	Inhibition	%	3.1	CHEMBL4454	Homo sapiens	Inhibition	%	3.1
	8103147	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	c1ccc(COc2ccc(Nc3ncnc4ccc(-c5ccco5)cc34)cc2)cc1		CHEMBL215993	=	Inhibition	%	7.56	CHEMBL4454	Homo sapiens	Inhibition	%	7.56
	8103343	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@H](N)c3ccccc3)cc21		CHEMBL1096634	=	Inhibition	%	0.69	CHEMBL4454	Homo sapiens	Inhibition	%	0.69
	8103481	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1coc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)c1.Cl		CHEMBL1909386	=	Inhibition	%	14.92	CHEMBL4454	Homo sapiens	Inhibition	%	14.92
	8103705	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NC(=O)c1cccc(Nc2nccc(Nc3cccc(F)c3)n2)c1		CHEMBL1909382	=	Inhibition	%	5.52	CHEMBL4454	Homo sapiens	Inhibition	%	5.52
	8103855	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(C)=O)s3)c2cc1OC		CHEMBL471789	=	Inhibition	%	6.26	CHEMBL4454	Homo sapiens	Inhibition	%	6.26
	8104040	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	N#Cc1ccc2c(-c3ccnc(NC4CC4)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1885746	=	Inhibition	%	1.53	CHEMBL4454	Homo sapiens	Inhibition	%	1.53
	8104412	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C)cc4)ncnc32)c1		CHEMBL303687	=	Inhibition	%	18.89	CHEMBL4454	Homo sapiens	Inhibition	%	18.89
	8104558	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(-c4cnco4)cc32)cc1		CHEMBL269827	=	Inhibition	%	3.25	CHEMBL4454	Homo sapiens	Inhibition	%	3.25
	8104782	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(-c4cnco4)cc32)cc1		CHEMBL269827	=	Inhibition	%	12.86	CHEMBL4454	Homo sapiens	Inhibition	%	12.86
	8104896	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL13972	=	Inhibition	%	3.69	CHEMBL4454	Homo sapiens	Inhibition	%	3.69
	8105260	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Cl)cc3)n2)cc1		CHEMBL275168	=	Inhibition	%	2.09	CHEMBL4454	Homo sapiens	Inhibition	%	2.09
	8105426	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2ccncc2)cc1C(N)=O		CHEMBL231013	=	Inhibition	%	4.6	CHEMBL4454	Homo sapiens	Inhibition	%	4.6
	8105788	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1OC		CHEMBL443563	=	Inhibition	%	29.4	CHEMBL4454	Homo sapiens	Inhibition	%	29.4
	8106068	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL205798	=	Inhibition	%	2.84	CHEMBL4454	Homo sapiens	Inhibition	%	2.84
	8106233	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-c2c[nH]c3c(N/N=C/c4ccncc4)ncnc23)c1		CHEMBL206010	=	Inhibition	%	54.17	CHEMBL4454	Homo sapiens	Inhibition	%	54.17
	8106613	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cccc(Nc2nccc(Nc3cccc4[nH]ncc34)n2)c1		CHEMBL251549	=	Inhibition	%	76.67	CHEMBL4454	Homo sapiens	Inhibition	%	76.67
	8106742	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	CCN(CC)S(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL275473	=	Inhibition	%	10.41	CHEMBL4454	Homo sapiens	Inhibition	%	10.41
	8106966	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	CCN(CC)S(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL275473	=	Inhibition	%	38.84	CHEMBL4454	Homo sapiens	Inhibition	%	38.84
	8107087	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	CCn1cc(-c2ccnc3[nH]ccc23)c(-c2cccc(NC(=O)Nc3ccc(OCc4ccccc4)cc3)c2)n1		CHEMBL505187	=	Inhibition	%	7.42	CHEMBL4454	Homo sapiens	Inhibition	%	7.42
	8107483	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3cc(C(F)(F)F)ccc32)cc1OCc1ccccc1Br		CHEMBL480371	=	Inhibition	%	2.13	CHEMBL4454	Homo sapiens	Inhibition	%	2.13
	8107684	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@H](N)c3ccccc3)cc21		CHEMBL1096634	=	Inhibition	%	5.54	CHEMBL4454	Homo sapiens	Inhibition	%	5.54
	8108043	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	Cl.NC(=O)c1cccc(Nc2nccc(Nc3cccc(F)c3)n2)c1		CHEMBL1909382	=	Inhibition	%	30.02	CHEMBL4454	Homo sapiens	Inhibition	%	30.02
	8108201	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL518968	=	Inhibition	%	4.08	CHEMBL4454	Homo sapiens	Inhibition	%	4.08
	8108376	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)cc2[nH]1.Cl		CHEMBL1909364	=	Inhibition	%	2.28	CHEMBL4454	Homo sapiens	Inhibition	%	2.28
	8108600	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)cc2[nH]1.Cl		CHEMBL1909364	=	Inhibition	%	4.23	CHEMBL4454	Homo sapiens	Inhibition	%	4.23
	8108747	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794069	=	Inhibition	%	2.78	CHEMBL4454	Homo sapiens	Inhibition	%	2.78
	8109113	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	O=S(=O)(CCOCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL212250	=	Inhibition	%	-0.06	CHEMBL4454	Homo sapiens	Inhibition	%	-0.06
	8109227	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	N#Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL13972	=	Inhibition	%	6.62	CHEMBL4454	Homo sapiens	Inhibition	%	6.62
	8109581	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Cl)cc3)n2)cc1		CHEMBL275168	=	Inhibition	%	2.83	CHEMBL4454	Homo sapiens	Inhibition	%	2.83
	8109752	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794070	=	Inhibition	%	3.65	CHEMBL4454	Homo sapiens	Inhibition	%	3.65
	8109976	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794070	=	Inhibition	%	4.89	CHEMBL4454	Homo sapiens	Inhibition	%	4.89
	8110108	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1		CHEMBL176553	=	Inhibition	%	5.71	CHEMBL4454	Homo sapiens	Inhibition	%	5.71
	8110387	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL205798	=	Inhibition	%	9.6	CHEMBL4454	Homo sapiens	Inhibition	%	9.6
	8110553	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1.CS(=O)(=O)O		CHEMBL1909405	=	Inhibition	%	1.41	CHEMBL4454	Homo sapiens	Inhibition	%	1.41
	8110777	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1.CS(=O)(=O)O		CHEMBL1909405	=	Inhibition	%	9.12	CHEMBL4454	Homo sapiens	Inhibition	%	9.12
	8110935	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CCN)ncc(OCCCN)c21.O=C(O)C(F)(F)F		CHEMBL1794064	=	Inhibition	%	5.41	CHEMBL4454	Homo sapiens	Inhibition	%	5.41
	8111282	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	CCc1cccc(NC(=O)Nc2ccc(Oc3ccc4nc(NC(=O)OC)[nH]c4c3)cc2)c1		CHEMBL243907	=	Inhibition	%	5.68	CHEMBL4454	Homo sapiens	Inhibition	%	5.68
	8111409	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	CCn1cc(-c2ccnc3[nH]ccc23)c(-c2cccc(NC(=O)Nc3ccc(OCc4ccccc4)cc3)c2)n1		CHEMBL505187	=	Inhibition	%	34.06	CHEMBL4454	Homo sapiens	Inhibition	%	34.06
	8111633	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@@H]3CCCN3)c21.O=C(O)C(F)(F)F		CHEMBL1909375	=	Inhibition	%	1.47	CHEMBL4454	Homo sapiens	Inhibition	%	1.47
	8111799	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3cc(C(F)(F)F)ccc32)cc1OCc1ccccc1Br		CHEMBL480371	=	Inhibition	%	2.99	CHEMBL4454	Homo sapiens	Inhibition	%	2.99
	8112004	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL192417	=	Inhibition	%	2.72	CHEMBL4454	Homo sapiens	Inhibition	%	2.72
	8112365	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2nc(C)c3c(N/N=C(\C)c4ccncc4)ncnc32)c1		CHEMBL442363	=	Inhibition	%	1.55	CHEMBL4454	Homo sapiens	Inhibition	%	1.55
	8112533	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL518968	=	Inhibition	%	10.11	CHEMBL4454	Homo sapiens	Inhibition	%	10.11
	8112929	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccoc1-c1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909388	=	Inhibition	%	2.61	CHEMBL4454	Homo sapiens	Inhibition	%	2.61
	8113081	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794069	=	Inhibition	%	13.71	CHEMBL4454	Homo sapiens	Inhibition	%	13.71
	8113441	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	O=S(=O)(CCOCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL212250	=	Inhibition	%	2.31	CHEMBL4454	Homo sapiens	Inhibition	%	2.31
	8113565	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1C.O=C(O)C(F)(F)F		CHEMBL1909400	=	Inhibition	%	1.96	CHEMBL4454	Homo sapiens	Inhibition	%	1.96
	8113789	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1C.O=C(O)C(F)(F)F		CHEMBL1909400	=	Inhibition	%	4.8	CHEMBL4454	Homo sapiens	Inhibition	%	4.8
	8113905	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)CCc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785003	=	Inhibition	%	-0.91	CHEMBL4454	Homo sapiens	Inhibition	%	-0.91
	8114305	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)o1.Cl		CHEMBL1909387	=	Inhibition	%	0.16	CHEMBL4454	Homo sapiens	Inhibition	%	0.16
	8114437	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1		CHEMBL176553	=	Inhibition	%	30.18	CHEMBL4454	Homo sapiens	Inhibition	%	30.18
	8114713	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCCCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477978	=	Inhibition	%	2.07	CHEMBL4454	Homo sapiens	Inhibition	%	2.07
	8115103	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL588025	=	Inhibition	%	3.04	CHEMBL4454	Homo sapiens	Inhibition	%	3.04
	8115268	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CCN)ncc(OCCCN)c21.O=C(O)C(F)(F)F		CHEMBL1794064	=	Inhibition	%	1.7	CHEMBL4454	Homo sapiens	Inhibition	%	1.7
	8115612	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	CCc1cccc(NC(=O)Nc2ccc(Oc3ccc4nc(NC(=O)OC)[nH]c4c3)cc2)c1		CHEMBL243907	=	Inhibition	%	5.18	CHEMBL4454	Homo sapiens	Inhibition	%	5.18
	8115969	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@@H]3CCCN3)c21.O=C(O)C(F)(F)F		CHEMBL1909375	=	Inhibition	%	2.16	CHEMBL4454	Homo sapiens	Inhibition	%	2.16
	8116128	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)(CO)CNC(=O)c1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL410072	=	Inhibition	%	3.82	CHEMBL4454	Homo sapiens	Inhibition	%	3.82
	8116331	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL192417	=	Inhibition	%	9.59	CHEMBL4454	Homo sapiens	Inhibition	%	9.59
	8116555	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794066	=	Inhibition	%	1.43	CHEMBL4454	Homo sapiens	Inhibition	%	1.43
	8116689	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2nc(C)c3c(N/N=C(\C)c4ccncc4)ncnc32)c1		CHEMBL442363	=	Inhibition	%	4.36	CHEMBL4454	Homo sapiens	Inhibition	%	4.36
	8116861	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncc(-c2cccc(S(N)(=O)=O)c2)c2scc(-c3ccc(F)c(Cl)c3)c12		CHEMBL241517	=	Inhibition	%	10.89	CHEMBL4454	Homo sapiens	Inhibition	%	10.89
	8117085	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	Nc1ncc(-c2cccc(S(N)(=O)=O)c2)c2scc(-c3ccc(F)c(Cl)c3)c12		CHEMBL241517	=	Inhibition	%	45.82	CHEMBL4454	Homo sapiens	Inhibition	%	45.82
	8117256	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccoc1-c1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909388	=	Inhibition	%	12.6	CHEMBL4454	Homo sapiens	Inhibition	%	12.6
	8117414	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OCCNC)cc21.Cl		CHEMBL1909350	=	Inhibition	%	0.15	CHEMBL4454	Homo sapiens	Inhibition	%	0.15
	8117638	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OCCNC)cc21.Cl		CHEMBL1909350	=	Inhibition	%	3.62	CHEMBL4454	Homo sapiens	Inhibition	%	3.62
	8117768	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2)o1.Cl		CHEMBL529066	=	Inhibition	%	2.49	CHEMBL4454	Homo sapiens	Inhibition	%	2.49
	8118130	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(F)c(F)c3)n2)cc1		CHEMBL1785004	=	Inhibition	%	2.76	CHEMBL4454	Homo sapiens	Inhibition	%	2.76
	8118246	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	NC(=O)CCc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785003	=	Inhibition	%	-0.62	CHEMBL4454	Homo sapiens	Inhibition	%	-0.62
	8118470	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	COc1c(C(N)=O)cc(-c2ccc(Cl)cc2)cc1-c1ccc(S(N)(=O)=O)cc1		CHEMBL268885	=	Inhibition	%	0.21	CHEMBL4454	Homo sapiens	Inhibition	%	0.21
	8118642	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)o1.Cl		CHEMBL1909387	=	Inhibition	%	3.55	CHEMBL4454	Homo sapiens	Inhibition	%	3.55
	8118778	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5ccco5)cc34)cc2Cl)c1		CHEMBL514938	=	Inhibition	%	3.8	CHEMBL4454	Homo sapiens	Inhibition	%	3.8
	8119002	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5ccco5)cc34)cc2Cl)c1		CHEMBL514938	=	Inhibition	%	8.35	CHEMBL4454	Homo sapiens	Inhibition	%	8.35
	8119049	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCCCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477978	=	Inhibition	%	5.25	CHEMBL4454	Homo sapiens	Inhibition	%	5.25
	8119273	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C)c(NC(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL511765	=	Inhibition	%	0.83	CHEMBL4454	Homo sapiens	Inhibition	%	0.83
	8119432	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL588025	=	Inhibition	%	24.41	CHEMBL4454	Homo sapiens	Inhibition	%	24.41
	8119599	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL205765	=	Inhibition	%	4.5	CHEMBL4454	Homo sapiens	Inhibition	%	4.5
	8119823	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL205765	=	Inhibition	%	3.79	CHEMBL4454	Homo sapiens	Inhibition	%	3.79
	8119942	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)cs1.Cl		CHEMBL1909355	=	Inhibition	%	5.78	CHEMBL4454	Homo sapiens	Inhibition	%	5.78
	8120305	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c(-c3ccc(C(F)(F)F)cc3)nn2n1		CHEMBL188247	=	Inhibition	%	4.97	CHEMBL4454	Homo sapiens	Inhibition	%	4.97
	8120465	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	CC(C)(CO)CNC(=O)c1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL410072	=	Inhibition	%	22.19	CHEMBL4454	Homo sapiens	Inhibition	%	22.19
	8120890	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794066	=	Inhibition	%	4.57	CHEMBL4454	Homo sapiens	Inhibition	%	4.57
	8121018	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc2c(c1)NC(=O)/C2=N/Nc1ccc(S(N)(=O)=O)cc1		CHEMBL271594	=	Inhibition	%	2.93	CHEMBL4454	Homo sapiens	Inhibition	%	2.93
	8121414	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(Cc5ccccc5)cc4)c3s2)C1)N1CCOCC1		CHEMBL1909409	=	Inhibition	%	5.25	CHEMBL4454	Homo sapiens	Inhibition	%	5.25
	8121581	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cccc(CCc4ccncc4)c32)cc1		CHEMBL1909399	=	Inhibition	%	4.48	CHEMBL4454	Homo sapiens	Inhibition	%	4.48
	8121968	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1Br		CHEMBL518953	=	Inhibition	%	1.44	CHEMBL4454	Homo sapiens	Inhibition	%	1.44
	8122089	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2)o1.Cl		CHEMBL529066	=	Inhibition	%	11.53	CHEMBL4454	Homo sapiens	Inhibition	%	11.53
	8122313	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL247228	=	Inhibition	%	0.42	CHEMBL4454	Homo sapiens	Inhibition	%	0.42
	8122451	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(F)c(F)c3)n2)cc1		CHEMBL1785004	=	Inhibition	%	3.69	CHEMBL4454	Homo sapiens	Inhibition	%	3.69
	8122795	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	COc1c(C(N)=O)cc(-c2ccc(Cl)cc2)cc1-c1ccc(S(N)(=O)=O)cc1		CHEMBL268885	=	Inhibition	%	2.86	CHEMBL4454	Homo sapiens	Inhibition	%	2.86
	8122962	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(F)c3)n2)cc1		CHEMBL14014	=	Inhibition	%	7.37	CHEMBL4454	Homo sapiens	Inhibition	%	7.37
	8123328	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	=	Inhibition	%	4.79	CHEMBL4454	Homo sapiens	Inhibition	%	4.79
	8123606	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C)c(NC(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL511765	=	Inhibition	%	2.7	CHEMBL4454	Homo sapiens	Inhibition	%	2.7
	8123756	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3-c2ccccc2)ccc1O		CHEMBL1789961	=	Inhibition	%	12.81	CHEMBL4454	Homo sapiens	Inhibition	%	12.81
	8124147	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2cnc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL204934	=	Inhibition	%	6.79	CHEMBL4454	Homo sapiens	Inhibition	%	6.79
	8124266	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)cs1.Cl		CHEMBL1909355	=	Inhibition	%	10.63	CHEMBL4454	Homo sapiens	Inhibition	%	10.63
	8124490	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL187081	=	Inhibition	%	7.08	CHEMBL4454	Homo sapiens	Inhibition	%	7.08
	8124629	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c(-c3ccc(C(F)(F)F)cc3)nn2n1		CHEMBL188247	=	Inhibition	%	18.43	CHEMBL4454	Homo sapiens	Inhibition	%	18.43
	8124794	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc5ccccc5)c4)c3s2)C1)N1CCOCC1		CHEMBL1909408	=	Inhibition	%	2.54	CHEMBL4454	Homo sapiens	Inhibition	%	2.54
	8125018	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc5ccccc5)c4)c3s2)C1)N1CCOCC1		CHEMBL1909408	=	Inhibition	%	11.25	CHEMBL4454	Homo sapiens	Inhibition	%	11.25
	8125219	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	CCc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL428877	=	Inhibition	%	2.39	CHEMBL4454	Homo sapiens	Inhibition	%	2.39
	8125349	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc2c(c1)NC(=O)/C2=N/Nc1ccc(S(N)(=O)=O)cc1		CHEMBL271594	=	Inhibition	%	15.5	CHEMBL4454	Homo sapiens	Inhibition	%	15.5
	8125573	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nnc(-c3cccnc3)cc12)C1CC1.O=C(O)C(F)(F)F		CHEMBL1909343	=	Inhibition	%	2.57	CHEMBL4454	Homo sapiens	Inhibition	%	2.57
	8125741	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(Cc5ccccc5)cc4)c3s2)C1)N1CCOCC1		CHEMBL1909409	=	Inhibition	%	20.79	CHEMBL4454	Homo sapiens	Inhibition	%	20.79
	8125905	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cccc(CCc4ccncc4)c32)cc1		CHEMBL1909399	=	Inhibition	%	10.82	CHEMBL4454	Homo sapiens	Inhibition	%	10.82
	8126129	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(C(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.Cl		CHEMBL1909345	=	Inhibition	%	1.72	CHEMBL4454	Homo sapiens	Inhibition	%	1.72
	8126293	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1Br		CHEMBL518953	=	Inhibition	%	6.14	CHEMBL4454	Homo sapiens	Inhibition	%	6.14
	8126632	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL247228	=	Inhibition	%	11.36	CHEMBL4454	Homo sapiens	Inhibition	%	11.36
	8126768	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL271595	=	Inhibition	%	2.87	CHEMBL4454	Homo sapiens	Inhibition	%	2.87
	8127114	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Oc4ccccc4)cc3)n2)cc1		CHEMBL13868	=	Inhibition	%	-0.13	CHEMBL4454	Homo sapiens	Inhibition	%	-0.13
	8127281	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(F)c3)n2)cc1		CHEMBL14014	=	Inhibition	%	12.12	CHEMBL4454	Homo sapiens	Inhibition	%	12.12
	8127505	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(F)c3)o2)c1		CHEMBL179465	=	Inhibition	%	40.24	CHEMBL4454	Homo sapiens	Inhibition	%	40.24
	8127647	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	=	Inhibition	%	14.59	CHEMBL4454	Homo sapiens	Inhibition	%	14.59
	8127935	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(Oc5ccccc5)c4)n3n2)cc(OC)c1OC		CHEMBL519881	=	Inhibition	%	0.02	CHEMBL4454	Homo sapiens	Inhibition	%	0.02
	8128087	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3-c2ccccc2)ccc1O		CHEMBL1789961	=	Inhibition	%	49.63	CHEMBL4454	Homo sapiens	Inhibition	%	49.63
	8128311	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)N(C)C)c1		CHEMBL220244	=	Inhibition	%	2.92	CHEMBL4454	Homo sapiens	Inhibition	%	2.92
	8128478	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2cnc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL204934	=	Inhibition	%	18.99	CHEMBL4454	Homo sapiens	Inhibition	%	18.99
	8128821	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL187081	=	Inhibition	%	19.33	CHEMBL4454	Homo sapiens	Inhibition	%	19.33
	8128958	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL352222	=	Inhibition	%	2.75	CHEMBL4454	Homo sapiens	Inhibition	%	2.75
	8129353	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2cc(-c3ccc4c(c3)CCC4=NO)c(-c3ccncc3)o2)cc1.Cl		CHEMBL1794072	=	Inhibition	%	1.5	CHEMBL4454	Homo sapiens	Inhibition	%	1.5
	8129542	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	CCc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL428877	=	Inhibition	%	6.95	CHEMBL4454	Homo sapiens	Inhibition	%	6.95
	8129905	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nnc(-c3cccnc3)cc12)C1CC1.O=C(O)C(F)(F)F		CHEMBL1909343	=	Inhibition	%	2.95	CHEMBL4454	Homo sapiens	Inhibition	%	2.95
	8130066	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)CNc1nccc(-c2cnn3ncccc23)n1		CHEMBL446024	=	Inhibition	%	2.09	CHEMBL4454	Homo sapiens	Inhibition	%	2.09
	8130462	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(C(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.Cl		CHEMBL1909345	=	Inhibition	%	3.35	CHEMBL4454	Homo sapiens	Inhibition	%	3.35
	8130622	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	CCN(CC)Cc1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL1882194	=	Inhibition	%	2.7	CHEMBL4454	Homo sapiens	Inhibition	%	2.7
	8130962	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL418348	=	Inhibition	%	1.66	CHEMBL4454	Homo sapiens	Inhibition	%	1.66
	8131101	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL271595	=	Inhibition	%	21.55	CHEMBL4454	Homo sapiens	Inhibition	%	21.55
	8131325	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL417804	=	Inhibition	%	3.48	CHEMBL4454	Homo sapiens	Inhibition	%	3.48
	8131445	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Oc4ccccc4)cc3)n2)cc1		CHEMBL13868	=	Inhibition	%	4.83	CHEMBL4454	Homo sapiens	Inhibition	%	4.83
	8131836	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(F)c3)o2)c1		CHEMBL179465	=	Inhibition	%	76.24	CHEMBL4454	Homo sapiens	Inhibition	%	76.24
	8131977	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL273564	=	Inhibition	%	3.07	CHEMBL4454	Homo sapiens	Inhibition	%	3.07
	8132263	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(Oc5ccccc5)c4)n3n2)cc(OC)c1OC		CHEMBL519881	=	Inhibition	%	4.22	CHEMBL4454	Homo sapiens	Inhibition	%	4.22
	8132634	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)N(C)C)c1		CHEMBL220244	=	Inhibition	%	9.21	CHEMBL4454	Homo sapiens	Inhibition	%	9.21
	8132802	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2Cl)c1		CHEMBL218970	=	Inhibition	%	5.13	CHEMBL4454	Homo sapiens	Inhibition	%	5.13
	8133147	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	Clc1ccc(CNc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL513330	=	Inhibition	%	3.59	CHEMBL4454	Homo sapiens	Inhibition	%	3.59
	8133285	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL352222	=	Inhibition	%	3.7	CHEMBL4454	Homo sapiens	Inhibition	%	3.7
	8133509	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062289	=	Inhibition	%	2.47	CHEMBL4454	Homo sapiens	Inhibition	%	2.47
	8133681	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2cc(-c3ccc4c(c3)CCC4=NO)c(-c3ccncc3)o2)cc1.Cl		CHEMBL1794072	=	Inhibition	%	7.33	CHEMBL4454	Homo sapiens	Inhibition	%	7.33
	8133861	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(N(C)c4ccnc(Nc5ccc(CS(C)(=O)=O)cc5)n4)cc3)cc2)CC1.Cl		CHEMBL1909360	=	Inhibition	%	5.31	CHEMBL4454	Homo sapiens	Inhibition	%	5.31
	8134233	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2cc3c(N)ncnc3o2)cc1		CHEMBL373073	=	Inhibition	%	1.49	CHEMBL4454	Homo sapiens	Inhibition	%	1.49
	8134393	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)CNc1nccc(-c2cnn3ncccc23)n1		CHEMBL446024	=	Inhibition	%	3.01	CHEMBL4454	Homo sapiens	Inhibition	%	3.01
	8134617	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccoc2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477583	=	Inhibition	%	2.23	CHEMBL4454	Homo sapiens	Inhibition	%	2.23
	8134801	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(N/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL1794058	=	Inhibition	%	1.13	CHEMBL4454	Homo sapiens	Inhibition	%	1.13
	8134961	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	CCN(CC)Cc1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL1882194	=	Inhibition	%	11.35	CHEMBL4454	Homo sapiens	Inhibition	%	11.35
	8135300	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL418348	=	Inhibition	%	2.81	CHEMBL4454	Homo sapiens	Inhibition	%	2.81
	8135665	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL417804	=	Inhibition	%	4.97	CHEMBL4454	Homo sapiens	Inhibition	%	4.97
	8135786	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL269450	=	Inhibition	%	0.72	CHEMBL4454	Homo sapiens	Inhibition	%	0.72
	8136010	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL269450	=	Inhibition	%	1.58	CHEMBL4454	Homo sapiens	Inhibition	%	1.58
	8136178	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(/C=N/Nc2ncnc3c2cnn3-c2cccc(OC)c2)c1		CHEMBL305477	=	Inhibition	%	1.37	CHEMBL4454	Homo sapiens	Inhibition	%	1.37
	8136322	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL273564	=	Inhibition	%	25.13	CHEMBL4454	Homo sapiens	Inhibition	%	25.13
	8136546	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc4c(c3)OCO4)n2)cc1		CHEMBL273611	=	Inhibition	%	3.23	CHEMBL4454	Homo sapiens	Inhibition	%	3.23
	8136612	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C)c(N(C)C(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL467581	=	Inhibition	%	0.53	CHEMBL4454	Homo sapiens	Inhibition	%	0.53
	8136971	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(Cl)c(Cl)c2)CC(=O)N1		CHEMBL374453	=	Inhibition	%	1.97	CHEMBL4454	Homo sapiens	Inhibition	%	1.97
	8137134	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2Cl)c1		CHEMBL218970	=	Inhibition	%	9.91	CHEMBL4454	Homo sapiens	Inhibition	%	9.91
	8137358	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	CCCNc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL67241	=	Inhibition	%	18.89	CHEMBL4454	Homo sapiens	Inhibition	%	18.89
	8137478	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	Clc1ccc(CNc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL513330	=	Inhibition	%	4.0	CHEMBL4454	Homo sapiens	Inhibition	%	4.0
	8137850	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062289	=	Inhibition	%	1.19	CHEMBL4454	Homo sapiens	Inhibition	%	1.19
	8138016	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccccc2F)sc2c1CCCC2		CHEMBL234838	=	Inhibition	%	1.26	CHEMBL4454	Homo sapiens	Inhibition	%	1.26
	8138195	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(N(C)c4ccnc(Nc5ccc(CS(C)(=O)=O)cc5)n4)cc3)cc2)CC1.Cl		CHEMBL1909360	=	Inhibition	%	26.32	CHEMBL4454	Homo sapiens	Inhibition	%	26.32
	8138419	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)cs1.Cl		CHEMBL1909356	=	Inhibition	%	2.47	CHEMBL4454	Homo sapiens	Inhibition	%	2.47
	8138567	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2cc3c(N)ncnc3o2)cc1		CHEMBL373073	=	Inhibition	%	7.14	CHEMBL4454	Homo sapiens	Inhibition	%	7.14
	8138949	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccoc2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477583	=	Inhibition	%	3.07	CHEMBL4454	Homo sapiens	Inhibition	%	3.07
	8139134	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(N/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL1794058	=	Inhibition	%	15.03	CHEMBL4454	Homo sapiens	Inhibition	%	15.03
	8139293	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(-c2ccccn2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909354	=	Inhibition	%	2.37	CHEMBL4454	Homo sapiens	Inhibition	%	2.37
	8139517	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(-c2ccccn2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909354	=	Inhibition	%	18.24	CHEMBL4454	Homo sapiens	Inhibition	%	18.24
	8139631	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(C(F)(F)F)c4)c3c2)o1.Cl		CHEMBL1909389	=	Inhibition	%	1.98	CHEMBL4454	Homo sapiens	Inhibition	%	1.98
	8139996	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909390	=	Inhibition	%	3.65	CHEMBL4454	Homo sapiens	Inhibition	%	3.65
	8140343	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	O=C([O-])c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1.[Li+]		CHEMBL1909401	=	Inhibition	%	0.55	CHEMBL4454	Homo sapiens	Inhibition	%	0.55
	8140502	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(/C=N/Nc2ncnc3c2cnn3-c2cccc(OC)c2)c1		CHEMBL305477	=	Inhibition	%	8.08	CHEMBL4454	Homo sapiens	Inhibition	%	8.08
	8140869	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc4c(c3)OCO4)n2)cc1		CHEMBL273611	=	Inhibition	%	7.38	CHEMBL4454	Homo sapiens	Inhibition	%	7.38
	8140947	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C)c(N(C)C(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL467581	=	Inhibition	%	2.0	CHEMBL4454	Homo sapiens	Inhibition	%	2.0
	8141171	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(N3CCc4ccccc43)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL458415	=	Inhibition	%	-0.2	CHEMBL4454	Homo sapiens	Inhibition	%	-0.2
	8141301	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(Cl)c(Cl)c2)CC(=O)N1		CHEMBL374453	=	Inhibition	%	6.08	CHEMBL4454	Homo sapiens	Inhibition	%	6.08
	8141685	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	CCCNc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL67241	=	Inhibition	%	51.98	CHEMBL4454	Homo sapiens	Inhibition	%	51.98
	8141804	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(C)cccc2C)c1		CHEMBL218859	=	Inhibition	%	6.6	CHEMBL4454	Homo sapiens	Inhibition	%	6.6
	8142028	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(C)cccc2C)c1		CHEMBL218859	=	Inhibition	%	29.57	CHEMBL4454	Homo sapiens	Inhibition	%	29.57
	8142189	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL188257	=	Inhibition	%	47.86	CHEMBL4454	Homo sapiens	Inhibition	%	47.86
	8142357	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccccc2F)sc2c1CCCC2		CHEMBL234838	=	Inhibition	%	1.21	CHEMBL4454	Homo sapiens	Inhibition	%	1.21
	8142757	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)cs1.Cl		CHEMBL1909356	=	Inhibition	%	4.41	CHEMBL4454	Homo sapiens	Inhibition	%	4.41
	8142906	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC(C)C)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477979	=	Inhibition	%	-1.7	CHEMBL4454	Homo sapiens	Inhibition	%	-1.7
	8143285	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)cc1		CHEMBL205966	=	Inhibition	%	3.78	CHEMBL4454	Homo sapiens	Inhibition	%	3.78
	8143472	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccc(I)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1880739	=	Inhibition	%	0.14	CHEMBL4454	Homo sapiens	Inhibition	%	0.14
	8143855	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)c(-c3ccccc3)nn2n1		CHEMBL434729	=	Inhibition	%	36.81	CHEMBL4454	Homo sapiens	Inhibition	%	36.81
	8143969	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(C(F)(F)F)c4)c3c2)o1.Cl		CHEMBL1909389	=	Inhibition	%	4.93	CHEMBL4454	Homo sapiens	Inhibition	%	4.93
	8144193	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Br)c4)c3c2)o1.Cl		CHEMBL1909392	=	Inhibition	%	4.84	CHEMBL4454	Homo sapiens	Inhibition	%	4.84
	8144332	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909390	=	Inhibition	%	6.21	CHEMBL4454	Homo sapiens	Inhibition	%	6.21
	8144686	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	O=C([O-])c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1.[Li+]		CHEMBL1909401	=	Inhibition	%	0.29	CHEMBL4454	Homo sapiens	Inhibition	%	0.29
	8144839	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccc(S(=O)(=O)N3CCCC3)cc2)c1N		CHEMBL230592	=	Inhibition	%	0.33	CHEMBL4454	Homo sapiens	Inhibition	%	0.33
	8145200	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=S(=O)(CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL1909395	=	Inhibition	%	2.78	CHEMBL4454	Homo sapiens	Inhibition	%	2.78
	8145513	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(N3CCc4ccccc43)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL458415	=	Inhibition	%	3.44	CHEMBL4454	Homo sapiens	Inhibition	%	3.44
	8145637	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)ccc12)C1CC1		CHEMBL101804	=	Inhibition	%	0.22	CHEMBL4454	Homo sapiens	Inhibition	%	0.22
	8145861	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)ccc12)C1CC1		CHEMBL101804	=	Inhibition	%	4.92	CHEMBL4454	Homo sapiens	Inhibition	%	4.92
	8146022	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2c(Cl)cccc2Cl)cc1)c1ccnc(Nc2cccc(CS(C)(=O)=O)c2)n1		CHEMBL189353	=	Inhibition	%	24.31	CHEMBL4454	Homo sapiens	Inhibition	%	24.31
	8146366	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Sc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.O=S(=O)(O)O		CHEMBL1909365	=	Inhibition	%	1.66	CHEMBL4454	Homo sapiens	Inhibition	%	1.66
	8146526	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL188257	=	Inhibition	%	79.76	CHEMBL4454	Homo sapiens	Inhibition	%	79.76
	8146693	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1794068	=	Inhibition	%	2.16	CHEMBL4454	Homo sapiens	Inhibition	%	2.16
	8146917	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1794068	=	Inhibition	%	13.41	CHEMBL4454	Homo sapiens	Inhibition	%	13.41
	8147086	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1.O=C(O)/C=C\C(=O)O		CHEMBL1909347	=	Inhibition	%	1.32	CHEMBL4454	Homo sapiens	Inhibition	%	1.32
	8147228	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC(C)C)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477979	=	Inhibition	%	-1.1	CHEMBL4454	Homo sapiens	Inhibition	%	-1.1
	8147452	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1cccc(Nc2nccc(-c3cnn4nc(-c5ccccc5)ccc34)n2)c1		CHEMBL189415	=	Inhibition	%	2.98	CHEMBL4454	Homo sapiens	Inhibition	%	2.98
	8147605	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	Nc1ccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)cc1		CHEMBL205966	=	Inhibition	%	4.78	CHEMBL4454	Homo sapiens	Inhibition	%	4.78
	8147792	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccc(I)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1880739	=	Inhibition	%	3.52	CHEMBL4454	Homo sapiens	Inhibition	%	3.52
	8148016	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1ccc2c(c1)C(=Cc1cc(Br)c(O)c(Br)c1)C(=O)N2		CHEMBL1794052	=	Inhibition	%	0.15	CHEMBL4454	Homo sapiens	Inhibition	%	0.15
	8148174	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)c(-c3ccccc3)nn2n1		CHEMBL434729	=	Inhibition	%	71.01	CHEMBL4454	Homo sapiens	Inhibition	%	71.01
	8148512	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Br)c4)c3c2)o1.Cl		CHEMBL1909392	=	Inhibition	%	10.79	CHEMBL4454	Homo sapiens	Inhibition	%	10.79
	8148651	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)(C)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275200	=	Inhibition	%	2.61	CHEMBL4454	Homo sapiens	Inhibition	%	2.61
	8148875	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	CC(C)(C)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275200	=	Inhibition	%	9.73	CHEMBL4454	Homo sapiens	Inhibition	%	9.73
	8149013	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275724	=	Inhibition	%	1.87	CHEMBL4454	Homo sapiens	Inhibition	%	1.87
	8149172	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccc(S(=O)(=O)N3CCCC3)cc2)c1N		CHEMBL230592	=	Inhibition	%	2.93	CHEMBL4454	Homo sapiens	Inhibition	%	2.93
	8149396	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCN(CC#N)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL384407	=	Inhibition	%	0.96	CHEMBL4454	Homo sapiens	Inhibition	%	0.96
	8149530	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	Cl.O=S(=O)(CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL1909395	=	Inhibition	%	5.07	CHEMBL4454	Homo sapiens	Inhibition	%	5.07
	8149852	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)Oc1cc(C)c(/C=C/c2cncc(C(=O)NC)c2)c(C)c1		CHEMBL218932	=	Inhibition	%	3.83	CHEMBL4454	Homo sapiens	Inhibition	%	3.83
	8150201	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccco4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909368	=	Inhibition	%	1.62	CHEMBL4454	Homo sapiens	Inhibition	%	1.62
	8150361	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2c(Cl)cccc2Cl)cc1)c1ccnc(Nc2cccc(CS(C)(=O)=O)c2)n1		CHEMBL189353	=	Inhibition	%	51.88	CHEMBL4454	Homo sapiens	Inhibition	%	51.88
	8150705	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Sc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.O=S(=O)(O)O		CHEMBL1909365	=	Inhibition	%	3.71	CHEMBL4454	Homo sapiens	Inhibition	%	3.71
	8150870	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2		CHEMBL456252	=	Inhibition	%	7.89	CHEMBL4454	Homo sapiens	Inhibition	%	7.89
	8151257	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2[nH]ncc2c1		CHEMBL495902	=	Inhibition	%	-1.47	CHEMBL4454	Homo sapiens	Inhibition	%	-1.47
	8151434	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1.O=C(O)/C=C\C(=O)O		CHEMBL1909347	=	Inhibition	%	3.79	CHEMBL4454	Homo sapiens	Inhibition	%	3.79
	8151796	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1cccc(Nc2nccc(-c3cnn4nc(-c5ccccc5)ccc34)n2)c1		CHEMBL189415	=	Inhibition	%	8.69	CHEMBL4454	Homo sapiens	Inhibition	%	8.69
	8151950	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL186213	=	Inhibition	%	10.16	CHEMBL4454	Homo sapiens	Inhibition	%	10.16
	8152362	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1ccc2c(c1)C(=Cc1cc(Br)c(O)c(Br)c1)C(=O)N2		CHEMBL1794052	=	Inhibition	%	9.32	CHEMBL4454	Homo sapiens	Inhibition	%	9.32
	8152520	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL318728	=	Inhibition	%	5.98	CHEMBL4454	Homo sapiens	Inhibition	%	5.98
	8152858	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2nccc(N(C)c3ccc4c(C)n[nH]c4c3)n2)c1.Cl		CHEMBL1909358	=	Inhibition	%	23.05	CHEMBL4454	Homo sapiens	Inhibition	%	23.05
	8153221	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	5.67	CHEMBL4454	Homo sapiens	Inhibition	%	5.67
	8153358	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275724	=	Inhibition	%	3.62	CHEMBL4454	Homo sapiens	Inhibition	%	3.62
	8153739	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCN(CC#N)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL384407	=	Inhibition	%	1.68	CHEMBL4454	Homo sapiens	Inhibition	%	1.68
	8153872	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)NCCNC)c21		CHEMBL506153	=	Inhibition	%	1.3	CHEMBL4454	Homo sapiens	Inhibition	%	1.3
	8154096	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)NCCNC)c21		CHEMBL506153	=	Inhibition	%	4.66	CHEMBL4454	Homo sapiens	Inhibition	%	4.66
	8154193	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)Oc1cc(C)c(/C=C/c2cncc(C(=O)NC)c2)c(C)c1		CHEMBL218932	=	Inhibition	%	24.56	CHEMBL4454	Homo sapiens	Inhibition	%	24.56
	8154543	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccco4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909368	=	Inhibition	%	9.51	CHEMBL4454	Homo sapiens	Inhibition	%	9.51
	8154702	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207410	=	Inhibition	%	4.48	CHEMBL4454	Homo sapiens	Inhibition	%	4.48
	8155046	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476351	=	Inhibition	%	0.72	CHEMBL4454	Homo sapiens	Inhibition	%	0.72
	8155222	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2		CHEMBL456252	=	Inhibition	%	10.65	CHEMBL4454	Homo sapiens	Inhibition	%	10.65
	8155446	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909402	=	Inhibition	%	2.64	CHEMBL4454	Homo sapiens	Inhibition	%	2.64
	8155607	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2[nH]ncc2c1		CHEMBL495902	=	Inhibition	%	1.41	CHEMBL4454	Homo sapiens	Inhibition	%	1.41
	8155785	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	CCc1nn2ncccc2c1-c1ccnc(NC2CC2)n1		CHEMBL524057	=	Inhibition	%	3.49	CHEMBL4454	Homo sapiens	Inhibition	%	3.49
	8156009	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	CCc1nn2ncccc2c1-c1ccnc(NC2CC2)n1		CHEMBL524057	=	Inhibition	%	3.74	CHEMBL4454	Homo sapiens	Inhibition	%	3.74
	8156147	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL183993	=	Inhibition	%	2.53	CHEMBL4454	Homo sapiens	Inhibition	%	2.53
	8156359	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL381604	=	Inhibition	%	4.81	CHEMBL4454	Homo sapiens	Inhibition	%	4.81
	8156733	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(C(C)=O)c3)o2)c1		CHEMBL191705	=	Inhibition	%	44.36	CHEMBL4454	Homo sapiens	Inhibition	%	44.36
	8156876	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL194062	=	Inhibition	%	2.45	CHEMBL4454	Homo sapiens	Inhibition	%	2.45
	8157100	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL194062	=	Inhibition	%	10.09	CHEMBL4454	Homo sapiens	Inhibition	%	10.09
	8157220	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]nc(C)c3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL218720	=	Inhibition	%	1.2	CHEMBL4454	Homo sapiens	Inhibition	%	1.2
	8157585	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(C(F)(F)F)c4)n3n2)cc(OC)c1OC		CHEMBL520037	=	Inhibition	%	7.22	CHEMBL4454	Homo sapiens	Inhibition	%	7.22
	8157715	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccccc4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909374	=	Inhibition	%	7.53	CHEMBL4454	Homo sapiens	Inhibition	%	7.53
	8157939	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1C1=C(Nc2ccccc2)C(=O)NC1=O		CHEMBL156263	=	Inhibition	%	4.72	CHEMBL4454	Homo sapiens	Inhibition	%	4.72
	8158100	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Inhibition	%	4.25	CHEMBL4454	Homo sapiens	Inhibition	%	4.25
	8158350	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc(S(C)(=O)=O)cc4C)n3C)ccc2c1		CHEMBL237571	=	Inhibition	%	4.62	CHEMBL4454	Homo sapiens	Inhibition	%	4.62
	8158508	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477182	=	Inhibition	%	1.54	CHEMBL4454	Homo sapiens	Inhibition	%	1.54
	8158732	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477182	=	Inhibition	%	6.32	CHEMBL4454	Homo sapiens	Inhibition	%	6.32
	8158901	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3cc(F)ccc3F)ccc12)C1CC1		CHEMBL261440	=	Inhibition	%	3.33	CHEMBL4454	Homo sapiens	Inhibition	%	3.33
	8159260	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1)N1CCOCC1		CHEMBL507329	=	Inhibition	%	4.25	CHEMBL4454	Homo sapiens	Inhibition	%	4.25
	8159380	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2cc(Cl)c3[nH]ncc3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL427058	=	Inhibition	%	4.88	CHEMBL4454	Homo sapiens	Inhibition	%	4.88
	8159735	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3cccc(O)c3)n[nH]2)cc1		CHEMBL103104	=	Inhibition	%	6.79	CHEMBL4454	Homo sapiens	Inhibition	%	6.79
	8159876	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(-c2nc3n(c2-c2ccc4c(c2)OCO4)CCC3)nc1		CHEMBL1909377	=	Inhibition	%	-0.63	CHEMBL4454	Homo sapiens	Inhibition	%	-0.63
	8160100	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(-c2nc3n(c2-c2ccc4c(c2)OCO4)CCC3)nc1		CHEMBL1909377	=	Inhibition	%	0.17	CHEMBL4454	Homo sapiens	Inhibition	%	0.17
	8160237	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)CN2CCOCC2)sc2c1CCCC2.O=C(O)C(=O)O		CHEMBL1909342	=	Inhibition	%	2.52	CHEMBL4454	Homo sapiens	Inhibition	%	2.52
	8160611	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL1888586	=	Inhibition	%	1.87	CHEMBL4454	Homo sapiens	Inhibition	%	1.87
	8160681	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(-c2cc3c(NC(=O)C4CC4)ncnc3o2)cc1		CHEMBL182283	=	Inhibition	%	2.06	CHEMBL4454	Homo sapiens	Inhibition	%	2.06
	8160905	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(-c2cc3c(NC(=O)C4CC4)ncnc3o2)cc1		CHEMBL182283	=	Inhibition	%	13.3	CHEMBL4454	Homo sapiens	Inhibition	%	13.3
	8161055	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)NCCN2CCOCC2)cc1)c1ccnc(Nc2ccc(CS(C)(=O)=O)cc2)n1.Cl		CHEMBL1909361	=	Inhibition	%	3.44	CHEMBL4454	Homo sapiens	Inhibition	%	3.44
	8161422	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c2c1		CHEMBL361894	=	Inhibition	%	4.29	CHEMBL4454	Homo sapiens	Inhibition	%	4.29
	8161547	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]nc(C)c3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL218720	=	Inhibition	%	3.75	CHEMBL4454	Homo sapiens	Inhibition	%	3.75
	8161771	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cccc(O)c1		CHEMBL160937	=	Inhibition	%	1.27	CHEMBL4454	Homo sapiens	Inhibition	%	1.27
	8161909	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(C(F)(F)F)c4)n3n2)cc(OC)c1OC		CHEMBL520037	=	Inhibition	%	14.01	CHEMBL4454	Homo sapiens	Inhibition	%	14.01
	8162263	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1C1=C(Nc2ccccc2)C(=O)NC1=O		CHEMBL156263	=	Inhibition	%	8.83	CHEMBL4454	Homo sapiens	Inhibition	%	8.83
	8162423	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(CCCNc2nc3ccc(Oc4ccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)cc4)cc3[nH]2)CC1.Cl		CHEMBL1909372	=	Inhibition	%	1.31	CHEMBL4454	Homo sapiens	Inhibition	%	1.31
	8162676	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CC[C@H](N)C3)c21.Cl		CHEMBL1909384	=	Inhibition	%	3.4	CHEMBL4454	Homo sapiens	Inhibition	%	3.4
	8163048	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(NC=C2C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL1794055	=	Inhibition	%	6.25	CHEMBL4454	Homo sapiens	Inhibition	%	6.25
	8163217	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3cc(F)ccc3F)ccc12)C1CC1		CHEMBL261440	=	Inhibition	%	7.71	CHEMBL4454	Homo sapiens	Inhibition	%	7.71
	8163575	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1)N1CCOCC1		CHEMBL507329	=	Inhibition	%	1.43	CHEMBL4454	Homo sapiens	Inhibition	%	1.43
	8163698	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2c(-c3ccncc3)nc3n2CCS3)cc1		CHEMBL266707	=	Inhibition	%	2.37	CHEMBL4454	Homo sapiens	Inhibition	%	2.37
	8163922	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2c(-c3ccncc3)nc3n2CCS3)cc1		CHEMBL266707	=	Inhibition	%	2.64	CHEMBL4454	Homo sapiens	Inhibition	%	2.64
	8164056	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)C1		CHEMBL477069	=	Inhibition	%	4.94	CHEMBL4454	Homo sapiens	Inhibition	%	4.94
	8164420	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	CC1(C)CC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC(C)(C)N1		CHEMBL95502	=	Inhibition	%	0.26	CHEMBL4454	Homo sapiens	Inhibition	%	0.26
	8164575	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)CN2CCOCC2)sc2c1CCCC2.O=C(O)C(=O)O		CHEMBL1909342	=	Inhibition	%	4.31	CHEMBL4454	Homo sapiens	Inhibition	%	4.31
	8164943	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL1888586	=	Inhibition	%	16.51	CHEMBL4454	Homo sapiens	Inhibition	%	16.51
	8165237	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1ncccc1Nc1nc(Nc2cc3c(cc2OC)CCCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL1895450	=	Inhibition	%	1.73	CHEMBL4454	Homo sapiens	Inhibition	%	1.73
	8165378	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)NCCN2CCOCC2)cc1)c1ccnc(Nc2ccc(CS(C)(=O)=O)cc2)n1.Cl		CHEMBL1909361	=	Inhibition	%	11.35	CHEMBL4454	Homo sapiens	Inhibition	%	11.35
	8165745	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c2c1		CHEMBL361894	=	Inhibition	%	14.52	CHEMBL4454	Homo sapiens	Inhibition	%	14.52
	8166095	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cccc(O)c1		CHEMBL160937	=	Inhibition	%	2.07	CHEMBL4454	Homo sapiens	Inhibition	%	2.07
	8166233	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1cccc(Nc2cc(-c3ccc(F)cc3)n[nH]2)c1		CHEMBL1909351	=	Inhibition	%	6.05	CHEMBL4454	Homo sapiens	Inhibition	%	6.05
	8166587	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Oc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccncc2)c1		CHEMBL1909413	=	Inhibition	%	5.71	CHEMBL4454	Homo sapiens	Inhibition	%	5.71
	8166912	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2nccc(Nc3ccc4c(C)n[nH]c4c3)n2)cc(OC)c1OC		CHEMBL479079	=	Inhibition	%	57.46	CHEMBL4454	Homo sapiens	Inhibition	%	57.46
	8167000	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CC[C@H](N)C3)c21.Cl		CHEMBL1909384	=	Inhibition	%	1.29	CHEMBL4454	Homo sapiens	Inhibition	%	1.29
	8167224	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21.Cl		CHEMBL1909363	=	Inhibition	%	4.08	CHEMBL4454	Homo sapiens	Inhibition	%	4.08
	8167365	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(NC=C2C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL1794055	=	Inhibition	%	36.23	CHEMBL4454	Homo sapiens	Inhibition	%	36.23
	8167529	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Inhibition	%	1.53	CHEMBL4454	Homo sapiens	Inhibition	%	1.53
	8167753	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Inhibition	%	5.24	CHEMBL4454	Homo sapiens	Inhibition	%	5.24
	8167886	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccc(F)cc21		CHEMBL426800	=	Inhibition	%	4.5	CHEMBL4454	Homo sapiens	Inhibition	%	4.5
	8168234	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)NC(=O)N1		CHEMBL384073	=	Inhibition	%	0.15	CHEMBL4454	Homo sapiens	Inhibition	%	0.15
	8168375	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)C1		CHEMBL477069	=	Inhibition	%	7.28	CHEMBL4454	Homo sapiens	Inhibition	%	7.28
	8168599	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1ccc2c(-c3ccnc(NCCCO)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1909404	=	Inhibition	%	3.07	CHEMBL4454	Homo sapiens	Inhibition	%	3.07
	8168735	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	CC1(C)CC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC(C)(C)N1		CHEMBL95502	=	Inhibition	%	3.54	CHEMBL4454	Homo sapiens	Inhibition	%	3.54
	8168899	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL495696	=	Inhibition	%	11.13	CHEMBL4454	Homo sapiens	Inhibition	%	11.13
	8169123	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	N#Cc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL495696	=	Inhibition	%	41.73	CHEMBL4454	Homo sapiens	Inhibition	%	41.73
	8169265	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL102936	=	Inhibition	%	1.59	CHEMBL4454	Homo sapiens	Inhibition	%	1.59
	8169569	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1ncccc1Nc1nc(Nc2cc3c(cc2OC)CCCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL1895450	=	Inhibition	%	7.26	CHEMBL4454	Homo sapiens	Inhibition	%	7.26
	8169703	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL157258	=	Inhibition	%	1.95	CHEMBL4454	Homo sapiens	Inhibition	%	1.95
	8169927	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL157258	=	Inhibition	%	3.43	CHEMBL4454	Homo sapiens	Inhibition	%	3.43
	8170072	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)cc3)c12		CHEMBL396107	=	Inhibition	%	1.01	CHEMBL4454	Homo sapiens	Inhibition	%	1.01
	8170421	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc2c1NC(=O)/C2=N\Nc1ccc(S(N)(=O)=O)cc1		CHEMBL1909398	=	Inhibition	%	0.52	CHEMBL4454	Homo sapiens	Inhibition	%	0.52
	8170561	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1cccc(Nc2cc(-c3ccc(F)cc3)n[nH]2)c1		CHEMBL1909351	=	Inhibition	%	14.42	CHEMBL4454	Homo sapiens	Inhibition	%	14.42
	8170785	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794065	=	Inhibition	%	5.04	CHEMBL4454	Homo sapiens	Inhibition	%	5.04
	8170920	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	Cl.Oc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccncc2)c1		CHEMBL1909413	=	Inhibition	%	19.52	CHEMBL4454	Homo sapiens	Inhibition	%	19.52
	8171117	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(CCCNc2nc3ccc(Oc4ccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)cc4)cc3[nH]2)CC1.Cl		CHEMBL1909372	=	Inhibition	%	8.15	CHEMBL4454	Homo sapiens	Inhibition	%	8.15
	8171341	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2nccc(Nc3ccc4c(C)n[nH]c4c3)n2)cc(OC)c1OC		CHEMBL479079	=	Inhibition	%	18.25	CHEMBL4454	Homo sapiens	Inhibition	%	18.25
	8171558	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21.Cl		CHEMBL1909363	=	Inhibition	%	5.54	CHEMBL4454	Homo sapiens	Inhibition	%	5.54
	8171699	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2(C)C		CHEMBL463931	=	Inhibition	%	1.11	CHEMBL4454	Homo sapiens	Inhibition	%	1.11
	8172076	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4cccc(F)c4)ncnc32)c1		CHEMBL69757	=	Inhibition	%	7.31	CHEMBL4454	Homo sapiens	Inhibition	%	7.31
	8172208	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccc(F)cc21		CHEMBL426800	=	Inhibition	%	1.73	CHEMBL4454	Homo sapiens	Inhibition	%	1.73
	8172432	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc2[nH]c(=O)[nH]c2c1		CHEMBL1794057	=	Inhibition	%	11.28	CHEMBL4454	Homo sapiens	Inhibition	%	11.28
	8172560	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)NC(=O)N1		CHEMBL384073	=	Inhibition	%	0.7	CHEMBL4454	Homo sapiens	Inhibition	%	0.7
	8172926	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1ccc2c(-c3ccnc(NCCCO)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1909404	=	Inhibition	%	12.06	CHEMBL4454	Homo sapiens	Inhibition	%	12.06
	8173062	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL407113	=	Inhibition	%	-1.55	CHEMBL4454	Homo sapiens	Inhibition	%	-1.55
	8173451	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL306865	=	Inhibition	%	28.99	CHEMBL4454	Homo sapiens	Inhibition	%	28.99
	8173592	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL102936	=	Inhibition	%	7.28	CHEMBL4454	Homo sapiens	Inhibition	%	7.28
	8173903	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCc4c[nH]cn4)cc32)cc1		CHEMBL272028	=	Inhibition	%	4.54	CHEMBL4454	Homo sapiens	Inhibition	%	4.54
	8174259	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1cncc(/C=C/c2c(C)cc(O)cc2C)c1		CHEMBL220243	=	Inhibition	%	5.81	CHEMBL4454	Homo sapiens	Inhibition	%	5.81
	8174407	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)cc3)c12		CHEMBL396107	=	Inhibition	%	15.87	CHEMBL4454	Homo sapiens	Inhibition	%	15.87
	8174631	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	O=C(NCC1CC1)c1ccc(-c2cccc(C(=O)NC3CC3)c2)cc1		CHEMBL479038	=	Inhibition	%	-0.78	CHEMBL4454	Homo sapiens	Inhibition	%	-0.78
	8174753	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc2c1NC(=O)/C2=N\Nc1ccc(S(N)(=O)=O)cc1		CHEMBL1909398	=	Inhibition	%	4.37	CHEMBL4454	Homo sapiens	Inhibition	%	4.37
	8175120	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794065	=	Inhibition	%	4.9	CHEMBL4454	Homo sapiens	Inhibition	%	4.9
	8175256	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL359963	=	Inhibition	%	3.66	CHEMBL4454	Homo sapiens	Inhibition	%	3.66
	8175512	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc(-n2cncn2)cc1		CHEMBL1794056	=	Inhibition	%	4.93	CHEMBL4454	Homo sapiens	Inhibition	%	4.93
	8175899	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nn(C)c2cc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)ccc12.Cl		CHEMBL1794073	=	Inhibition	%	14.76	CHEMBL4454	Homo sapiens	Inhibition	%	14.76
	8176052	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2(C)C		CHEMBL463931	=	Inhibition	%	6.75	CHEMBL4454	Homo sapiens	Inhibition	%	6.75
	8176276	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	NCc1ccc(-n2c(-c3nonc3N)nc3cnccc32)cc1		CHEMBL188268	=	Inhibition	%	1.73	CHEMBL4454	Homo sapiens	Inhibition	%	1.73
	8176425	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4cccc(F)c4)ncnc32)c1		CHEMBL69757	=	Inhibition	%	32.6	CHEMBL4454	Homo sapiens	Inhibition	%	32.6
	8176781	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc2[nH]c(=O)[nH]c2c1		CHEMBL1794057	=	Inhibition	%	26.5	CHEMBL4454	Homo sapiens	Inhibition	%	26.5
	8176911	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCn4ccnc4)cc3)c2)nc1		CHEMBL208437	=	Inhibition	%	0.78	CHEMBL4454	Homo sapiens	Inhibition	%	0.78
	8177277	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909352	=	Inhibition	%	9.4	CHEMBL4454	Homo sapiens	Inhibition	%	9.4
	8177415	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL407113	=	Inhibition	%	-0.19	CHEMBL4454	Homo sapiens	Inhibition	%	-0.19
	8177639	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c4c(c3c2c1)C(=O)NC4=O		CHEMBL1956068	=	Inhibition	%	10.82	CHEMBL4454	Homo sapiens	Inhibition	%	10.82
	8177803	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL306865	=	Inhibition	%	69.98	CHEMBL4454	Homo sapiens	Inhibition	%	69.98
	8177943	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C1Nc2ccc(-c3cccnc3)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1794050	=	Inhibition	%	1.1	CHEMBL4454	Homo sapiens	Inhibition	%	1.1
	8178167	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C1Nc2ccc(-c3cccnc3)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1794050	=	Inhibition	%	7.55	CHEMBL4454	Homo sapiens	Inhibition	%	7.55
	8178255	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCc4c[nH]cn4)cc32)cc1		CHEMBL272028	=	Inhibition	%	19.06	CHEMBL4454	Homo sapiens	Inhibition	%	19.06
	8178479	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)C(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL517123	=	Inhibition	%	1.56	CHEMBL4454	Homo sapiens	Inhibition	%	1.56
	8178606	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1cncc(/C=C/c2c(C)cc(O)cc2C)c1		CHEMBL220243	=	Inhibition	%	20.95	CHEMBL4454	Homo sapiens	Inhibition	%	20.95
	8178979	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	O=C(NCC1CC1)c1ccc(-c2cccc(C(=O)NC3CC3)c2)cc1		CHEMBL479038	=	Inhibition	%	4.28	CHEMBL4454	Homo sapiens	Inhibition	%	4.28
	8179102	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	CCNC(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL512076	=	Inhibition	%	1.28	CHEMBL4454	Homo sapiens	Inhibition	%	1.28
	8179470	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCc4ccncc4)cc32)cc1		CHEMBL272165	=	Inhibition	%	4.24	CHEMBL4454	Homo sapiens	Inhibition	%	4.24
	8179607	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL359963	=	Inhibition	%	7.87	CHEMBL4454	Homo sapiens	Inhibition	%	7.87
	8179831	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	CCCN(CCS(C)(=O)=O)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1.Cl		CHEMBL1909394	=	Inhibition	%	3.69	CHEMBL4454	Homo sapiens	Inhibition	%	3.69
	8179864	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc(-n2cncn2)cc1		CHEMBL1794056	=	Inhibition	%	12.76	CHEMBL4454	Homo sapiens	Inhibition	%	12.76
	8180088	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nnc(-c4ccccc4)cc23)CC1.Cl		CHEMBL1909344	=	Inhibition	%	5.18	CHEMBL4454	Homo sapiens	Inhibition	%	5.18
	8180242	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	Cc1nn(C)c2cc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)ccc12.Cl		CHEMBL1794073	=	Inhibition	%	48.04	CHEMBL4454	Homo sapiens	Inhibition	%	48.04
	8180622	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	NCc1ccc(-n2c(-c3nonc3N)nc3cnccc32)cc1		CHEMBL188268	=	Inhibition	%	3.12	CHEMBL4454	Homo sapiens	Inhibition	%	3.12
	8180770	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL272414	=	Inhibition	%	2.49	CHEMBL4454	Homo sapiens	Inhibition	%	2.49
	8181127	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2ccc(S(C)(=O)=O)cc12		CHEMBL237347	=	Inhibition	%	76.21	CHEMBL4454	Homo sapiens	Inhibition	%	76.21
	8181258	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCn4ccnc4)cc3)c2)nc1		CHEMBL208437	=	Inhibition	%	2.78	CHEMBL4454	Homo sapiens	Inhibition	%	2.78
	8181482	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	C/C(Nc1ccc(S(N)(=O)=O)cc1)=C1/C(=O)Nc2ccccc21		CHEMBL405042	=	Inhibition	%	0.92	CHEMBL4454	Homo sapiens	Inhibition	%	0.92
	8181622	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909352	=	Inhibition	%	51.51	CHEMBL4454	Homo sapiens	Inhibition	%	51.51
	8181985	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c4c(c3c2c1)C(=O)NC4=O		CHEMBL1956068	=	Inhibition	%	28.03	CHEMBL4454	Homo sapiens	Inhibition	%	28.03
	8182148	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2ccc(F)cc2)c(-c2ccc3ncccc3n2)s1		CHEMBL361237	=	Inhibition	%	6.43	CHEMBL4454	Homo sapiens	Inhibition	%	6.43
	8182512	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(Nc2nccc(-c3c(-c4ccc(C(F)(F)F)cc4)nn4ncccc34)n2)cc1F		CHEMBL188784	=	Inhibition	%	-0.18	CHEMBL4454	Homo sapiens	Inhibition	%	-0.18
	8182828	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	CN(C)C(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL517123	=	Inhibition	%	4.75	CHEMBL4454	Homo sapiens	Inhibition	%	4.75
	8182950	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(F)cc4)ncnc32)c1		CHEMBL65884	=	Inhibition	%	11.36	CHEMBL4454	Homo sapiens	Inhibition	%	11.36
	8183323	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(OC)c3)o2)c1		CHEMBL179311	=	Inhibition	%	19.85	CHEMBL4454	Homo sapiens	Inhibition	%	19.85
	8183452	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	CCNC(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL512076	=	Inhibition	%	1.88	CHEMBL4454	Homo sapiens	Inhibition	%	1.88
	8183676	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL185939	=	Inhibition	%	25.55	CHEMBL4454	Homo sapiens	Inhibition	%	25.55
	8183818	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCc4ccncc4)cc32)cc1		CHEMBL272165	=	Inhibition	%	12.49	CHEMBL4454	Homo sapiens	Inhibition	%	12.49
	8184178	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	CCCN(CCS(C)(=O)=O)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1.Cl		CHEMBL1909394	=	Inhibition	%	7.51	CHEMBL4454	Homo sapiens	Inhibition	%	7.51
	8184444	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nnc(-c4ccccc4)cc23)CC1.Cl		CHEMBL1909344	=	Inhibition	%	4.46	CHEMBL4454	Homo sapiens	Inhibition	%	4.46
	8184591	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Fc1cccc(COc2ccc(Nc3ncnc4cc(-c5ccc[nH]5)sc34)cc2Cl)c1		CHEMBL1909415	=	Inhibition	%	3.74	CHEMBL4454	Homo sapiens	Inhibition	%	3.74
	8184972	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL365297	=	Inhibition	%	68.25	CHEMBL4454	Homo sapiens	Inhibition	%	68.25
	8185121	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL272414	=	Inhibition	%	16.69	CHEMBL4454	Homo sapiens	Inhibition	%	16.69
	8185345	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)NCc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207247	=	Inhibition	%	-0.22	CHEMBL4454	Homo sapiens	Inhibition	%	-0.22
	8185476	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2ccc(S(C)(=O)=O)cc12		CHEMBL237347	=	Inhibition	%	81.76	CHEMBL4454	Homo sapiens	Inhibition	%	81.76
	8185831	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	C/C(Nc1ccc(S(N)(=O)=O)cc1)=C1/C(=O)Nc2ccccc21		CHEMBL405042	=	Inhibition	%	11.41	CHEMBL4454	Homo sapiens	Inhibition	%	11.41
	8185970	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccccc3)ccc12)C1CC1		CHEMBL405021	=	Inhibition	%	1.51	CHEMBL4454	Homo sapiens	Inhibition	%	1.51
	8186335	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(F)c(F)c3)n2)cc1		CHEMBL427159	=	Inhibition	%	20.4	CHEMBL4454	Homo sapiens	Inhibition	%	20.4
	8186499	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2ccc(F)cc2)c(-c2ccc3ncccc3n2)s1		CHEMBL361237	=	Inhibition	%	14.11	CHEMBL4454	Homo sapiens	Inhibition	%	14.11
	8186723	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(C2=C(N3CCc4ccccc43)C(=O)NC2=O)cc1		CHEMBL347580	=	Inhibition	%	5.11	CHEMBL4454	Homo sapiens	Inhibition	%	5.11
	8186862	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(Nc2nccc(-c3c(-c4ccc(C(F)(F)F)cc4)nn4ncccc34)n2)cc1F		CHEMBL188784	=	Inhibition	%	4.23	CHEMBL4454	Homo sapiens	Inhibition	%	4.23
	8187184	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(N)=O)c1		CHEMBL218088	=	Inhibition	%	5.81	CHEMBL4454	Homo sapiens	Inhibition	%	5.81
	8187308	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(F)cc4)ncnc32)c1		CHEMBL65884	=	Inhibition	%	29.7	CHEMBL4454	Homo sapiens	Inhibition	%	29.7
	8187532	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2c(-c3ccnc(Nc4cccc(OC(F)(F)F)c4)n3)cnn2n1		CHEMBL365248	=	Inhibition	%	5.29	CHEMBL4454	Homo sapiens	Inhibition	%	5.29
	8187680	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(OC)c3)o2)c1		CHEMBL179311	=	Inhibition	%	65.16	CHEMBL4454	Homo sapiens	Inhibition	%	65.16
	8188033	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL185939	=	Inhibition	%	61.1	CHEMBL4454	Homo sapiens	Inhibition	%	61.1
	8188176	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL270054	=	Inhibition	%	4.13	CHEMBL4454	Homo sapiens	Inhibition	%	4.13
	8188535	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(S(C)(=O)=O)cc4)ncnc32)c1		CHEMBL66292	=	Inhibition	%	28.49	CHEMBL4454	Homo sapiens	Inhibition	%	28.49
	8188809	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	10.86	CHEMBL4454	Homo sapiens	Inhibition	%	10.86
	8188957	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	Cl.Fc1cccc(COc2ccc(Nc3ncnc4cc(-c5ccc[nH]5)sc34)cc2Cl)c1		CHEMBL1909415	=	Inhibition	%	10.97	CHEMBL4454	Homo sapiens	Inhibition	%	10.97
	8189181	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3c2cnn3C(C)C)ccc1O		CHEMBL63728	=	Inhibition	%	9.02	CHEMBL4454	Homo sapiens	Inhibition	%	9.02
	8189337	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL365297	=	Inhibition	%	83.95	CHEMBL4454	Homo sapiens	Inhibition	%	83.95
	8189710	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	CC(=O)NCc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207247	=	Inhibition	%	4.83	CHEMBL4454	Homo sapiens	Inhibition	%	4.83
	8189842	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	C#Cc1cccc(Nc2ncnc3ccc(OCCCCNCCS(C)(=O)=O)cc23)c1		CHEMBL517907	=	Inhibition	%	10.52	CHEMBL4454	Homo sapiens	Inhibition	%	10.52
	8190198	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1-c1cc(/C=C2\C(=O)Nc3ncc(Br)cc32)cc(Br)c1O		CHEMBL176857	=	Inhibition	%	2.7	CHEMBL4454	Homo sapiens	Inhibition	%	2.7
	8190338	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccccc3)ccc12)C1CC1		CHEMBL405021	=	Inhibition	%	12.81	CHEMBL4454	Homo sapiens	Inhibition	%	12.81
	8190562	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccncc2)cc(-c2ccccc2)c1N		CHEMBL230911	=	Inhibition	%	6.05	CHEMBL4454	Homo sapiens	Inhibition	%	6.05
	8190699	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(F)c(F)c3)n2)cc1		CHEMBL427159	=	Inhibition	%	60.8	CHEMBL4454	Homo sapiens	Inhibition	%	60.8
	8191087	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(C2=C(N3CCc4ccccc43)C(=O)NC2=O)cc1		CHEMBL347580	=	Inhibition	%	3.99	CHEMBL4454	Homo sapiens	Inhibition	%	3.99
	8191225	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCNC(=O)Nc1ccc(N(C)c2ccnc(Nc3ccc(CS(C)(=O)=O)cc3)n2)cc1.Cl		CHEMBL1909362	=	Inhibition	%	1.07	CHEMBL4454	Homo sapiens	Inhibition	%	1.07
	8191545	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(N)=O)c1		CHEMBL218088	=	Inhibition	%	38.14	CHEMBL4454	Homo sapiens	Inhibition	%	38.14
	8191891	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2c(-c3ccnc(Nc4cccc(OC(F)(F)F)c4)n3)cnn2n1		CHEMBL365248	=	Inhibition	%	7.16	CHEMBL4454	Homo sapiens	Inhibition	%	7.16
	8192040	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	CCc1cccc(CC)c1/C=C/c1cncc(C(=O)NC)c1		CHEMBL385426	=	Inhibition	%	3.25	CHEMBL4454	Homo sapiens	Inhibition	%	3.25
	8192393	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(CNC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)cc1		CHEMBL269985	=	Inhibition	%	8.93	CHEMBL4454	Homo sapiens	Inhibition	%	8.93
	8192537	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL270054	=	Inhibition	%	7.63	CHEMBL4454	Homo sapiens	Inhibition	%	7.63
	8192761	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2C)c1		CHEMBL218969	=	Inhibition	%	5.41	CHEMBL4454	Homo sapiens	Inhibition	%	5.41
	8192897	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(S(C)(=O)=O)cc4)ncnc32)c1		CHEMBL66292	=	Inhibition	%	64.02	CHEMBL4454	Homo sapiens	Inhibition	%	64.02
	8193169	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	30.09	CHEMBL4454	Homo sapiens	Inhibition	%	30.09
	8193538	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3c2cnn3C(C)C)ccc1O		CHEMBL63728	=	Inhibition	%	40.42	CHEMBL4454	Homo sapiens	Inhibition	%	40.42
	8193695	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(N/C=C2\C(=O)Nc3ccccc32)c1		CHEMBL1794059	=	Inhibition	%	5.5	CHEMBL4454	Homo sapiens	Inhibition	%	5.5
	8194068	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(N3CCCC3)nccc21		CHEMBL187985	=	Inhibition	%	-0.82	CHEMBL4454	Homo sapiens	Inhibition	%	-0.82
	8194199	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	C#Cc1cccc(Nc2ncnc3ccc(OCCCCNCCS(C)(=O)=O)cc23)c1		CHEMBL517907	=	Inhibition	%	15.54	CHEMBL4454	Homo sapiens	Inhibition	%	15.54
	8194423	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc(C)c(O)c3)c2cc1OC.Cl		CHEMBL1909357	=	Inhibition	%	15.27	CHEMBL4454	Homo sapiens	Inhibition	%	15.27
	8194554	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1-c1cc(/C=C2\C(=O)Nc3ncc(Br)cc32)cc(Br)c1O		CHEMBL176857	=	Inhibition	%	11.62	CHEMBL4454	Homo sapiens	Inhibition	%	11.62
	8194921	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccncc2)cc(-c2ccccc2)c1N		CHEMBL230911	=	Inhibition	%	26.96	CHEMBL4454	Homo sapiens	Inhibition	%	26.96
	8195054	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(NCCO)n2)CC1		CHEMBL330422	=	Inhibition	%	5.33	CHEMBL4454	Homo sapiens	Inhibition	%	5.33
	8195278	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(NCCO)n2)CC1		CHEMBL330422	=	Inhibition	%	2.78	CHEMBL4454	Homo sapiens	Inhibition	%	2.78
	8195442	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccc(C(=O)c3ccco3)cc2C1=Cc1cc(Cl)c(O)c(Cl)c1		CHEMBL1789963	=	Inhibition	%	2.46	CHEMBL4454	Homo sapiens	Inhibition	%	2.46
	8195581	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCNC(=O)Nc1ccc(N(C)c2ccnc(Nc3ccc(CS(C)(=O)=O)cc3)n2)cc1.Cl		CHEMBL1909362	=	Inhibition	%	9.57	CHEMBL4454	Homo sapiens	Inhibition	%	9.57
	8195805	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	OCc1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL267228	=	Inhibition	%	3.43	CHEMBL4454	Homo sapiens	Inhibition	%	3.43
	8195903	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)N=C(c2ccc(C(F)(F)F)nc2)N1		CHEMBL485598	=	Inhibition	%	1.36	CHEMBL4454	Homo sapiens	Inhibition	%	1.36
	8196244	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(Cc2nc3ccc(Nc4ncnc5ccccc45)cc3[nH]2)cc1		CHEMBL1909379	=	Inhibition	%	5.51	CHEMBL4454	Homo sapiens	Inhibition	%	5.51
	8196394	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	CCc1cccc(CC)c1/C=C/c1cncc(C(=O)NC)c1		CHEMBL385426	=	Inhibition	%	11.65	CHEMBL4454	Homo sapiens	Inhibition	%	11.65
	8196618	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccccc4)n3)c(-c3ccc(F)cc3)nn2n1		CHEMBL189459	=	Inhibition	%	40.71	CHEMBL4454	Homo sapiens	Inhibition	%	40.71
	8196746	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(CNC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)cc1		CHEMBL269985	=	Inhibition	%	6.92	CHEMBL4454	Homo sapiens	Inhibition	%	6.92
	8197111	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2C)c1		CHEMBL218969	=	Inhibition	%	9.23	CHEMBL4454	Homo sapiens	Inhibition	%	9.23
	8197248	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cc(OC)cc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL188426	=	Inhibition	%	1.32	CHEMBL4454	Homo sapiens	Inhibition	%	1.32
	8197472	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cc(OC)cc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL188426	=	Inhibition	%	9.11	CHEMBL4454	Homo sapiens	Inhibition	%	9.11
	8197523	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccncc2)c1N		CHEMBL231623	=	Inhibition	%	5.32	CHEMBL4454	Homo sapiens	Inhibition	%	5.32
	8197747	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccncc2)c1N		CHEMBL231623	=	Inhibition	%	3.24	CHEMBL4454	Homo sapiens	Inhibition	%	3.24
	8197887	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL514162	=	Inhibition	%	3.61	CHEMBL4454	Homo sapiens	Inhibition	%	3.61
	8198044	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(N/C=C2\C(=O)Nc3ccccc32)c1		CHEMBL1794059	=	Inhibition	%	13.75	CHEMBL4454	Homo sapiens	Inhibition	%	13.75
	8198268	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL1909406	=	Inhibition	%	3.23	CHEMBL4454	Homo sapiens	Inhibition	%	3.23
	8198406	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(N3CCCC3)nccc21		CHEMBL187985	=	Inhibition	%	-0.02	CHEMBL4454	Homo sapiens	Inhibition	%	-0.02
	8198760	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc(C)c(O)c3)c2cc1OC.Cl		CHEMBL1909357	=	Inhibition	%	46.22	CHEMBL4454	Homo sapiens	Inhibition	%	46.22
	8198891	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(N2CCc3ccccc32)=C1c1ccc(Cl)cc1		CHEMBL156524	=	Inhibition	%	2.39	CHEMBL4454	Homo sapiens	Inhibition	%	2.39
	8199115	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(N2CCc3ccccc32)=C1c1ccc(Cl)cc1		CHEMBL156524	=	Inhibition	%	8.07	CHEMBL4454	Homo sapiens	Inhibition	%	8.07
	8199263	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4nc(Cc5ccccc5)[nH]c4c3)ncnc2cn1		CHEMBL531804	=	Inhibition	%	17.2	CHEMBL4454	Homo sapiens	Inhibition	%	17.2
	8199621	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncncc3C#Cc3ccccc3)cc2Cl)c1		CHEMBL379093	=	Inhibition	%	5.41	CHEMBL4454	Homo sapiens	Inhibition	%	5.41
	8199784	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccc(C(=O)c3ccco3)cc2C1=Cc1cc(Cl)c(O)c(Cl)c1		CHEMBL1789963	=	Inhibition	%	11.55	CHEMBL4454	Homo sapiens	Inhibition	%	11.55
	8200146	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	OCc1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL267228	=	Inhibition	%	8.26	CHEMBL4454	Homo sapiens	Inhibition	%	8.26
	8200250	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)N=C(c2ccc(C(F)(F)F)nc2)N1		CHEMBL485598	=	Inhibition	%	7.33	CHEMBL4454	Homo sapiens	Inhibition	%	7.33
	8200474	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	Clc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccccc3)n2)cc1		CHEMBL189148	=	Inhibition	%	25.14	CHEMBL4454	Homo sapiens	Inhibition	%	25.14
	8200589	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(Cc2nc3ccc(Nc4ncnc5ccccc45)cc3[nH]2)cc1		CHEMBL1909379	=	Inhibition	%	18.21	CHEMBL4454	Homo sapiens	Inhibition	%	18.21
	8200963	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccccc4)n3)c(-c3ccc(F)cc3)nn2n1		CHEMBL189459	=	Inhibition	%	78.4	CHEMBL4454	Homo sapiens	Inhibition	%	78.4
	8201093	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4cccs4)c(C(N)=O)s3)c2cc1OC		CHEMBL480382	=	Inhibition	%	11.05	CHEMBL4454	Homo sapiens	Inhibition	%	11.05
	8201317	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4cccs4)c(C(N)=O)s3)c2cc1OC		CHEMBL480382	=	Inhibition	%	13.66	CHEMBL4454	Homo sapiens	Inhibition	%	13.66
	8201452	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2cc3ccncc3cc2OCc2ccccc2)cc1		CHEMBL483748	=	Inhibition	%	5.99	CHEMBL4454	Homo sapiens	Inhibition	%	5.99
	8201809	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4C)n3C)ccc2c1		CHEMBL237570	=	Inhibition	%	0.53	CHEMBL4454	Homo sapiens	Inhibition	%	0.53
	8202088	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(C(F)(F)F)c4)c3c2)o1		CHEMBL215814	=	Inhibition	%	3.99	CHEMBL4454	Homo sapiens	Inhibition	%	3.99
	8202228	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL514162	=	Inhibition	%	19.05	CHEMBL4454	Homo sapiens	Inhibition	%	19.05
	8202619	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	Cl.Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL1909406	=	Inhibition	%	5.64	CHEMBL4454	Homo sapiens	Inhibition	%	5.64
	8202744	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL381948	=	Inhibition	%	5.85	CHEMBL4454	Homo sapiens	Inhibition	%	5.85
	8203098	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2)=C1Nc1ccccc1		CHEMBL346551	=	Inhibition	%	7.27	CHEMBL4454	Homo sapiens	Inhibition	%	7.27
	8203453	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	Cc1c2ccc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)cc2nn1C.Cl		CHEMBL1909359	=	Inhibition	%	25.97	CHEMBL4454	Homo sapiens	Inhibition	%	25.97
	8203599	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4nc(Cc5ccccc5)[nH]c4c3)ncnc2cn1		CHEMBL531804	=	Inhibition	%	42.16	CHEMBL4454	Homo sapiens	Inhibition	%	42.16
	8203957	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncncc3C#Cc3ccccc3)cc2Cl)c1		CHEMBL379093	=	Inhibition	%	2.24	CHEMBL4454	Homo sapiens	Inhibition	%	2.24
	8204123	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)OC(C)(C)C)c1		CHEMBL374060	=	Inhibition	%	8.01	CHEMBL4454	Homo sapiens	Inhibition	%	8.01
	8204484	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2cc(-c3ccccn3)ccc12.Cl		CHEMBL581096	=	Inhibition	%	52.19	CHEMBL4454	Homo sapiens	Inhibition	%	52.19
	8204813	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	Clc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccccc3)n2)cc1		CHEMBL189148	=	Inhibition	%	70.22	CHEMBL4454	Homo sapiens	Inhibition	%	70.22
	8204928	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3[nH]ncc23)ccc1O		CHEMBL66004	=	Inhibition	%	12.42	CHEMBL4454	Homo sapiens	Inhibition	%	12.42
	8205152	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3[nH]ncc23)ccc1O		CHEMBL66004	=	Inhibition	%	52.59	CHEMBL4454	Homo sapiens	Inhibition	%	52.59
	8205301	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	c1cc(-c2cnn3nc(N4CCOCC4)ccc23)nc(NC2CC2)n1		CHEMBL495771	=	Inhibition	%	3.22	CHEMBL4454	Homo sapiens	Inhibition	%	3.22
	8205661	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL188240	=	Inhibition	%	6.66	CHEMBL4454	Homo sapiens	Inhibition	%	6.66
	8205800	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2cc3ccncc3cc2OCc2ccccc2)cc1		CHEMBL483748	=	Inhibition	%	4.64	CHEMBL4454	Homo sapiens	Inhibition	%	4.64
	8206156	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4C)n3C)ccc2c1		CHEMBL237570	=	Inhibition	%	4.65	CHEMBL4454	Homo sapiens	Inhibition	%	4.65
	8206432	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(C(F)(F)F)c4)c3c2)o1		CHEMBL215814	=	Inhibition	%	2.16	CHEMBL4454	Homo sapiens	Inhibition	%	2.16
	8206575	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nc(-c2ccc3c(c2)C(=Cc2cc(Br)c(O)c(Br)c2)C(=O)N3)cs1		CHEMBL1794053	=	Inhibition	%	-0.02	CHEMBL4454	Homo sapiens	Inhibition	%	-0.02
	8206799	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nc(-c2ccc3c(c2)C(=Cc2cc(Br)c(O)c(Br)c2)C(=O)N3)cs1		CHEMBL1794053	=	Inhibition	%	5.44	CHEMBL4454	Homo sapiens	Inhibition	%	5.44
	8206979	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCCn1c(-c2nonc2N)nc2cnccc21		CHEMBL191105	=	Inhibition	%	1.37	CHEMBL4454	Homo sapiens	Inhibition	%	1.37
	8207105	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL381948	=	Inhibition	%	3.11	CHEMBL4454	Homo sapiens	Inhibition	%	3.11
	8207329	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2cccc(Cl)c2)c(-c2ccc3ncccc3n2)s1		CHEMBL365663	=	Inhibition	%	4.53	CHEMBL4454	Homo sapiens	Inhibition	%	4.53
	8207459	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2)=C1Nc1ccccc1		CHEMBL346551	=	Inhibition	%	10.73	CHEMBL4454	Homo sapiens	Inhibition	%	10.73
	8207815	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	Cc1c2ccc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)cc2nn1C.Cl		CHEMBL1909359	=	Inhibition	%	64.74	CHEMBL4454	Homo sapiens	Inhibition	%	64.74
	8207960	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(NCCCN4CCOCC4)n3)c2c1		CHEMBL524901	=	Inhibition	%	2.2	CHEMBL4454	Homo sapiens	Inhibition	%	2.2
	8208184	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(NCCCN4CCOCC4)n3)c2c1		CHEMBL524901	=	Inhibition	%	0.54	CHEMBL4454	Homo sapiens	Inhibition	%	0.54
	8208316	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL202891	=	Inhibition	%	5.33	CHEMBL4454	Homo sapiens	Inhibition	%	5.33
	8208482	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)OC(C)(C)C)c1		CHEMBL374060	=	Inhibition	%	34.03	CHEMBL4454	Homo sapiens	Inhibition	%	34.03
	8208706	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc3ccccc3c2)CC(=O)N1		CHEMBL441702	=	Inhibition	%	3.21	CHEMBL4454	Homo sapiens	Inhibition	%	3.21
	8208839	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2cc(-c3ccccn3)ccc12.Cl		CHEMBL581096	=	Inhibition	%	82.67	CHEMBL4454	Homo sapiens	Inhibition	%	82.67
	8209168	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccc4F)c3)o2)c1		CHEMBL372474	=	Inhibition	%	11.88	CHEMBL4454	Homo sapiens	Inhibition	%	11.88
	8209508	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2ccccn2)c(-c2ccc3ncccc3n2)s1		CHEMBL181361	=	Inhibition	%	1.09	CHEMBL4454	Homo sapiens	Inhibition	%	1.09
	8209658	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	c1cc(-c2cnn3nc(N4CCOCC4)ccc23)nc(NC2CC2)n1		CHEMBL495771	=	Inhibition	%	8.79	CHEMBL4454	Homo sapiens	Inhibition	%	8.79
	8210018	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	CCOc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL188240	=	Inhibition	%	5.06	CHEMBL4454	Homo sapiens	Inhibition	%	5.06
	8210159	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)CC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL516908	=	Inhibition	%	7.45	CHEMBL4454	Homo sapiens	Inhibition	%	7.45
	8210383	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)CC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL516908	=	Inhibition	%	6.65	CHEMBL4454	Homo sapiens	Inhibition	%	6.65
	8210519	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nc(-c4cccs4)c(Br)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062290	=	Inhibition	%	-0.94	CHEMBL4454	Homo sapiens	Inhibition	%	-0.94
	8210778	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCc4ccc(Cl)cc4)cc3)c2)o1		CHEMBL402108	=	Inhibition	%	4.76	CHEMBL4454	Homo sapiens	Inhibition	%	4.76
	8211146	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL473420	=	Inhibition	%	3.32	CHEMBL4454	Homo sapiens	Inhibition	%	3.32
	8211316	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCCn1c(-c2nonc2N)nc2cnccc21		CHEMBL191105	=	Inhibition	%	2.22	CHEMBL4454	Homo sapiens	Inhibition	%	2.22
	8211663	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2cccc(Cl)c2)c(-c2ccc3ncccc3n2)s1		CHEMBL365663	=	Inhibition	%	4.6	CHEMBL4454	Homo sapiens	Inhibition	%	4.6
	8211792	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(Br)cc12)C1CC1		CHEMBL260417	=	Inhibition	%	7.15	CHEMBL4454	Homo sapiens	Inhibition	%	7.15
	8212016	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(Br)cc12)C1CC1		CHEMBL260417	=	Inhibition	%	21.28	CHEMBL4454	Homo sapiens	Inhibition	%	21.28
	8212148	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2cc3ccncc3cc2OCc2ccccc2)c1		CHEMBL483747	=	Inhibition	%	1.58	CHEMBL4454	Homo sapiens	Inhibition	%	1.58
	8212513	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccc(F)cc3)ccc12)C1CC1		CHEMBL419903	=	Inhibition	%	1.35	CHEMBL4454	Homo sapiens	Inhibition	%	1.35
	8212646	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL202891	=	Inhibition	%	4.21	CHEMBL4454	Homo sapiens	Inhibition	%	4.21
	8213040	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc3ccccc3c2)CC(=O)N1		CHEMBL441702	=	Inhibition	%	15.11	CHEMBL4454	Homo sapiens	Inhibition	%	15.11
	8213169	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	1.63	CHEMBL4454	Homo sapiens	Inhibition	%	1.63
	8213393	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	4.78	CHEMBL4454	Homo sapiens	Inhibition	%	4.78
	8213497	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccc4F)c3)o2)c1		CHEMBL372474	=	Inhibition	%	52.11	CHEMBL4454	Homo sapiens	Inhibition	%	52.11
	8213834	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2ccccn2)c(-c2ccc3ncccc3n2)s1		CHEMBL181361	=	Inhibition	%	2.08	CHEMBL4454	Homo sapiens	Inhibition	%	2.08
	8213981	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL103098	=	Inhibition	%	1.76	CHEMBL4454	Homo sapiens	Inhibition	%	1.76
	8214205	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL103098	=	Inhibition	%	6.23	CHEMBL4454	Homo sapiens	Inhibition	%	6.23
	8214342	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL222419	=	Inhibition	%	8.54	CHEMBL4454	Homo sapiens	Inhibition	%	8.54
	8214700	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(Nc2ccnc(Nc3cccc(C(N)=O)c3)n2)cc1O.Cl		CHEMBL1909381	=	Inhibition	%	52.58	CHEMBL4454	Homo sapiens	Inhibition	%	52.58
	8214852	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nc(-c4cccs4)c(Br)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062290	=	Inhibition	%	0.5	CHEMBL4454	Homo sapiens	Inhibition	%	0.5
	8215103	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCc4ccc(Cl)cc4)cc3)c2)o1		CHEMBL402108	=	Inhibition	%	1.82	CHEMBL4454	Homo sapiens	Inhibition	%	1.82
	8215480	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL473420	=	Inhibition	%	17.21	CHEMBL4454	Homo sapiens	Inhibition	%	17.21
	8215644	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(ccn5Cc5cc(F)ccc5F)c4)c3s2)C1)N1CCOCC1		CHEMBL1909410	=	Inhibition	%	2.14	CHEMBL4454	Homo sapiens	Inhibition	%	2.14
	8215987	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(=O)NC[C@@H](O)CO)c2cc[nH]c2n1		CHEMBL450071	=	Inhibition	%	4.37	CHEMBL4454	Homo sapiens	Inhibition	%	4.37
	8216330	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccc(C(F)(F)F)cc32)cc1OCc1ccccc1Br		CHEMBL481510	=	Inhibition	%	3.5	CHEMBL4454	Homo sapiens	Inhibition	%	3.5
	8216466	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2cc3ccncc3cc2OCc2ccccc2)c1		CHEMBL483747	=	Inhibition	%	7.39	CHEMBL4454	Homo sapiens	Inhibition	%	7.39
	8216828	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccc(F)cc3)ccc12)C1CC1		CHEMBL419903	=	Inhibition	%	9.07	CHEMBL4454	Homo sapiens	Inhibition	%	9.07
	8216962	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2cccc(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1		CHEMBL257113	=	Inhibition	%	5.74	CHEMBL4454	Homo sapiens	Inhibition	%	5.74
	8217186	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2cccc(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1		CHEMBL257113	=	Inhibition	%	2.02	CHEMBL4454	Homo sapiens	Inhibition	%	2.02
	8217360	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(Oc2ccc(Nc3ncc(-c4ccccc4)o3)cc2)cc1		CHEMBL1909341	=	Inhibition	%	1.2	CHEMBL4454	Homo sapiens	Inhibition	%	1.2
	8217715	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4S(C)(=O)=O)c(C#N)s3)c2cc1OC		CHEMBL373751	=	Inhibition	%	15.17	CHEMBL4454	Homo sapiens	Inhibition	%	15.17
	8217816	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccc(Cl)cc2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL160876	=	Inhibition	%	0.15	CHEMBL4454	Homo sapiens	Inhibition	%	0.15
	8218040	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccc(Cl)cc2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL160876	=	Inhibition	%	2.1	CHEMBL4454	Homo sapiens	Inhibition	%	2.1
	8218155	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1.Cl.O		CHEMBL1909414	=	Inhibition	%	2.2	CHEMBL4454	Homo sapiens	Inhibition	%	2.2
	8218506	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C(=O)NCCN(C)C)cc4)ncnc32)c1.Cl		CHEMBL1909383	=	Inhibition	%	47.44	CHEMBL4454	Homo sapiens	Inhibition	%	47.44
	8218649	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL222419	=	Inhibition	%	17.3	CHEMBL4454	Homo sapiens	Inhibition	%	17.3
	8219004	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(Nc2ccnc(Nc3cccc(C(N)=O)c3)n2)cc1O.Cl		CHEMBL1909381	=	Inhibition	%	72.76	CHEMBL4454	Homo sapiens	Inhibition	%	72.76
	8219164	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCN4CCOCC4)cc3)c2)nc1		CHEMBL205158	=	Inhibition	%	4.14	CHEMBL4454	Homo sapiens	Inhibition	%	4.14
	8219388	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCN4CCOCC4)cc3)c2)nc1		CHEMBL205158	=	Inhibition	%	6.86	CHEMBL4454	Homo sapiens	Inhibition	%	6.86
	8219414	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2CCCN2CCOCC2)n1		CHEMBL274863	=	Inhibition	%	2.89	CHEMBL4454	Homo sapiens	Inhibition	%	2.89
	8219638	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2CCCN2CCOCC2)n1		CHEMBL274863	=	Inhibition	%	3.22	CHEMBL4454	Homo sapiens	Inhibition	%	3.22
	8219799	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL196022	=	Inhibition	%	0.55	CHEMBL4454	Homo sapiens	Inhibition	%	0.55
	8219968	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(ccn5Cc5cc(F)ccc5F)c4)c3s2)C1)N1CCOCC1		CHEMBL1909410	=	Inhibition	%	2.6	CHEMBL4454	Homo sapiens	Inhibition	%	2.6
	8220192	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)c3ccccc23)sc2c1CCCC2		CHEMBL233002	=	Inhibition	%	2.54	CHEMBL4454	Homo sapiens	Inhibition	%	2.54
	8220321	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(=O)NC[C@@H](O)CO)c2cc[nH]c2n1		CHEMBL450071	=	Inhibition	%	1.14	CHEMBL4454	Homo sapiens	Inhibition	%	1.14
	8220659	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccc(C(F)(F)F)cc32)cc1OCc1ccccc1Br		CHEMBL481510	=	Inhibition	%	1.54	CHEMBL4454	Homo sapiens	Inhibition	%	1.54
	8220797	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C1\CCc2cc(O)ccc21		CHEMBL175321	=	Inhibition	%	2.44	CHEMBL4454	Homo sapiens	Inhibition	%	2.44
	8221021	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C1\CCc2cc(O)ccc21		CHEMBL175321	=	Inhibition	%	15.41	CHEMBL4454	Homo sapiens	Inhibition	%	15.41
	8221157	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	3.54	CHEMBL4454	Homo sapiens	Inhibition	%	3.54
	8221514	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc(F)c2C(=O)O)c2cc[nH]c2n1		CHEMBL514261	=	Inhibition	%	4.76	CHEMBL4454	Homo sapiens	Inhibition	%	4.76
	8221679	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(Oc2ccc(Nc3ncc(-c4ccccc4)o3)cc2)cc1		CHEMBL1909341	=	Inhibition	%	4.81	CHEMBL4454	Homo sapiens	Inhibition	%	4.81
	8222034	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4S(C)(=O)=O)c(C#N)s3)c2cc1OC		CHEMBL373751	=	Inhibition	%	59.64	CHEMBL4454	Homo sapiens	Inhibition	%	59.64
	8222356	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(C(C)=O)c3)o2)c1		CHEMBL191705	=	Inhibition	%	13.2	CHEMBL4454	Homo sapiens	Inhibition	%	13.2
	8222490	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1.Cl.O		CHEMBL1909414	=	Inhibition	%	5.88	CHEMBL4454	Homo sapiens	Inhibition	%	5.88
	8222832	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C(=O)NCCN(C)C)cc4)ncnc32)c1.Cl		CHEMBL1909383	=	Inhibition	%	82.08	CHEMBL4454	Homo sapiens	Inhibition	%	82.08
	8222976	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)cc1.Cl		CHEMBL1909396	=	Inhibition	%	16.96	CHEMBL4454	Homo sapiens	Inhibition	%	16.96
	8223200	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)cc1.Cl		CHEMBL1909396	=	Inhibition	%	61.05	CHEMBL4454	Homo sapiens	Inhibition	%	61.05
	8223329	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccccc4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909374	=	Inhibition	%	9.57	CHEMBL4454	Homo sapiens	Inhibition	%	9.57
	8223714	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Inhibition	%	-0.01	CHEMBL4454	Homo sapiens	Inhibition	%	-0.01
	8223964	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc(S(C)(=O)=O)cc4C)n3C)ccc2c1		CHEMBL237571	=	Inhibition	%	3.77	CHEMBL4454	Homo sapiens	Inhibition	%	3.77
	8224126	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL196022	=	Inhibition	%	5.25	CHEMBL4454	Homo sapiens	Inhibition	%	5.25
	8224520	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)c3ccccc23)sc2c1CCCC2		CHEMBL233002	=	Inhibition	%	3.07	CHEMBL4454	Homo sapiens	Inhibition	%	3.07
	8224655	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCN2C(=O)C1CC1		CHEMBL232601	=	Inhibition	%	2.87	CHEMBL4454	Homo sapiens	Inhibition	%	2.87
	8224879	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCN2C(=O)C1CC1		CHEMBL232601	=	Inhibition	%	-0.28	CHEMBL4454	Homo sapiens	Inhibition	%	-0.28
	8224993	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2cc(Cl)c3[nH]ncc3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL427058	=	Inhibition	%	2.78	CHEMBL4454	Homo sapiens	Inhibition	%	2.78
	8225351	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3cccc(O)c3)n[nH]2)cc1		CHEMBL103104	=	Inhibition	%	2.88	CHEMBL4454	Homo sapiens	Inhibition	%	2.88
	8225489	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	2.49	CHEMBL4454	Homo sapiens	Inhibition	%	2.49
	8225848	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc(F)c2C(=O)O)c2cc[nH]c2n1		CHEMBL514261	=	Inhibition	%	4.0	CHEMBL4454	Homo sapiens	Inhibition	%	4.0
	8226006	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	1.9	CHEMBL4454	Homo sapiens	Inhibition	%	1.9
	8226230	CHEMBL1962297	GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	8.7	CHEMBL4454	Homo sapiens	Inhibition	%	8.7
	8226355	CHEMBL1962296	GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL381604	=	Inhibition	%	0.12	CHEMBL4454	Homo sapiens	Inhibition	%	0.12
	10838588	CHEMBL2014428	Inhibition of FGR at 10 uM	B	COc1ccc2c3ccnc(C(F)(F)F)c3n(CCCCN)c2c1		CHEMBL2012574	=	Inhibition	%	11.0	CHEMBL4454	Homo sapiens	INH	%	11.0
	10850676	CHEMBL2019796	Inhibition of human Fgr at 1 uM	B	Cn1cc(-c2cccc(-c3cnc(N)c(C(=O)N[C@H]4C5CC6CC4C[C@@](O)(C6)C5)n3)c2)cn1		CHEMBL2018022	>	Inhibition	%	50.0	CHEMBL4454	Homo sapiens	INH	%	50.0
	10867122	CHEMBL2026969	Inhibition of FGR at 1 uM	B	CCCS(=O)(=O)Nc1ccc(F)c(-c2cc3cnc(Nc4ccccc4)nc3n(C)c2=O)c1F		CHEMBL2023500	>	Inhibition	%	90.0	CHEMBL4454	Homo sapiens	INH	%	90.0
	10867123	CHEMBL2026969	Inhibition of FGR at 1 uM	B	CCCS(=O)(=O)Nc1ccc(F)c(-c2cc3cnc(Nc4cnn(C)c4)nc3n(C)c2=O)c1F		CHEMBL2023502	>	Inhibition	%	90.0	CHEMBL4454	Homo sapiens	INH	%	90.0
	10867124	CHEMBL2026969	Inhibition of FGR at 1 uM	B	CCCS(=O)(=O)Nc1ccc(F)c(-c2cc3cnc(Nc4cccnc4)nc3n(C)c2=O)c1F		CHEMBL2023501	>	Inhibition	%	90.0	CHEMBL4454	Homo sapiens	INH	%	90.0
	10886637	CHEMBL2034081	Inhibition of FGR at 1 uM	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)Nc2cnc3[nH]nc(OC)c3c2)c1F		CHEMBL1822067	=	Inhibition	%	88.0	CHEMBL4454	Homo sapiens	INH	%	88.0
	10886638	CHEMBL2034081	Inhibition of FGR at 1 uM	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)Nc2cnc3cc(-c4ccccc4)nn3c2)c1F		CHEMBL2030242	=	Inhibition	%	34.0	CHEMBL4454	Homo sapiens	INH	%	34.0
	10984765	CHEMBL2072061	Inhibition of human Fgr at 1 uM	B	Nc1cc(Nc2cnccn2)nc(-c2ccnc(N3CCNCC3)c2)c1		CHEMBL2069349	>	Inhibition	%	50.0	CHEMBL4454	Homo sapiens	INH	%	50.0
	12046308	CHEMBL2156638	Inhibition of Fgr at 1 uM	B	CC(C)(O)C1CCN(Cc2ccc3nc(-c4c(F)ccc5[nH]ccc45)nc(N4CCOCC4)c3n2)CC1		CHEMBL2152768	=	Inhibition	%	2.7	CHEMBL4454	Homo sapiens	INH	%	2.7
	12051564	CHEMBL2154704	Inhibition of Fgr	B	CC(C)Oc1cc(-n2cnc3ccc(N[C@@H](C)c4ccc(F)cn4)nc32)n[nH]1		CHEMBL2151321	=	IC50	nM	2.2	CHEMBL4454	Homo sapiens	IC50	nM	2.2
	12051586	CHEMBL2154965	Inhibition of Fgr at 10 uM	B	CC(C)Oc1cc(-n2cnc3ccc(N[C@@H](C)c4ccc(F)cn4)nc32)n[nH]1		CHEMBL2151321	>	Inhibition	%	30.0	CHEMBL4454	Homo sapiens	INH	%	30.0
	12074598	CHEMBL2160995	Inhibition of FGR at 0.1 uM	B	CN(C)CC(=O)N1CCC(c2ccc(NC(=O)c3nc(C#N)c[nH]3)c(C3=CCCCC3)c2)CC1		CHEMBL1908842	<	Inhibition	%	50.0	CHEMBL4454	Homo sapiens	INH	%	50.0
	12074608	CHEMBL2161005	Inhibition of FGR at 1 uM	B	CN(C)CC(=O)N1CCC(c2ccc(NC(=O)c3nc(C#N)c[nH]3)c(C3=CCCCC3)c2)CC1		CHEMBL1908842	>	Inhibition	%	50.0	CHEMBL4454	Homo sapiens	INH	%	50.0
	12173609	CHEMBL2213548	Inhibition of FGR assessed as residual activity at 10 uM relative to control	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	100.0	CHEMBL4454	Homo sapiens	Activity	%	100.0
	12183885	CHEMBL2211502	Inhibition of FGR	B	CC(C)(C)NS(=O)(=O)c1cncc(-c2ccn3nc(N)nc3c2)c1		CHEMBL2205766	<	IC50	nM	10000.0	CHEMBL4454	Homo sapiens	pIC50		5.0
	12231231	CHEMBL2219074	Millipore: Percentage of residual kinase activity of FGR at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1cc(C=C(C#N)C#N)cc(Br)c1O		CHEMBL2218926	=	Residual Activity	%	113.0	CHEMBL4454	Homo sapiens	Residual Activity	%	113.0
	12231232	CHEMBL2219074	Millipore: Percentage of residual kinase activity of FGR at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL266487	=	Residual Activity	%	98.0	CHEMBL4454	Homo sapiens	Residual Activity	%	98.0
	12231233	CHEMBL2219074	Millipore: Percentage of residual kinase activity of FGR at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1		CHEMBL387187	=	Residual Activity	%	90.0	CHEMBL4454	Homo sapiens	Residual Activity	%	90.0
	12231234	CHEMBL2219074	Millipore: Percentage of residual kinase activity of FGR at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12		CHEMBL439259	=	Residual Activity	%	99.0	CHEMBL4454	Homo sapiens	Residual Activity	%	99.0
	12231235	CHEMBL2219074	Millipore: Percentage of residual kinase activity of FGR at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CNc1cc2c(Nc3cccc(Br)c3)ncnc2cn1		CHEMBL53753	=	Residual Activity	%	73.0	CHEMBL4454	Homo sapiens	Residual Activity	%	73.0
	12231236	CHEMBL2219074	Millipore: Percentage of residual kinase activity of FGR at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL65063	=	Residual Activity	%	104.0	CHEMBL4454	Homo sapiens	Residual Activity	%	104.0
	12231237	CHEMBL2219074	Millipore: Percentage of residual kinase activity of FGR at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL104279	=	Residual Activity	%	9.0	CHEMBL4454	Homo sapiens	Residual Activity	%	9.0
	12233850	CHEMBL2219074	Millipore: Percentage of residual kinase activity of FGR at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1OC		CHEMBL7917	=	Residual Activity	%	52.0	CHEMBL4454	Homo sapiens	Residual Activity	%	52.0
	12233851	CHEMBL2219074	Millipore: Percentage of residual kinase activity of FGR at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc2cc3nc(-c4cccs4)cnc3cc2n1C		CHEMBL2218927	=	Residual Activity	%	109.0	CHEMBL4454	Homo sapiens	Residual Activity	%	109.0
	12233852	CHEMBL2219074	Millipore: Percentage of residual kinase activity of FGR at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cnc2cc3c(Nc4cccc(Br)c4)ncnc3cc21		CHEMBL174426	=	Residual Activity	%	63.0	CHEMBL4454	Homo sapiens	Residual Activity	%	63.0
	12233853	CHEMBL2219074	Millipore: Percentage of residual kinase activity of FGR at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC#CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cn1		CHEMBL203644	=	Residual Activity	%	105.0	CHEMBL4454	Homo sapiens	Residual Activity	%	105.0
	12233854	CHEMBL2219074	Millipore: Percentage of residual kinase activity of FGR at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1nc2ccccc2n1CCN1CCOCC1)c1cccc([N+](=O)[O-])c1		CHEMBL379787	=	Residual Activity	%	102.0	CHEMBL4454	Homo sapiens	Residual Activity	%	102.0
	12233855	CHEMBL2219074	Millipore: Percentage of residual kinase activity of FGR at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL188762	=	Residual Activity	%	102.0	CHEMBL4454	Homo sapiens	Residual Activity	%	102.0
	12233856	CHEMBL2219074	Millipore: Percentage of residual kinase activity of FGR at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Residual Activity	%	35.0	CHEMBL4454	Homo sapiens	Residual Activity	%	35.0
	12233857	CHEMBL2219074	Millipore: Percentage of residual kinase activity of FGR at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NCCNc1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1		CHEMBL471901	=	Residual Activity	%	30.0	CHEMBL4454	Homo sapiens	Residual Activity	%	30.0
	12233858	CHEMBL2219074	Millipore: Percentage of residual kinase activity of FGR at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C		CHEMBL86943	=	Residual Activity	%	87.0	CHEMBL4454	Homo sapiens	Residual Activity	%	87.0
	12233859	CHEMBL2219074	Millipore: Percentage of residual kinase activity of FGR at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC[n+]1c(/C=C/N(C)c2ccccc2)n(-c2ccccc2)c2ccc(-c3nc4ccccc4s3)cc21		CHEMBL1186409	=	Residual Activity	%	98.0	CHEMBL4454	Homo sapiens	Residual Activity	%	98.0
	12233860	CHEMBL2219074	Millipore: Percentage of residual kinase activity of FGR at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1OC		CHEMBL13045	=	Residual Activity	%	116.0	CHEMBL4454	Homo sapiens	Residual Activity	%	116.0
	12233861	CHEMBL2219074	Millipore: Percentage of residual kinase activity of FGR at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C(=O)Nc2sc3c(c2C(N)=O)CCCC3)cc1OC		CHEMBL210833	=	Residual Activity	%	110.0	CHEMBL4454	Homo sapiens	Residual Activity	%	110.0
	12233862	CHEMBL2219074	Millipore: Percentage of residual kinase activity of FGR at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	Residual Activity	%	69.0	CHEMBL4454	Homo sapiens	Residual Activity	%	69.0
	12233863	CHEMBL2219074	Millipore: Percentage of residual kinase activity of FGR at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCC(=O)Oc1ccc2[nH]c(C(=O)c3cc4ccccc4[nH]3)cc2c1		CHEMBL266325	=	Residual Activity	%	97.0	CHEMBL4454	Homo sapiens	Residual Activity	%	97.0
	12233864	CHEMBL2219074	Millipore: Percentage of residual kinase activity of FGR at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2cc(Nc3ccc(F)cc3)c(Nc3ccc(F)cc3)cc21		CHEMBL7939	=	Residual Activity	%	89.0	CHEMBL4454	Homo sapiens	Residual Activity	%	89.0
	12233865	CHEMBL2219074	Millipore: Percentage of residual kinase activity of FGR at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])/C=C/c1ccc2c(c1)OCO2		CHEMBL596380	=	Residual Activity	%	90.0	CHEMBL4454	Homo sapiens	Residual Activity	%	90.0
	12233866	CHEMBL2219074	Millipore: Percentage of residual kinase activity of FGR at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1ccc(Cl)cc1)c1ccccc1NCc1ccncc1		CHEMBL101683	=	Residual Activity	%	90.0	CHEMBL4454	Homo sapiens	Residual Activity	%	90.0
	12233867	CHEMBL2219074	Millipore: Percentage of residual kinase activity of FGR at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL331237	=	Residual Activity	%	103.0	CHEMBL4454	Homo sapiens	Residual Activity	%	103.0
	12233868	CHEMBL2219074	Millipore: Percentage of residual kinase activity of FGR at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCC		CHEMBL35820	=	Residual Activity	%	54.0	CHEMBL4454	Homo sapiens	Residual Activity	%	54.0
	12233869	CHEMBL2219074	Millipore: Percentage of residual kinase activity of FGR at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1cc2cc(O)ccc2[nH]1)c1cc2cc(O)ccc2[nH]1		CHEMBL377193	=	Residual Activity	%	5.0	CHEMBL4454	Homo sapiens	Residual Activity	%	5.0
	12233870	CHEMBL2219074	Millipore: Percentage of residual kinase activity of FGR at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(O)c(Br)c3)c2cc1OC		CHEMBL473773	=	Residual Activity	%	39.0	CHEMBL4454	Homo sapiens	Residual Activity	%	39.0
	12233871	CHEMBL2219074	Millipore: Percentage of residual kinase activity of FGR at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC		CHEMBL102346	=	Residual Activity	%	96.0	CHEMBL4454	Homo sapiens	Residual Activity	%	96.0
	12233872	CHEMBL2219074	Millipore: Percentage of residual kinase activity of FGR at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1		CHEMBL366266	=	Residual Activity	%	98.0	CHEMBL4454	Homo sapiens	Residual Activity	%	98.0
	12233873	CHEMBL2219074	Millipore: Percentage of residual kinase activity of FGR at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454	=	Residual Activity	%	90.0	CHEMBL4454	Homo sapiens	Residual Activity	%	90.0
	12233874	CHEMBL2219074	Millipore: Percentage of residual kinase activity of FGR at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	=	Residual Activity	%	8.0	CHEMBL4454	Homo sapiens	Residual Activity	%	8.0
	12233875	CHEMBL2219074	Millipore: Percentage of residual kinase activity of FGR at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Residual Activity	%	107.0	CHEMBL4454	Homo sapiens	Residual Activity	%	107.0
	12233876	CHEMBL2219074	Millipore: Percentage of residual kinase activity of FGR at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12		CHEMBL104468	=	Residual Activity	%	107.0	CHEMBL4454	Homo sapiens	Residual Activity	%	107.0
	12233877	CHEMBL2219074	Millipore: Percentage of residual kinase activity of FGR at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Residual Activity	%	101.0	CHEMBL4454	Homo sapiens	Residual Activity	%	101.0
	12233878	CHEMBL2219074	Millipore: Percentage of residual kinase activity of FGR at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)N(CCC(=O)c1ccc2ccccc2c1)Cc1ccccc1		CHEMBL596674	=	Residual Activity	%	106.0	CHEMBL4454	Homo sapiens	Residual Activity	%	106.0
	12233879	CHEMBL2219074	Millipore: Percentage of residual kinase activity of FGR at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2		CHEMBL120077	=	Residual Activity	%	20.0	CHEMBL4454	Homo sapiens	Residual Activity	%	20.0
	12233880	CHEMBL2219074	Millipore: Percentage of residual kinase activity of FGR at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	=	Residual Activity	%	98.0	CHEMBL4454	Homo sapiens	Residual Activity	%	98.0
	12233881	CHEMBL2219074	Millipore: Percentage of residual kinase activity of FGR at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226838	=	Residual Activity	%	111.0	CHEMBL4454	Homo sapiens	Residual Activity	%	111.0
	12233882	CHEMBL2219074	Millipore: Percentage of residual kinase activity of FGR at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Br)cc2/C1=C\c1cc2c([nH]1)CCCC2		CHEMBL2218925	=	Residual Activity	%	81.0	CHEMBL4454	Homo sapiens	Residual Activity	%	81.0
	12233883	CHEMBL2219074	Millipore: Percentage of residual kinase activity of FGR at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCCCN1c2ccccc2Oc2ccc(Cl)cc21		CHEMBL1398474	=	Residual Activity	%	111.0	CHEMBL4454	Homo sapiens	Residual Activity	%	111.0
	12233884	CHEMBL2219074	Millipore: Percentage of residual kinase activity of FGR at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)c1ccc(N2CCOCC2)cc1O		CHEMBL1317546	=	Residual Activity	%	110.0	CHEMBL4454	Homo sapiens	Residual Activity	%	110.0
	12233885	CHEMBL2219074	Millipore: Percentage of residual kinase activity of FGR at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Residual Activity	%	41.0	CHEMBL4454	Homo sapiens	Residual Activity	%	41.0
	12233886	CHEMBL2219074	Millipore: Percentage of residual kinase activity of FGR at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(-c3cccnc3)cc2/C1=C\c1ccc[nH]1		CHEMBL2218929	=	Residual Activity	%	11.0	CHEMBL4454	Homo sapiens	Residual Activity	%	11.0
	12233887	CHEMBL2219074	Millipore: Percentage of residual kinase activity of FGR at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=S)NC(=O)c4ccccc4C)cc3)c2cc1OC		CHEMBL2218930	=	Residual Activity	%	14.0	CHEMBL4454	Homo sapiens	Residual Activity	%	14.0
	12233888	CHEMBL2219074	Millipore: Percentage of residual kinase activity of FGR at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc2c(-c3ccncc3)c[nH]c2c1		CHEMBL380071	=	Residual Activity	%	117.0	CHEMBL4454	Homo sapiens	Residual Activity	%	117.0
	12233889	CHEMBL2219074	Millipore: Percentage of residual kinase activity of FGR at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C=C(C#N)C#N)cc1		CHEMBL77456	=	Residual Activity	%	107.0	CHEMBL4454	Homo sapiens	Residual Activity	%	107.0
	12233890	CHEMBL2219074	Millipore: Percentage of residual kinase activity of FGR at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711	=	Residual Activity	%	53.0	CHEMBL4454	Homo sapiens	Residual Activity	%	53.0
	12233891	CHEMBL2219074	Millipore: Percentage of residual kinase activity of FGR at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-c2nc3nnnn3nc21		CHEMBL599894	=	Residual Activity	%	104.0	CHEMBL4454	Homo sapiens	Residual Activity	%	104.0
	12233892	CHEMBL2219074	Millipore: Percentage of residual kinase activity of FGR at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Residual Activity	%	118.0	CHEMBL4454	Homo sapiens	Residual Activity	%	118.0
	12233893	CHEMBL2219074	Millipore: Percentage of residual kinase activity of FGR at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)c(C1=C(c3c[nH]c4ccccc34)C(=O)NC1=O)cn2CCCN(C)C		CHEMBL261491	=	Residual Activity	%	86.0	CHEMBL4454	Homo sapiens	Residual Activity	%	86.0
	12233894	CHEMBL2219074	Millipore: Percentage of residual kinase activity of FGR at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCCC1		CHEMBL47940	=	Residual Activity	%	2.0	CHEMBL4454	Homo sapiens	Residual Activity	%	2.0
	12233895	CHEMBL2219074	Millipore: Percentage of residual kinase activity of FGR at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc3ncsc3c2/C1=C/c1c[nH]cn1		CHEMBL235641	=	Residual Activity	%	47.0	CHEMBL4454	Homo sapiens	Residual Activity	%	47.0
	12233896	CHEMBL2219074	Millipore: Percentage of residual kinase activity of FGR at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cncc2cccc(S(=O)(=O)N3CCCN(C(=O)CN)C[C@H]3C)c12		CHEMBL2218931	=	Residual Activity	%	99.0	CHEMBL4454	Homo sapiens	Residual Activity	%	99.0
	12233897	CHEMBL2219074	Millipore: Percentage of residual kinase activity of FGR at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL56543	=	Residual Activity	%	110.0	CHEMBL4454	Homo sapiens	Residual Activity	%	110.0
	12233898	CHEMBL2219074	Millipore: Percentage of residual kinase activity of FGR at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(-c2cnc3c(-c4ccsc4)cnn3c2)cc1		CHEMBL92461	=	Residual Activity	%	101.0	CHEMBL4454	Homo sapiens	Residual Activity	%	101.0
	12233899	CHEMBL2219074	Millipore: Percentage of residual kinase activity of FGR at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC		CHEMBL382590	=	Residual Activity	%	71.0	CHEMBL4454	Homo sapiens	Residual Activity	%	71.0
	12233900	CHEMBL2219074	Millipore: Percentage of residual kinase activity of FGR at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1c2ccccc2[nH]c(=S)n1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1		CHEMBL261131	=	Residual Activity	%	110.0	CHEMBL4454	Homo sapiens	Residual Activity	%	110.0
	12233901	CHEMBL2219074	Millipore: Percentage of residual kinase activity of FGR at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]c3c2oc2ccccc23)cc1		CHEMBL406375	=	Residual Activity	%	102.0	CHEMBL4454	Homo sapiens	Residual Activity	%	102.0
	12233902	CHEMBL2219074	Millipore: Percentage of residual kinase activity of FGR at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Residual Activity	%	115.0	CHEMBL4454	Homo sapiens	Residual Activity	%	115.0
	12233903	CHEMBL2219074	Millipore: Percentage of residual kinase activity of FGR at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1cc(Cl)c(O)c(Cl)c1		CHEMBL2218932	=	Residual Activity	%	96.0	CHEMBL4454	Homo sapiens	Residual Activity	%	96.0
	12233904	CHEMBL2219074	Millipore: Percentage of residual kinase activity of FGR at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Residual Activity	%	7.0	CHEMBL4454	Homo sapiens	Residual Activity	%	7.0
	12233905	CHEMBL2219074	Millipore: Percentage of residual kinase activity of FGR at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CC(C#N)=C(N)/C(C#N)=C/c1ccc(O)cc1		CHEMBL76589	=	Residual Activity	%	109.0	CHEMBL4454	Homo sapiens	Residual Activity	%	109.0
	12233906	CHEMBL2219074	Millipore: Percentage of residual kinase activity of FGR at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1ccccc1)c1ccc(N2CCOCC2)cc1O		CHEMBL478980	=	Residual Activity	%	106.0	CHEMBL4454	Homo sapiens	Residual Activity	%	106.0
	12233907	CHEMBL2219074	Millipore: Percentage of residual kinase activity of FGR at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1		CHEMBL483847	=	Residual Activity	%	118.0	CHEMBL4454	Homo sapiens	Residual Activity	%	118.0
	12233908	CHEMBL2219074	Millipore: Percentage of residual kinase activity of FGR at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)c1ccc(/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL328710	=	Residual Activity	%	90.0	CHEMBL4454	Homo sapiens	Residual Activity	%	90.0
	12233909	CHEMBL2219074	Millipore: Percentage of residual kinase activity of FGR at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1/C=C/C=C(\C)C(=O)NC2=CC(=O)C=C(C2=O)[C@H](OC)[C@@H](C)C[C@H](OC)[C@H](OC)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O		CHEMBL479533	=	Residual Activity	%	99.0	CHEMBL4454	Homo sapiens	Residual Activity	%	99.0
	12233910	CHEMBL2219074	Millipore: Percentage of residual kinase activity of FGR at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCNCC2)oc2c(-c3ccccc3)cccc12		CHEMBL1363184	=	Residual Activity	%	106.0	CHEMBL4454	Homo sapiens	Residual Activity	%	106.0
	12233911	CHEMBL2219074	Millipore: Percentage of residual kinase activity of FGR at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C\c2ccc3nccnc3c2)S1		CHEMBL2218934	=	Residual Activity	%	107.0	CHEMBL4454	Homo sapiens	Residual Activity	%	107.0
	12233912	CHEMBL2219074	Millipore: Percentage of residual kinase activity of FGR at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		CHEMBL97771	=	Residual Activity	%	7.0	CHEMBL4454	Homo sapiens	Residual Activity	%	7.0
	12233913	CHEMBL2219074	Millipore: Percentage of residual kinase activity of FGR at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc2ncc(-c3ccccc3)nc2cc1C		CHEMBL7724	=	Residual Activity	%	113.0	CHEMBL4454	Homo sapiens	Residual Activity	%	113.0
	12233914	CHEMBL2219074	Millipore: Percentage of residual kinase activity of FGR at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1		CHEMBL383899	=	Residual Activity	%	59.0	CHEMBL4454	Homo sapiens	Residual Activity	%	59.0
	12233915	CHEMBL2219074	Millipore: Percentage of residual kinase activity of FGR at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	Residual Activity	%	96.0	CHEMBL4454	Homo sapiens	Residual Activity	%	96.0
	12233916	CHEMBL2219074	Millipore: Percentage of residual kinase activity of FGR at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2cc1OC		CHEMBL563845	=	Residual Activity	%	67.0	CHEMBL4454	Homo sapiens	Residual Activity	%	67.0
	12233917	CHEMBL2219074	Millipore: Percentage of residual kinase activity of FGR at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2cnc(Nc3ccc(OCCN4CCCC4)cc3)s2)cc1		CHEMBL2218935	=	Residual Activity	%	63.0	CHEMBL4454	Homo sapiens	Residual Activity	%	63.0
	12233918	CHEMBL2219074	Millipore: Percentage of residual kinase activity of FGR at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC1=C(C(=O)N2CCN(C)CC2)C(C)=C(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)C1		CHEMBL2218936	=	Residual Activity	%	35.0	CHEMBL4454	Homo sapiens	Residual Activity	%	35.0
	12233919	CHEMBL2219074	Millipore: Percentage of residual kinase activity of FGR at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C/c2ccc3c(c2)OC(F)(F)O3)S1		CHEMBL1231533	=	Residual Activity	%	105.0	CHEMBL4454	Homo sapiens	Residual Activity	%	105.0
	12233920	CHEMBL2219074	Millipore: Percentage of residual kinase activity of FGR at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C		CHEMBL13485	=	Residual Activity	%	8.0	CHEMBL4454	Homo sapiens	Residual Activity	%	8.0
	12233921	CHEMBL2219074	Millipore: Percentage of residual kinase activity of FGR at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncc(-c3ccccc3)nc2cc1OC		CHEMBL71191	=	Residual Activity	%	110.0	CHEMBL4454	Homo sapiens	Residual Activity	%	110.0
	12233922	CHEMBL2219074	Millipore: Percentage of residual kinase activity of FGR at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Residual Activity	%	1.0	CHEMBL4454	Homo sapiens	Residual Activity	%	1.0
	12233923	CHEMBL2219074	Millipore: Percentage of residual kinase activity of FGR at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN([C@@H](Cc1ccc(OS(=O)(=O)c2cccc3cnccc23)cc1)C(=O)N1CCN(c2ccccc2)CC1)S(=O)(=O)c1cccc2cnccc12		CHEMBL28324	=	Residual Activity	%	105.0	CHEMBL4454	Homo sapiens	Residual Activity	%	105.0
	12233924	CHEMBL2219074	Millipore: Percentage of residual kinase activity of FGR at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Residual Activity	%	63.0	CHEMBL4454	Homo sapiens	Residual Activity	%	63.0
	12233925	CHEMBL2219074	Millipore: Percentage of residual kinase activity of FGR at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3cc(Br)ccc3c21		CHEMBL64758	=	Residual Activity	%	100.0	CHEMBL4454	Homo sapiens	Residual Activity	%	100.0
	12233926	CHEMBL2219074	Millipore: Percentage of residual kinase activity of FGR at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Residual Activity	%	103.0	CHEMBL4454	Homo sapiens	Residual Activity	%	103.0
	12233927	CHEMBL2219074	Millipore: Percentage of residual kinase activity of FGR at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Residual Activity	%	21.0	CHEMBL4454	Homo sapiens	Residual Activity	%	21.0
	12233928	CHEMBL2219074	Millipore: Percentage of residual kinase activity of FGR at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(CCCc1ccc(-c2ccccc2F)cc1)Nc1ccc(O)cc1		CHEMBL235658	=	Residual Activity	%	93.0	CHEMBL4454	Homo sapiens	Residual Activity	%	93.0
	12233929	CHEMBL2219074	Millipore: Percentage of residual kinase activity of FGR at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)c3ccccc3)c2)[nH]1		CHEMBL111364	=	Residual Activity	%	84.0	CHEMBL4454	Homo sapiens	Residual Activity	%	84.0
	12233930	CHEMBL2219074	Millipore: Percentage of residual kinase activity of FGR at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Residual Activity	%	87.0	CHEMBL4454	Homo sapiens	Residual Activity	%	87.0
	12233931	CHEMBL2219074	Millipore: Percentage of residual kinase activity of FGR at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(-c2cccc3c2Sc2ccccc2S3)oc(N2CCOCC2)c1		CHEMBL222102	=	Residual Activity	%	99.0	CHEMBL4454	Homo sapiens	Residual Activity	%	99.0
	12233932	CHEMBL2219074	Millipore: Percentage of residual kinase activity of FGR at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12		CHEMBL126077	=	Residual Activity	%	8.0	CHEMBL4454	Homo sapiens	Residual Activity	%	8.0
	12233933	CHEMBL2219074	Millipore: Percentage of residual kinase activity of FGR at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(OC)c2c(=S)c3ccccc3[nH]c12		CHEMBL1331734	=	Residual Activity	%	94.0	CHEMBL4454	Homo sapiens	Residual Activity	%	94.0
	12233934	CHEMBL2219074	Millipore: Percentage of residual kinase activity of FGR at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL259551	=	Residual Activity	%	86.0	CHEMBL4454	Homo sapiens	Residual Activity	%	86.0
	12233935	CHEMBL2219074	Millipore: Percentage of residual kinase activity of FGR at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1		CHEMBL359482	=	Residual Activity	%	18.0	CHEMBL4454	Homo sapiens	Residual Activity	%	18.0
	12233936	CHEMBL2219074	Millipore: Percentage of residual kinase activity of FGR at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	=	Residual Activity	%	83.0	CHEMBL4454	Homo sapiens	Residual Activity	%	83.0
	12233937	CHEMBL2219074	Millipore: Percentage of residual kinase activity of FGR at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c(-c2ccc(F)cc2)c(-c2ccncc2)nn1-c1ccc(Cl)cc1		CHEMBL91730	=	Residual Activity	%	86.0	CHEMBL4454	Homo sapiens	Residual Activity	%	86.0
	12233938	CHEMBL2219074	Millipore: Percentage of residual kinase activity of FGR at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Residual Activity	%	98.0	CHEMBL4454	Homo sapiens	Residual Activity	%	98.0
	12233939	CHEMBL2219074	Millipore: Percentage of residual kinase activity of FGR at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(NC(NC(=S)Nc1ccc(F)c([N+](=O)[O-])c1)C(Cl)(Cl)Cl)C(c1ccccc1)c1ccccc1		CHEMBL1221601	=	Residual Activity	%	105.0	CHEMBL4454	Homo sapiens	Residual Activity	%	105.0
	12233940	CHEMBL2219074	Millipore: Percentage of residual kinase activity of FGR at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(S(=O)(=O)/C=C/C#N)cc1		CHEMBL403183	=	Residual Activity	%	108.0	CHEMBL4454	Homo sapiens	Residual Activity	%	108.0
	12233941	CHEMBL2219074	Millipore: Percentage of residual kinase activity of FGR at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1		CHEMBL290904	=	Residual Activity	%	90.0	CHEMBL4454	Homo sapiens	Residual Activity	%	90.0
	12233942	CHEMBL2219074	Millipore: Percentage of residual kinase activity of FGR at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL2218938	=	Residual Activity	%	89.0	CHEMBL4454	Homo sapiens	Residual Activity	%	89.0
	12233943	CHEMBL2219074	Millipore: Percentage of residual kinase activity of FGR at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1n1cncc21		CHEMBL413188	=	Residual Activity	%	75.0	CHEMBL4454	Homo sapiens	Residual Activity	%	75.0
	12233944	CHEMBL2219074	Millipore: Percentage of residual kinase activity of FGR at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Residual Activity	%	3.0	CHEMBL4454	Homo sapiens	Residual Activity	%	3.0
	12233945	CHEMBL2219074	Millipore: Percentage of residual kinase activity of FGR at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cccc(-c2cc(=O)c3ccccc3o2)c1N		CHEMBL35482	=	Residual Activity	%	97.0	CHEMBL4454	Homo sapiens	Residual Activity	%	97.0
	12233946	CHEMBL2219074	Millipore: Percentage of residual kinase activity of FGR at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C1CCC3O1		CHEMBL304428	=	Residual Activity	%	102.0	CHEMBL4454	Homo sapiens	Residual Activity	%	102.0
	12233947	CHEMBL2219074	Millipore: Percentage of residual kinase activity of FGR at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Residual Activity	%	40.0	CHEMBL4454	Homo sapiens	Residual Activity	%	40.0
	12233948	CHEMBL2219074	Millipore: Percentage of residual kinase activity of FGR at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2c(NCc3ccccc3)nc(NCCCO)nc21		CHEMBL83980	=	Residual Activity	%	103.0	CHEMBL4454	Homo sapiens	Residual Activity	%	103.0
	12233949	CHEMBL2219074	Millipore: Percentage of residual kinase activity of FGR at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21		CHEMBL408982	=	Residual Activity	%	83.0	CHEMBL4454	Homo sapiens	Residual Activity	%	83.0
	12233950	CHEMBL2219074	Millipore: Percentage of residual kinase activity of FGR at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21		CHEMBL602937	=	Residual Activity	%	92.0	CHEMBL4454	Homo sapiens	Residual Activity	%	92.0
	12233951	CHEMBL2219074	Millipore: Percentage of residual kinase activity of FGR at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc(OC)c(/C=C2\C(=O)Nc3ccccc32)c(OC)c1		CHEMBL404941	=	Residual Activity	%	86.0	CHEMBL4454	Homo sapiens	Residual Activity	%	86.0
	12233952	CHEMBL2219074	Millipore: Percentage of residual kinase activity of FGR at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Residual Activity	%	48.0	CHEMBL4454	Homo sapiens	Residual Activity	%	48.0
	12233953	CHEMBL2219074	Millipore: Percentage of residual kinase activity of FGR at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17331	=	Residual Activity	%	103.0	CHEMBL4454	Homo sapiens	Residual Activity	%	103.0
	12233954	CHEMBL2219074	Millipore: Percentage of residual kinase activity of FGR at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc(-c2ccccc2)c(-c2ccncc2)o1		CHEMBL36450	=	Residual Activity	%	95.0	CHEMBL4454	Homo sapiens	Residual Activity	%	95.0
	12233955	CHEMBL2219074	Millipore: Percentage of residual kinase activity of FGR at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CCCc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2		CHEMBL260138	=	Residual Activity	%	15.0	CHEMBL4454	Homo sapiens	Residual Activity	%	15.0
	12233956	CHEMBL2219074	Millipore: Percentage of residual kinase activity of FGR at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C\c1c(Cl)[nH]c2ccccc12		CHEMBL261425	=	Residual Activity	%	97.0	CHEMBL4454	Homo sapiens	Residual Activity	%	97.0
	12233957	CHEMBL2219074	Millipore: Percentage of residual kinase activity of FGR at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL179583	=	Residual Activity	%	99.0	CHEMBL4454	Homo sapiens	Residual Activity	%	99.0
	12233958	CHEMBL2219074	Millipore: Percentage of residual kinase activity of FGR at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1sc(=O)n(Cc2ccccc2)c1=O		CHEMBL284861	=	Residual Activity	%	90.0	CHEMBL4454	Homo sapiens	Residual Activity	%	90.0
	12233959	CHEMBL2219074	Millipore: Percentage of residual kinase activity of FGR at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Residual Activity	%	28.0	CHEMBL4454	Homo sapiens	Residual Activity	%	28.0
	12233960	CHEMBL2219074	Millipore: Percentage of residual kinase activity of FGR at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)C/C=C/c2ccc(Cl)cc2)cc1		CHEMBL155333	=	Residual Activity	%	95.0	CHEMBL4454	Homo sapiens	Residual Activity	%	95.0
	12233961	CHEMBL2219074	Millipore: Percentage of residual kinase activity of FGR at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	=	Residual Activity	%	81.0	CHEMBL4454	Homo sapiens	Residual Activity	%	81.0
	12233962	CHEMBL2219074	Millipore: Percentage of residual kinase activity of FGR at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL313417	=	Residual Activity	%	109.0	CHEMBL4454	Homo sapiens	Residual Activity	%	109.0
	12233963	CHEMBL2219074	Millipore: Percentage of residual kinase activity of FGR at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12		CHEMBL75680	=	Residual Activity	%	57.0	CHEMBL4454	Homo sapiens	Residual Activity	%	57.0
	12233964	CHEMBL2219074	Millipore: Percentage of residual kinase activity of FGR at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL367625	=	Residual Activity	%	18.0	CHEMBL4454	Homo sapiens	Residual Activity	%	18.0
	12233965	CHEMBL2219074	Millipore: Percentage of residual kinase activity of FGR at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21		CHEMBL311228	=	Residual Activity	%	48.0	CHEMBL4454	Homo sapiens	Residual Activity	%	48.0
	12233966	CHEMBL2219074	Millipore: Percentage of residual kinase activity of FGR at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1		CHEMBL288064	=	Residual Activity	%	80.0	CHEMBL4454	Homo sapiens	Residual Activity	%	80.0
	12233967	CHEMBL2219074	Millipore: Percentage of residual kinase activity of FGR at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\OCCC(O)CO		CHEMBL1802727	=	Residual Activity	%	3.0	CHEMBL4454	Homo sapiens	Residual Activity	%	3.0
	12233968	CHEMBL2219074	Millipore: Percentage of residual kinase activity of FGR at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(/N)SC1C=CC=CC1)c1cccc(C(O)c2ccncc2)c1		CHEMBL2218939	=	Residual Activity	%	103.0	CHEMBL4454	Homo sapiens	Residual Activity	%	103.0
	12233969	CHEMBL2219074	Millipore: Percentage of residual kinase activity of FGR at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23327	=	Residual Activity	%	23.0	CHEMBL4454	Homo sapiens	Residual Activity	%	23.0
	12233970	CHEMBL2219074	Millipore: Percentage of residual kinase activity of FGR at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1		CHEMBL1076555	=	Residual Activity	%	96.0	CHEMBL4454	Homo sapiens	Residual Activity	%	96.0
	12233971	CHEMBL2219074	Millipore: Percentage of residual kinase activity of FGR at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(OC)cc2)[nH]c2nccnc12		CHEMBL306498	=	Residual Activity	%	61.0	CHEMBL4454	Homo sapiens	Residual Activity	%	61.0
	12233972	CHEMBL2219074	Millipore: Percentage of residual kinase activity of FGR at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F		CHEMBL261720	=	Residual Activity	%	9.0	CHEMBL4454	Homo sapiens	Residual Activity	%	9.0
	12233973	CHEMBL2219074	Millipore: Percentage of residual kinase activity of FGR at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNc2nc(N(CCO)CCO)nc3c2ncn3C(C)C)cc1		CHEMBL80713	=	Residual Activity	%	77.0	CHEMBL4454	Homo sapiens	Residual Activity	%	77.0
	12233974	CHEMBL2219074	Millipore: Percentage of residual kinase activity of FGR at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Residual Activity	%	31.0	CHEMBL4454	Homo sapiens	Residual Activity	%	31.0
	12233975	CHEMBL2219074	Millipore: Percentage of residual kinase activity of FGR at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Residual Activity	%	75.0	CHEMBL4454	Homo sapiens	Residual Activity	%	75.0
	12233976	CHEMBL2219074	Millipore: Percentage of residual kinase activity of FGR at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1C(Cl)=C(N2C(=O)CCC2=O)C(=O)c2ccccc21		CHEMBL404939	=	Residual Activity	%	94.0	CHEMBL4454	Homo sapiens	Residual Activity	%	94.0
	12233977	CHEMBL2219074	Millipore: Percentage of residual kinase activity of FGR at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1		CHEMBL405759	=	Residual Activity	%	0.0	CHEMBL4454	Homo sapiens	Residual Activity	%	0.0
	12233978	CHEMBL2219074	Millipore: Percentage of residual kinase activity of FGR at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL286721	=	Residual Activity	%	33.0	CHEMBL4454	Homo sapiens	Residual Activity	%	33.0
	12233979	CHEMBL2219074	Millipore: Percentage of residual kinase activity of FGR at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nc3ccccc3nc12		CHEMBL259389	=	Residual Activity	%	100.0	CHEMBL4454	Homo sapiens	Residual Activity	%	100.0
	12233980	CHEMBL2219074	Millipore: Percentage of residual kinase activity of FGR at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)C(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL1802728	=	Residual Activity	%	55.0	CHEMBL4454	Homo sapiens	Residual Activity	%	55.0
	12233981	CHEMBL2219074	Millipore: Percentage of residual kinase activity of FGR at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL409450	=	Residual Activity	%	1.0	CHEMBL4454	Homo sapiens	Residual Activity	%	1.0
	12233982	CHEMBL2219074	Millipore: Percentage of residual kinase activity of FGR at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1nc2c3c(cccc31)C(=O)c1ccccc1-2		CHEMBL1802485	=	Residual Activity	%	98.0	CHEMBL4454	Homo sapiens	Residual Activity	%	98.0
	12233983	CHEMBL2219074	Millipore: Percentage of residual kinase activity of FGR at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(\N)Sc1ccc(N)cc1)c1ccccc1C(F)(F)F		CHEMBL2218940	=	Residual Activity	%	88.0	CHEMBL4454	Homo sapiens	Residual Activity	%	88.0
	12233984	CHEMBL2219074	Millipore: Percentage of residual kinase activity of FGR at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Residual Activity	%	104.0	CHEMBL4454	Homo sapiens	Residual Activity	%	104.0
	12233985	CHEMBL2219074	Millipore: Percentage of residual kinase activity of FGR at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21		CHEMBL1182777	=	Residual Activity	%	97.0	CHEMBL4454	Homo sapiens	Residual Activity	%	97.0
	12233986	CHEMBL2219074	Millipore: Percentage of residual kinase activity of FGR at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	Residual Activity	%	28.0	CHEMBL4454	Homo sapiens	Residual Activity	%	28.0
	12233987	CHEMBL2219074	Millipore: Percentage of residual kinase activity of FGR at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Residual Activity	%	109.0	CHEMBL4454	Homo sapiens	Residual Activity	%	109.0
	12233988	CHEMBL2219074	Millipore: Percentage of residual kinase activity of FGR at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)c1nn(-c2c(Cl)cccc2Cl)c2nc(Cc3ccc(OCCO)cc3)[nH]c(=O)c12		CHEMBL258721	=	Residual Activity	%	110.0	CHEMBL4454	Homo sapiens	Residual Activity	%	110.0
	12233989	CHEMBL2219074	Millipore: Percentage of residual kinase activity of FGR at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)O/N=C1C(=C2\C(=O)Nc3cc(Br)ccc32)\Nc2ccccc2\1		CHEMBL2218941	=	Residual Activity	%	10.0	CHEMBL4454	Homo sapiens	Residual Activity	%	10.0
	12233990	CHEMBL2219074	Millipore: Percentage of residual kinase activity of FGR at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Residual Activity	%	81.0	CHEMBL4454	Homo sapiens	Residual Activity	%	81.0
	12233991	CHEMBL2219074	Millipore: Percentage of residual kinase activity of FGR at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	Residual Activity	%	56.0	CHEMBL4454	Homo sapiens	Residual Activity	%	56.0
	12233992	CHEMBL2219074	Millipore: Percentage of residual kinase activity of FGR at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCc1nc(-c2ccc(OC)cc2)[nH]c1-c1ccncc1		CHEMBL278724	=	Residual Activity	%	111.0	CHEMBL4454	Homo sapiens	Residual Activity	%	111.0
	12233993	CHEMBL2219074	Millipore: Percentage of residual kinase activity of FGR at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL258805	=	Residual Activity	%	69.0	CHEMBL4454	Homo sapiens	Residual Activity	%	69.0
	12233994	CHEMBL2219074	Millipore: Percentage of residual kinase activity of FGR at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)/C=C/c1cc(Br)c(Br)c(Br)c1Br		CHEMBL270724	=	Residual Activity	%	104.0	CHEMBL4454	Homo sapiens	Residual Activity	%	104.0
	12233995	CHEMBL2219074	Millipore: Percentage of residual kinase activity of FGR at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N/C(=N\[N+](=O)[O-])N/N=C\c1ccc(-c2cccc([N+](=O)[O-])c2)o1		CHEMBL221271	=	Residual Activity	%	121.0	CHEMBL4454	Homo sapiens	Residual Activity	%	121.0
	12233996	CHEMBL2219074	Millipore: Percentage of residual kinase activity of FGR at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1cnccn1		CHEMBL272629	=	Residual Activity	%	95.0	CHEMBL4454	Homo sapiens	Residual Activity	%	95.0
	12233997	CHEMBL2219074	Millipore: Percentage of residual kinase activity of FGR at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Residual Activity	%	99.0	CHEMBL4454	Homo sapiens	Residual Activity	%	99.0
	12233998	CHEMBL2219074	Millipore: Percentage of residual kinase activity of FGR at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ccc2ncnc(NCCc3ccc(Oc4ccccc4)cc3)c2c1		CHEMBL522502	=	Residual Activity	%	84.0	CHEMBL4454	Homo sapiens	Residual Activity	%	84.0
	12233999	CHEMBL2219074	Millipore: Percentage of residual kinase activity of FGR at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Residual Activity	%	93.0	CHEMBL4454	Homo sapiens	Residual Activity	%	93.0
	12234000	CHEMBL2219074	Millipore: Percentage of residual kinase activity of FGR at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1cnc2cnc(NCc3cccnc3)cc2c1Nc1ccc(F)c(Cl)c1		CHEMBL200381	=	Residual Activity	%	11.0	CHEMBL4454	Homo sapiens	Residual Activity	%	11.0
	12234001	CHEMBL2219075	Millipore: Percentage of residual kinase activity of FGR at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1cc(C=C(C#N)C#N)cc(Br)c1O		CHEMBL2218926	=	Residual Activity	%	96.0	CHEMBL4454	Homo sapiens	Residual Activity	%	96.0
	12234002	CHEMBL2219075	Millipore: Percentage of residual kinase activity of FGR at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL266487	=	Residual Activity	%	60.0	CHEMBL4454	Homo sapiens	Residual Activity	%	60.0
	12234003	CHEMBL2219075	Millipore: Percentage of residual kinase activity of FGR at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1		CHEMBL387187	=	Residual Activity	%	81.0	CHEMBL4454	Homo sapiens	Residual Activity	%	81.0
	12234004	CHEMBL2219075	Millipore: Percentage of residual kinase activity of FGR at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12		CHEMBL439259	=	Residual Activity	%	82.0	CHEMBL4454	Homo sapiens	Residual Activity	%	82.0
	12234005	CHEMBL2219075	Millipore: Percentage of residual kinase activity of FGR at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CNc1cc2c(Nc3cccc(Br)c3)ncnc2cn1		CHEMBL53753	=	Residual Activity	%	60.0	CHEMBL4454	Homo sapiens	Residual Activity	%	60.0
	12234006	CHEMBL2219075	Millipore: Percentage of residual kinase activity of FGR at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL65063	=	Residual Activity	%	85.0	CHEMBL4454	Homo sapiens	Residual Activity	%	85.0
	12234007	CHEMBL2219075	Millipore: Percentage of residual kinase activity of FGR at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL104279	=	Residual Activity	%	10.0	CHEMBL4454	Homo sapiens	Residual Activity	%	10.0
	12234008	CHEMBL2219075	Millipore: Percentage of residual kinase activity of FGR at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1OC		CHEMBL7917	=	Residual Activity	%	12.0	CHEMBL4454	Homo sapiens	Residual Activity	%	12.0
	12234009	CHEMBL2219075	Millipore: Percentage of residual kinase activity of FGR at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc2cc3nc(-c4cccs4)cnc3cc2n1C		CHEMBL2218927	=	Residual Activity	%	69.0	CHEMBL4454	Homo sapiens	Residual Activity	%	69.0
	12234010	CHEMBL2219075	Millipore: Percentage of residual kinase activity of FGR at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cnc2cc3c(Nc4cccc(Br)c4)ncnc3cc21		CHEMBL174426	=	Residual Activity	%	35.0	CHEMBL4454	Homo sapiens	Residual Activity	%	35.0
	12234011	CHEMBL2219075	Millipore: Percentage of residual kinase activity of FGR at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC#CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cn1		CHEMBL203644	=	Residual Activity	%	95.0	CHEMBL4454	Homo sapiens	Residual Activity	%	95.0
	12234012	CHEMBL2219075	Millipore: Percentage of residual kinase activity of FGR at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1nc2ccccc2n1CCN1CCOCC1)c1cccc([N+](=O)[O-])c1		CHEMBL379787	=	Residual Activity	%	92.0	CHEMBL4454	Homo sapiens	Residual Activity	%	92.0
	12234013	CHEMBL2219075	Millipore: Percentage of residual kinase activity of FGR at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL188762	=	Residual Activity	%	76.0	CHEMBL4454	Homo sapiens	Residual Activity	%	76.0
	12234014	CHEMBL2219075	Millipore: Percentage of residual kinase activity of FGR at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Residual Activity	%	4.0	CHEMBL4454	Homo sapiens	Residual Activity	%	4.0
	12234015	CHEMBL2219075	Millipore: Percentage of residual kinase activity of FGR at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NCCNc1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1		CHEMBL471901	=	Residual Activity	%	6.0	CHEMBL4454	Homo sapiens	Residual Activity	%	6.0
	12234016	CHEMBL2219075	Millipore: Percentage of residual kinase activity of FGR at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C		CHEMBL86943	=	Residual Activity	%	74.0	CHEMBL4454	Homo sapiens	Residual Activity	%	74.0
	12234017	CHEMBL2219075	Millipore: Percentage of residual kinase activity of FGR at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC[n+]1c(/C=C/N(C)c2ccccc2)n(-c2ccccc2)c2ccc(-c3nc4ccccc4s3)cc21		CHEMBL1186409	=	Residual Activity	%	88.0	CHEMBL4454	Homo sapiens	Residual Activity	%	88.0
	12234018	CHEMBL2219075	Millipore: Percentage of residual kinase activity of FGR at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1OC		CHEMBL13045	=	Residual Activity	%	77.0	CHEMBL4454	Homo sapiens	Residual Activity	%	77.0
	12234019	CHEMBL2219075	Millipore: Percentage of residual kinase activity of FGR at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C(=O)Nc2sc3c(c2C(N)=O)CCCC3)cc1OC		CHEMBL210833	=	Residual Activity	%	93.0	CHEMBL4454	Homo sapiens	Residual Activity	%	93.0
	12234020	CHEMBL2219075	Millipore: Percentage of residual kinase activity of FGR at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	Residual Activity	%	70.0	CHEMBL4454	Homo sapiens	Residual Activity	%	70.0
	12234021	CHEMBL2219075	Millipore: Percentage of residual kinase activity of FGR at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCC(=O)Oc1ccc2[nH]c(C(=O)c3cc4ccccc4[nH]3)cc2c1		CHEMBL266325	=	Residual Activity	%	82.0	CHEMBL4454	Homo sapiens	Residual Activity	%	82.0
	12234022	CHEMBL2219075	Millipore: Percentage of residual kinase activity of FGR at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2cc(Nc3ccc(F)cc3)c(Nc3ccc(F)cc3)cc21		CHEMBL7939	=	Residual Activity	%	44.0	CHEMBL4454	Homo sapiens	Residual Activity	%	44.0
	12234023	CHEMBL2219075	Millipore: Percentage of residual kinase activity of FGR at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])/C=C/c1ccc2c(c1)OCO2		CHEMBL596380	=	Residual Activity	%	92.0	CHEMBL4454	Homo sapiens	Residual Activity	%	92.0
	12234024	CHEMBL2219075	Millipore: Percentage of residual kinase activity of FGR at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1ccc(Cl)cc1)c1ccccc1NCc1ccncc1		CHEMBL101683	=	Residual Activity	%	88.0	CHEMBL4454	Homo sapiens	Residual Activity	%	88.0
	12234025	CHEMBL2219075	Millipore: Percentage of residual kinase activity of FGR at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL331237	=	Residual Activity	%	105.0	CHEMBL4454	Homo sapiens	Residual Activity	%	105.0
	12234026	CHEMBL2219075	Millipore: Percentage of residual kinase activity of FGR at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCC		CHEMBL35820	=	Residual Activity	%	10.0	CHEMBL4454	Homo sapiens	Residual Activity	%	10.0
	12234027	CHEMBL2219075	Millipore: Percentage of residual kinase activity of FGR at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1cc2cc(O)ccc2[nH]1)c1cc2cc(O)ccc2[nH]1		CHEMBL377193	=	Residual Activity	%	2.0	CHEMBL4454	Homo sapiens	Residual Activity	%	2.0
	12234028	CHEMBL2219075	Millipore: Percentage of residual kinase activity of FGR at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(O)c(Br)c3)c2cc1OC		CHEMBL473773	=	Residual Activity	%	6.0	CHEMBL4454	Homo sapiens	Residual Activity	%	6.0
	12234029	CHEMBL2219075	Millipore: Percentage of residual kinase activity of FGR at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC		CHEMBL102346	=	Residual Activity	%	97.0	CHEMBL4454	Homo sapiens	Residual Activity	%	97.0
	12234030	CHEMBL2219075	Millipore: Percentage of residual kinase activity of FGR at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1		CHEMBL366266	=	Residual Activity	%	59.0	CHEMBL4454	Homo sapiens	Residual Activity	%	59.0
	12234031	CHEMBL2219075	Millipore: Percentage of residual kinase activity of FGR at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454	=	Residual Activity	%	51.0	CHEMBL4454	Homo sapiens	Residual Activity	%	51.0
	12234032	CHEMBL2219075	Millipore: Percentage of residual kinase activity of FGR at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	=	Residual Activity	%	4.0	CHEMBL4454	Homo sapiens	Residual Activity	%	4.0
	12234033	CHEMBL2219075	Millipore: Percentage of residual kinase activity of FGR at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Residual Activity	%	83.0	CHEMBL4454	Homo sapiens	Residual Activity	%	83.0
	12234034	CHEMBL2219075	Millipore: Percentage of residual kinase activity of FGR at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12		CHEMBL104468	=	Residual Activity	%	94.0	CHEMBL4454	Homo sapiens	Residual Activity	%	94.0
	12234035	CHEMBL2219075	Millipore: Percentage of residual kinase activity of FGR at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Residual Activity	%	83.0	CHEMBL4454	Homo sapiens	Residual Activity	%	83.0
	12234036	CHEMBL2219075	Millipore: Percentage of residual kinase activity of FGR at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)N(CCC(=O)c1ccc2ccccc2c1)Cc1ccccc1		CHEMBL596674	=	Residual Activity	%	94.0	CHEMBL4454	Homo sapiens	Residual Activity	%	94.0
	12234037	CHEMBL2219075	Millipore: Percentage of residual kinase activity of FGR at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2		CHEMBL120077	=	Residual Activity	%	4.0	CHEMBL4454	Homo sapiens	Residual Activity	%	4.0
	12234038	CHEMBL2219075	Millipore: Percentage of residual kinase activity of FGR at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	=	Residual Activity	%	99.0	CHEMBL4454	Homo sapiens	Residual Activity	%	99.0
	12234039	CHEMBL2219075	Millipore: Percentage of residual kinase activity of FGR at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226838	=	Residual Activity	%	88.0	CHEMBL4454	Homo sapiens	Residual Activity	%	88.0
	12234040	CHEMBL2219075	Millipore: Percentage of residual kinase activity of FGR at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Br)cc2/C1=C\c1cc2c([nH]1)CCCC2		CHEMBL2218925	=	Residual Activity	%	72.0	CHEMBL4454	Homo sapiens	Residual Activity	%	72.0
	12234041	CHEMBL2219075	Millipore: Percentage of residual kinase activity of FGR at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCCCN1c2ccccc2Oc2ccc(Cl)cc21		CHEMBL1398474	=	Residual Activity	%	95.0	CHEMBL4454	Homo sapiens	Residual Activity	%	95.0
	12234042	CHEMBL2219075	Millipore: Percentage of residual kinase activity of FGR at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)c1ccc(N2CCOCC2)cc1O		CHEMBL1317546	=	Residual Activity	%	102.0	CHEMBL4454	Homo sapiens	Residual Activity	%	102.0
	12234043	CHEMBL2219075	Millipore: Percentage of residual kinase activity of FGR at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Residual Activity	%	47.0	CHEMBL4454	Homo sapiens	Residual Activity	%	47.0
	12234044	CHEMBL2219075	Millipore: Percentage of residual kinase activity of FGR at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(-c3cccnc3)cc2/C1=C\c1ccc[nH]1		CHEMBL2218929	=	Residual Activity	%	2.0	CHEMBL4454	Homo sapiens	Residual Activity	%	2.0
	12234045	CHEMBL2219075	Millipore: Percentage of residual kinase activity of FGR at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=S)NC(=O)c4ccccc4C)cc3)c2cc1OC		CHEMBL2218930	=	Residual Activity	%	3.0	CHEMBL4454	Homo sapiens	Residual Activity	%	3.0
	12234046	CHEMBL2219075	Millipore: Percentage of residual kinase activity of FGR at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc2c(-c3ccncc3)c[nH]c2c1		CHEMBL380071	=	Residual Activity	%	91.0	CHEMBL4454	Homo sapiens	Residual Activity	%	91.0
	12234047	CHEMBL2219075	Millipore: Percentage of residual kinase activity of FGR at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C=C(C#N)C#N)cc1		CHEMBL77456	=	Residual Activity	%	94.0	CHEMBL4454	Homo sapiens	Residual Activity	%	94.0
	12234048	CHEMBL2219075	Millipore: Percentage of residual kinase activity of FGR at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711	=	Residual Activity	%	30.0	CHEMBL4454	Homo sapiens	Residual Activity	%	30.0
	12234049	CHEMBL2219075	Millipore: Percentage of residual kinase activity of FGR at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-c2nc3nnnn3nc21		CHEMBL599894	=	Residual Activity	%	78.0	CHEMBL4454	Homo sapiens	Residual Activity	%	78.0
	12234050	CHEMBL2219075	Millipore: Percentage of residual kinase activity of FGR at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Residual Activity	%	97.0	CHEMBL4454	Homo sapiens	Residual Activity	%	97.0
	12234051	CHEMBL2219075	Millipore: Percentage of residual kinase activity of FGR at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)c(C1=C(c3c[nH]c4ccccc34)C(=O)NC1=O)cn2CCCN(C)C		CHEMBL261491	=	Residual Activity	%	33.0	CHEMBL4454	Homo sapiens	Residual Activity	%	33.0
	12234052	CHEMBL2219075	Millipore: Percentage of residual kinase activity of FGR at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCCC1		CHEMBL47940	=	Residual Activity	%	0.0	CHEMBL4454	Homo sapiens	Residual Activity	%	0.0
	12234053	CHEMBL2219075	Millipore: Percentage of residual kinase activity of FGR at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc3ncsc3c2/C1=C/c1c[nH]cn1		CHEMBL235641	=	Residual Activity	%	15.0	CHEMBL4454	Homo sapiens	Residual Activity	%	15.0
	12234054	CHEMBL2219075	Millipore: Percentage of residual kinase activity of FGR at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cncc2cccc(S(=O)(=O)N3CCCN(C(=O)CN)C[C@H]3C)c12		CHEMBL2218931	=	Residual Activity	%	53.0	CHEMBL4454	Homo sapiens	Residual Activity	%	53.0
	12234055	CHEMBL2219075	Millipore: Percentage of residual kinase activity of FGR at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL56543	=	Residual Activity	%	82.0	CHEMBL4454	Homo sapiens	Residual Activity	%	82.0
	12234056	CHEMBL2219075	Millipore: Percentage of residual kinase activity of FGR at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(-c2cnc3c(-c4ccsc4)cnn3c2)cc1		CHEMBL92461	=	Residual Activity	%	100.0	CHEMBL4454	Homo sapiens	Residual Activity	%	100.0
	12234057	CHEMBL2219075	Millipore: Percentage of residual kinase activity of FGR at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC		CHEMBL382590	=	Residual Activity	%	25.0	CHEMBL4454	Homo sapiens	Residual Activity	%	25.0
	12234058	CHEMBL2219075	Millipore: Percentage of residual kinase activity of FGR at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1c2ccccc2[nH]c(=S)n1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1		CHEMBL261131	=	Residual Activity	%	91.0	CHEMBL4454	Homo sapiens	Residual Activity	%	91.0
	12234059	CHEMBL2219075	Millipore: Percentage of residual kinase activity of FGR at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]c3c2oc2ccccc23)cc1		CHEMBL406375	=	Residual Activity	%	49.0	CHEMBL4454	Homo sapiens	Residual Activity	%	49.0
	12234060	CHEMBL2219075	Millipore: Percentage of residual kinase activity of FGR at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Residual Activity	%	97.0	CHEMBL4454	Homo sapiens	Residual Activity	%	97.0
	12234061	CHEMBL2219075	Millipore: Percentage of residual kinase activity of FGR at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1cc(Cl)c(O)c(Cl)c1		CHEMBL2218932	=	Residual Activity	%	42.0	CHEMBL4454	Homo sapiens	Residual Activity	%	42.0
	12234062	CHEMBL2219075	Millipore: Percentage of residual kinase activity of FGR at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Residual Activity	%	4.0	CHEMBL4454	Homo sapiens	Residual Activity	%	4.0
	12234063	CHEMBL2219075	Millipore: Percentage of residual kinase activity of FGR at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CC(C#N)=C(N)/C(C#N)=C/c1ccc(O)cc1		CHEMBL76589	=	Residual Activity	%	96.0	CHEMBL4454	Homo sapiens	Residual Activity	%	96.0
	12234064	CHEMBL2219075	Millipore: Percentage of residual kinase activity of FGR at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1ccccc1)c1ccc(N2CCOCC2)cc1O		CHEMBL478980	=	Residual Activity	%	102.0	CHEMBL4454	Homo sapiens	Residual Activity	%	102.0
	12234065	CHEMBL2219075	Millipore: Percentage of residual kinase activity of FGR at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1		CHEMBL483847	=	Residual Activity	%	106.0	CHEMBL4454	Homo sapiens	Residual Activity	%	106.0
	12234066	CHEMBL2219075	Millipore: Percentage of residual kinase activity of FGR at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)c1ccc(/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL328710	=	Residual Activity	%	44.0	CHEMBL4454	Homo sapiens	Residual Activity	%	44.0
	12234067	CHEMBL2219075	Millipore: Percentage of residual kinase activity of FGR at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1/C=C/C=C(\C)C(=O)NC2=CC(=O)C=C(C2=O)[C@H](OC)[C@@H](C)C[C@H](OC)[C@H](OC)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O		CHEMBL479533	=	Residual Activity	%	100.0	CHEMBL4454	Homo sapiens	Residual Activity	%	100.0
	12234068	CHEMBL2219075	Millipore: Percentage of residual kinase activity of FGR at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCNCC2)oc2c(-c3ccccc3)cccc12		CHEMBL1363184	=	Residual Activity	%	90.0	CHEMBL4454	Homo sapiens	Residual Activity	%	90.0
	12234069	CHEMBL2219075	Millipore: Percentage of residual kinase activity of FGR at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C\c2ccc3nccnc3c2)S1		CHEMBL2218934	=	Residual Activity	%	89.0	CHEMBL4454	Homo sapiens	Residual Activity	%	89.0
	12234070	CHEMBL2219075	Millipore: Percentage of residual kinase activity of FGR at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		CHEMBL97771	=	Residual Activity	%	2.0	CHEMBL4454	Homo sapiens	Residual Activity	%	2.0
	12234071	CHEMBL2219075	Millipore: Percentage of residual kinase activity of FGR at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc2ncc(-c3ccccc3)nc2cc1C		CHEMBL7724	=	Residual Activity	%	91.0	CHEMBL4454	Homo sapiens	Residual Activity	%	91.0
	12234072	CHEMBL2219075	Millipore: Percentage of residual kinase activity of FGR at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1		CHEMBL383899	=	Residual Activity	%	67.0	CHEMBL4454	Homo sapiens	Residual Activity	%	67.0
	12234073	CHEMBL2219075	Millipore: Percentage of residual kinase activity of FGR at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	Residual Activity	%	55.0	CHEMBL4454	Homo sapiens	Residual Activity	%	55.0
	12234074	CHEMBL2219075	Millipore: Percentage of residual kinase activity of FGR at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2cc1OC		CHEMBL563845	=	Residual Activity	%	42.0	CHEMBL4454	Homo sapiens	Residual Activity	%	42.0
	12234075	CHEMBL2219075	Millipore: Percentage of residual kinase activity of FGR at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2cnc(Nc3ccc(OCCN4CCCC4)cc3)s2)cc1		CHEMBL2218935	=	Residual Activity	%	11.0	CHEMBL4454	Homo sapiens	Residual Activity	%	11.0
	12234076	CHEMBL2219075	Millipore: Percentage of residual kinase activity of FGR at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC1=C(C(=O)N2CCN(C)CC2)C(C)=C(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)C1		CHEMBL2218936	=	Residual Activity	%	17.0	CHEMBL4454	Homo sapiens	Residual Activity	%	17.0
	12234077	CHEMBL2219075	Millipore: Percentage of residual kinase activity of FGR at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C/c2ccc3c(c2)OC(F)(F)O3)S1		CHEMBL1231533	=	Residual Activity	%	101.0	CHEMBL4454	Homo sapiens	Residual Activity	%	101.0
	12234078	CHEMBL2219075	Millipore: Percentage of residual kinase activity of FGR at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C		CHEMBL13485	=	Residual Activity	%	2.0	CHEMBL4454	Homo sapiens	Residual Activity	%	2.0
	12234079	CHEMBL2219075	Millipore: Percentage of residual kinase activity of FGR at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncc(-c3ccccc3)nc2cc1OC		CHEMBL71191	=	Residual Activity	%	101.0	CHEMBL4454	Homo sapiens	Residual Activity	%	101.0
	12234080	CHEMBL2219075	Millipore: Percentage of residual kinase activity of FGR at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Residual Activity	%	1.0	CHEMBL4454	Homo sapiens	Residual Activity	%	1.0
	12234081	CHEMBL2219075	Millipore: Percentage of residual kinase activity of FGR at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN([C@@H](Cc1ccc(OS(=O)(=O)c2cccc3cnccc23)cc1)C(=O)N1CCN(c2ccccc2)CC1)S(=O)(=O)c1cccc2cnccc12		CHEMBL28324	=	Residual Activity	%	96.0	CHEMBL4454	Homo sapiens	Residual Activity	%	96.0
	12234082	CHEMBL2219075	Millipore: Percentage of residual kinase activity of FGR at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Residual Activity	%	20.0	CHEMBL4454	Homo sapiens	Residual Activity	%	20.0
	12234083	CHEMBL2219075	Millipore: Percentage of residual kinase activity of FGR at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3cc(Br)ccc3c21		CHEMBL64758	=	Residual Activity	%	91.0	CHEMBL4454	Homo sapiens	Residual Activity	%	91.0
	12236685	CHEMBL2219075	Millipore: Percentage of residual kinase activity of FGR at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Residual Activity	%	90.0	CHEMBL4454	Homo sapiens	Residual Activity	%	90.0
	12236686	CHEMBL2219075	Millipore: Percentage of residual kinase activity of FGR at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Residual Activity	%	9.0	CHEMBL4454	Homo sapiens	Residual Activity	%	9.0
	12236687	CHEMBL2219075	Millipore: Percentage of residual kinase activity of FGR at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(CCCc1ccc(-c2ccccc2F)cc1)Nc1ccc(O)cc1		CHEMBL235658	=	Residual Activity	%	92.0	CHEMBL4454	Homo sapiens	Residual Activity	%	92.0
	12236688	CHEMBL2219075	Millipore: Percentage of residual kinase activity of FGR at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)c3ccccc3)c2)[nH]1		CHEMBL111364	=	Residual Activity	%	71.0	CHEMBL4454	Homo sapiens	Residual Activity	%	71.0
	12236689	CHEMBL2219075	Millipore: Percentage of residual kinase activity of FGR at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Residual Activity	%	51.0	CHEMBL4454	Homo sapiens	Residual Activity	%	51.0
	12236690	CHEMBL2219075	Millipore: Percentage of residual kinase activity of FGR at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(-c2cccc3c2Sc2ccccc2S3)oc(N2CCOCC2)c1		CHEMBL222102	=	Residual Activity	%	93.0	CHEMBL4454	Homo sapiens	Residual Activity	%	93.0
	12236691	CHEMBL2219075	Millipore: Percentage of residual kinase activity of FGR at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12		CHEMBL126077	=	Residual Activity	%	1.0	CHEMBL4454	Homo sapiens	Residual Activity	%	1.0
	12236692	CHEMBL2219075	Millipore: Percentage of residual kinase activity of FGR at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(OC)c2c(=S)c3ccccc3[nH]c12		CHEMBL1331734	=	Residual Activity	%	99.0	CHEMBL4454	Homo sapiens	Residual Activity	%	99.0
	12236693	CHEMBL2219075	Millipore: Percentage of residual kinase activity of FGR at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL259551	=	Residual Activity	%	50.0	CHEMBL4454	Homo sapiens	Residual Activity	%	50.0
	12236694	CHEMBL2219075	Millipore: Percentage of residual kinase activity of FGR at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1		CHEMBL359482	=	Residual Activity	%	2.0	CHEMBL4454	Homo sapiens	Residual Activity	%	2.0
	12236695	CHEMBL2219075	Millipore: Percentage of residual kinase activity of FGR at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	=	Residual Activity	%	81.0	CHEMBL4454	Homo sapiens	Residual Activity	%	81.0
	12236696	CHEMBL2219075	Millipore: Percentage of residual kinase activity of FGR at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c(-c2ccc(F)cc2)c(-c2ccncc2)nn1-c1ccc(Cl)cc1		CHEMBL91730	=	Residual Activity	%	65.0	CHEMBL4454	Homo sapiens	Residual Activity	%	65.0
	12236697	CHEMBL2219075	Millipore: Percentage of residual kinase activity of FGR at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Residual Activity	%	91.0	CHEMBL4454	Homo sapiens	Residual Activity	%	91.0
	12236698	CHEMBL2219075	Millipore: Percentage of residual kinase activity of FGR at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(NC(NC(=S)Nc1ccc(F)c([N+](=O)[O-])c1)C(Cl)(Cl)Cl)C(c1ccccc1)c1ccccc1		CHEMBL1221601	=	Residual Activity	%	107.0	CHEMBL4454	Homo sapiens	Residual Activity	%	107.0
	12236699	CHEMBL2219075	Millipore: Percentage of residual kinase activity of FGR at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(S(=O)(=O)/C=C/C#N)cc1		CHEMBL403183	=	Residual Activity	%	105.0	CHEMBL4454	Homo sapiens	Residual Activity	%	105.0
	12236700	CHEMBL2219075	Millipore: Percentage of residual kinase activity of FGR at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1		CHEMBL290904	=	Residual Activity	%	109.0	CHEMBL4454	Homo sapiens	Residual Activity	%	109.0
	12236701	CHEMBL2219075	Millipore: Percentage of residual kinase activity of FGR at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL2218938	=	Residual Activity	%	95.0	CHEMBL4454	Homo sapiens	Residual Activity	%	95.0
	12236702	CHEMBL2219075	Millipore: Percentage of residual kinase activity of FGR at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1n1cncc21		CHEMBL413188	=	Residual Activity	%	45.0	CHEMBL4454	Homo sapiens	Residual Activity	%	45.0
	12236703	CHEMBL2219075	Millipore: Percentage of residual kinase activity of FGR at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Residual Activity	%	-1.0	CHEMBL4454	Homo sapiens	Residual Activity	%	-1.0
	12236704	CHEMBL2219075	Millipore: Percentage of residual kinase activity of FGR at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cccc(-c2cc(=O)c3ccccc3o2)c1N		CHEMBL35482	=	Residual Activity	%	100.0	CHEMBL4454	Homo sapiens	Residual Activity	%	100.0
	12236705	CHEMBL2219075	Millipore: Percentage of residual kinase activity of FGR at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C1CCC3O1		CHEMBL304428	=	Residual Activity	%	96.0	CHEMBL4454	Homo sapiens	Residual Activity	%	96.0
	12236706	CHEMBL2219075	Millipore: Percentage of residual kinase activity of FGR at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Residual Activity	%	48.0	CHEMBL4454	Homo sapiens	Residual Activity	%	48.0
	12236707	CHEMBL2219075	Millipore: Percentage of residual kinase activity of FGR at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2c(NCc3ccccc3)nc(NCCCO)nc21		CHEMBL83980	=	Residual Activity	%	103.0	CHEMBL4454	Homo sapiens	Residual Activity	%	103.0
	12236708	CHEMBL2219075	Millipore: Percentage of residual kinase activity of FGR at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21		CHEMBL408982	=	Residual Activity	%	73.0	CHEMBL4454	Homo sapiens	Residual Activity	%	73.0
	12236709	CHEMBL2219075	Millipore: Percentage of residual kinase activity of FGR at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21		CHEMBL602937	=	Residual Activity	%	85.0	CHEMBL4454	Homo sapiens	Residual Activity	%	85.0
	12236710	CHEMBL2219075	Millipore: Percentage of residual kinase activity of FGR at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc(OC)c(/C=C2\C(=O)Nc3ccccc32)c(OC)c1		CHEMBL404941	=	Residual Activity	%	76.0	CHEMBL4454	Homo sapiens	Residual Activity	%	76.0
	12236711	CHEMBL2219075	Millipore: Percentage of residual kinase activity of FGR at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Residual Activity	%	19.0	CHEMBL4454	Homo sapiens	Residual Activity	%	19.0
	12236712	CHEMBL2219075	Millipore: Percentage of residual kinase activity of FGR at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17331	=	Residual Activity	%	96.0	CHEMBL4454	Homo sapiens	Residual Activity	%	96.0
	12236713	CHEMBL2219075	Millipore: Percentage of residual kinase activity of FGR at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc(-c2ccccc2)c(-c2ccncc2)o1		CHEMBL36450	=	Residual Activity	%	92.0	CHEMBL4454	Homo sapiens	Residual Activity	%	92.0
	12236714	CHEMBL2219075	Millipore: Percentage of residual kinase activity of FGR at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CCCc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2		CHEMBL260138	=	Residual Activity	%	6.0	CHEMBL4454	Homo sapiens	Residual Activity	%	6.0
	12236715	CHEMBL2219075	Millipore: Percentage of residual kinase activity of FGR at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C\c1c(Cl)[nH]c2ccccc12		CHEMBL261425	=	Residual Activity	%	64.0	CHEMBL4454	Homo sapiens	Residual Activity	%	64.0
	12236716	CHEMBL2219075	Millipore: Percentage of residual kinase activity of FGR at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL179583	=	Residual Activity	%	90.0	CHEMBL4454	Homo sapiens	Residual Activity	%	90.0
	12236717	CHEMBL2219075	Millipore: Percentage of residual kinase activity of FGR at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1sc(=O)n(Cc2ccccc2)c1=O		CHEMBL284861	=	Residual Activity	%	95.0	CHEMBL4454	Homo sapiens	Residual Activity	%	95.0
	12236718	CHEMBL2219075	Millipore: Percentage of residual kinase activity of FGR at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Residual Activity	%	4.0	CHEMBL4454	Homo sapiens	Residual Activity	%	4.0
	12236719	CHEMBL2219075	Millipore: Percentage of residual kinase activity of FGR at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)C/C=C/c2ccc(Cl)cc2)cc1		CHEMBL155333	=	Residual Activity	%	80.0	CHEMBL4454	Homo sapiens	Residual Activity	%	80.0
	12236720	CHEMBL2219075	Millipore: Percentage of residual kinase activity of FGR at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	=	Residual Activity	%	25.0	CHEMBL4454	Homo sapiens	Residual Activity	%	25.0
	12236721	CHEMBL2219075	Millipore: Percentage of residual kinase activity of FGR at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL313417	=	Residual Activity	%	97.0	CHEMBL4454	Homo sapiens	Residual Activity	%	97.0
	12236722	CHEMBL2219075	Millipore: Percentage of residual kinase activity of FGR at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12		CHEMBL75680	=	Residual Activity	%	36.0	CHEMBL4454	Homo sapiens	Residual Activity	%	36.0
	12236723	CHEMBL2219075	Millipore: Percentage of residual kinase activity of FGR at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL367625	=	Residual Activity	%	3.0	CHEMBL4454	Homo sapiens	Residual Activity	%	3.0
	12236724	CHEMBL2219075	Millipore: Percentage of residual kinase activity of FGR at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21		CHEMBL311228	=	Residual Activity	%	12.0	CHEMBL4454	Homo sapiens	Residual Activity	%	12.0
	12236725	CHEMBL2219075	Millipore: Percentage of residual kinase activity of FGR at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1		CHEMBL288064	=	Residual Activity	%	81.0	CHEMBL4454	Homo sapiens	Residual Activity	%	81.0
	12236726	CHEMBL2219075	Millipore: Percentage of residual kinase activity of FGR at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\OCCC(O)CO		CHEMBL1802727	=	Residual Activity	%	3.0	CHEMBL4454	Homo sapiens	Residual Activity	%	3.0
	12236727	CHEMBL2219075	Millipore: Percentage of residual kinase activity of FGR at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(/N)SC1C=CC=CC1)c1cccc(C(O)c2ccncc2)c1		CHEMBL2218939	=	Residual Activity	%	83.0	CHEMBL4454	Homo sapiens	Residual Activity	%	83.0
	12236728	CHEMBL2219075	Millipore: Percentage of residual kinase activity of FGR at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23327	=	Residual Activity	%	0.0	CHEMBL4454	Homo sapiens	Residual Activity	%	0.0
	12236729	CHEMBL2219075	Millipore: Percentage of residual kinase activity of FGR at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1		CHEMBL1076555	=	Residual Activity	%	93.0	CHEMBL4454	Homo sapiens	Residual Activity	%	93.0
	12236730	CHEMBL2219075	Millipore: Percentage of residual kinase activity of FGR at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(OC)cc2)[nH]c2nccnc12		CHEMBL306498	=	Residual Activity	%	78.0	CHEMBL4454	Homo sapiens	Residual Activity	%	78.0
	12236731	CHEMBL2219075	Millipore: Percentage of residual kinase activity of FGR at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F		CHEMBL261720	=	Residual Activity	%	1.0	CHEMBL4454	Homo sapiens	Residual Activity	%	1.0
	12236732	CHEMBL2219075	Millipore: Percentage of residual kinase activity of FGR at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNc2nc(N(CCO)CCO)nc3c2ncn3C(C)C)cc1		CHEMBL80713	=	Residual Activity	%	85.0	CHEMBL4454	Homo sapiens	Residual Activity	%	85.0
	12236733	CHEMBL2219075	Millipore: Percentage of residual kinase activity of FGR at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Residual Activity	%	28.0	CHEMBL4454	Homo sapiens	Residual Activity	%	28.0
	12236734	CHEMBL2219075	Millipore: Percentage of residual kinase activity of FGR at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Residual Activity	%	38.0	CHEMBL4454	Homo sapiens	Residual Activity	%	38.0
	12236735	CHEMBL2219075	Millipore: Percentage of residual kinase activity of FGR at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1C(Cl)=C(N2C(=O)CCC2=O)C(=O)c2ccccc21		CHEMBL404939	=	Residual Activity	%	96.0	CHEMBL4454	Homo sapiens	Residual Activity	%	96.0
	12236736	CHEMBL2219075	Millipore: Percentage of residual kinase activity of FGR at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1		CHEMBL405759	=	Residual Activity	%	2.0	CHEMBL4454	Homo sapiens	Residual Activity	%	2.0
	12236737	CHEMBL2219075	Millipore: Percentage of residual kinase activity of FGR at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL286721	=	Residual Activity	%	3.0	CHEMBL4454	Homo sapiens	Residual Activity	%	3.0
	12236738	CHEMBL2219075	Millipore: Percentage of residual kinase activity of FGR at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nc3ccccc3nc12		CHEMBL259389	=	Residual Activity	%	87.0	CHEMBL4454	Homo sapiens	Residual Activity	%	87.0
	12236739	CHEMBL2219075	Millipore: Percentage of residual kinase activity of FGR at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)C(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL1802728	=	Residual Activity	%	7.0	CHEMBL4454	Homo sapiens	Residual Activity	%	7.0
	12236740	CHEMBL2219075	Millipore: Percentage of residual kinase activity of FGR at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL409450	=	Residual Activity	%	2.0	CHEMBL4454	Homo sapiens	Residual Activity	%	2.0
	12236741	CHEMBL2219075	Millipore: Percentage of residual kinase activity of FGR at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1nc2c3c(cccc31)C(=O)c1ccccc1-2		CHEMBL1802485	=	Residual Activity	%	89.0	CHEMBL4454	Homo sapiens	Residual Activity	%	89.0
	12236742	CHEMBL2219075	Millipore: Percentage of residual kinase activity of FGR at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(\N)Sc1ccc(N)cc1)c1ccccc1C(F)(F)F		CHEMBL2218940	=	Residual Activity	%	73.0	CHEMBL4454	Homo sapiens	Residual Activity	%	73.0
	12236743	CHEMBL2219075	Millipore: Percentage of residual kinase activity of FGR at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Residual Activity	%	59.0	CHEMBL4454	Homo sapiens	Residual Activity	%	59.0
	12236744	CHEMBL2219075	Millipore: Percentage of residual kinase activity of FGR at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21		CHEMBL1182777	=	Residual Activity	%	87.0	CHEMBL4454	Homo sapiens	Residual Activity	%	87.0
	12236745	CHEMBL2219075	Millipore: Percentage of residual kinase activity of FGR at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	Residual Activity	%	2.0	CHEMBL4454	Homo sapiens	Residual Activity	%	2.0
	12236746	CHEMBL2219075	Millipore: Percentage of residual kinase activity of FGR at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Residual Activity	%	102.0	CHEMBL4454	Homo sapiens	Residual Activity	%	102.0
	12236747	CHEMBL2219075	Millipore: Percentage of residual kinase activity of FGR at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)c1nn(-c2c(Cl)cccc2Cl)c2nc(Cc3ccc(OCCO)cc3)[nH]c(=O)c12		CHEMBL258721	=	Residual Activity	%	95.0	CHEMBL4454	Homo sapiens	Residual Activity	%	95.0
	12236748	CHEMBL2219075	Millipore: Percentage of residual kinase activity of FGR at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)O/N=C1C(=C2\C(=O)Nc3cc(Br)ccc32)\Nc2ccccc2\1		CHEMBL2218941	=	Residual Activity	%	-1.0	CHEMBL4454	Homo sapiens	Residual Activity	%	-1.0
	12236749	CHEMBL2219075	Millipore: Percentage of residual kinase activity of FGR at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Residual Activity	%	44.0	CHEMBL4454	Homo sapiens	Residual Activity	%	44.0
	12236750	CHEMBL2219075	Millipore: Percentage of residual kinase activity of FGR at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	Residual Activity	%	18.0	CHEMBL4454	Homo sapiens	Residual Activity	%	18.0
	12236751	CHEMBL2219075	Millipore: Percentage of residual kinase activity of FGR at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCc1nc(-c2ccc(OC)cc2)[nH]c1-c1ccncc1		CHEMBL278724	=	Residual Activity	%	102.0	CHEMBL4454	Homo sapiens	Residual Activity	%	102.0
	12236752	CHEMBL2219075	Millipore: Percentage of residual kinase activity of FGR at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL258805	=	Residual Activity	%	16.0	CHEMBL4454	Homo sapiens	Residual Activity	%	16.0
	12236753	CHEMBL2219075	Millipore: Percentage of residual kinase activity of FGR at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)/C=C/c1cc(Br)c(Br)c(Br)c1Br		CHEMBL270724	=	Residual Activity	%	103.0	CHEMBL4454	Homo sapiens	Residual Activity	%	103.0
	12236754	CHEMBL2219075	Millipore: Percentage of residual kinase activity of FGR at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N/C(=N\[N+](=O)[O-])N/N=C\c1ccc(-c2cccc([N+](=O)[O-])c2)o1		CHEMBL221271	=	Residual Activity	%	113.0	CHEMBL4454	Homo sapiens	Residual Activity	%	113.0
	12236755	CHEMBL2219075	Millipore: Percentage of residual kinase activity of FGR at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1cnccn1		CHEMBL272629	=	Residual Activity	%	97.0	CHEMBL4454	Homo sapiens	Residual Activity	%	97.0
	12236756	CHEMBL2219075	Millipore: Percentage of residual kinase activity of FGR at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Residual Activity	%	135.0	CHEMBL4454	Homo sapiens	Residual Activity	%	135.0
	12236757	CHEMBL2219075	Millipore: Percentage of residual kinase activity of FGR at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ccc2ncnc(NCCc3ccc(Oc4ccccc4)cc3)c2c1		CHEMBL522502	=	Residual Activity	%	60.0	CHEMBL4454	Homo sapiens	Residual Activity	%	60.0
	12236758	CHEMBL2219075	Millipore: Percentage of residual kinase activity of FGR at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Residual Activity	%	40.0	CHEMBL4454	Homo sapiens	Residual Activity	%	40.0
	12236759	CHEMBL2219075	Millipore: Percentage of residual kinase activity of FGR at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1cnc2cnc(NCc3cccnc3)cc2c1Nc1ccc(F)c(Cl)c1		CHEMBL200381	=	Residual Activity	%	4.0	CHEMBL4454	Homo sapiens	Residual Activity	%	4.0
	12626678	CHEMBL2317128	Inhibition of FGR (unknown origin) at 1 uM	B	COc1cc(Nc2ncc(Cl)c(-c3cccc(CC#N)c3)n2)ccc1N1CCN(C)CC1		CHEMBL2312140	=	Inhibition	%	50.0	CHEMBL4454	Homo sapiens	INH	%	50.0
	12660162	CHEMBL2329213	Inhibition of FGR (unknown origin) at 1 uM	B	COc1cc(Oc2ccccc2)ccc1-c1nc([C@H]2C[C@@](C)(O)C2)n2ccnc(N)c12		CHEMBL2325940	>	Inhibition	%	80.0	CHEMBL4454	Homo sapiens	INH	%	80.0
	12728829	CHEMBL2352902	Inhibition of FGR (unknown origin) assessed as remaining activity at 10 uM relative to control	B	O=c1[nH]c2ncc(-c3ccc(-c4nc[nH]n4)cc3)nc2n1CCC1CCOCC1		CHEMBL2348865	=	Activity	%	76.0	CHEMBL4454	Homo sapiens	Activity	%	76.0
	12729074	CHEMBL2352252	Inhibition of FGR (unknown origin) assessed as remaining activity at 1 uM relative to control	B	CC(C)(O)c1ccc(-c2cnc3c(n2)N(CC2CCOCC2)CC(=O)N3)cn1		CHEMBL2348862	=	Activity	%	103.0	CHEMBL4454	Homo sapiens	Activity	%	103.0
	12729762	CHEMBL2349762	Inhibition of FGR (unknown origin) using [gamma-33P]ATP	B	CCc1ccc(-c2ccc3c(c2)-c2c(cnn2CC)S(=O)(=O)N3C)cc1		CHEMBL2333436	>	IC50	nM	10000.0	CHEMBL4454	Homo sapiens	IC50	uM	10.0
	12729763	CHEMBL2349762	Inhibition of FGR (unknown origin) using [gamma-33P]ATP	B	CCc1ccc(-c2ccc3c(c2)-c2[nH]ncc2S(=O)(=O)N3C)cc1		CHEMBL2333445	=	IC50	nM	1900.0	CHEMBL4454	Homo sapiens	IC50	uM	1.9
	12729957	CHEMBL2352193	Inhibition of FGR (unknown origin) using [gamma-33P]ATP assessed as residual activity at 3 uM	B	CCc1ccc(-c2ccc3c(c2)-c2[nH]ncc2S(=O)(=O)N3C)cc1		CHEMBL2333445	=	Activity	%	47.0	CHEMBL4454	Homo sapiens	Activity	%	47.0
	12730217	CHEMBL2352902	Inhibition of FGR (unknown origin) assessed as remaining activity at 10 uM relative to control	B	CC(C)(O)c1ccc(-c2cnc3c(n2)N(CC2CCOCC2)CC(=O)N3)cn1		CHEMBL2348862	=	Activity	%	92.0	CHEMBL4454	Homo sapiens	Activity	%	92.0
	13365835	CHEMBL2406315	Inhibition of TEL-fused FGR (unknown origin) by cell-based assay	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	=	IC50	nM	1947.0	CHEMBL4454	Homo sapiens	IC50	nM	1947.0
	13375861	CHEMBL2405123	Inhibition of FGR (unknown origin) at 10 uM relative to control	B	CC[C@@H]1C(=O)N(C)c2cnc(-n3ccnc3-c3ccc(F)cc3)nc2N1c1ccn(C)n1		CHEMBL2402081	=	Inhibition	%	1.0	CHEMBL4454	Homo sapiens	INH	%	1.0
	13442356	CHEMBL2427788	Competitive binding affinity to FGR (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3ccc4ccccc43)n2)CC1		CHEMBL2425646	<	Inhibition	%	50.0	CHEMBL4454	Homo sapiens	INH	%	50.0
	13445491	CHEMBL2427788	Competitive binding affinity to FGR (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-c3n[nH]c4ccccc34)n2)CC1		CHEMBL2425644	=	Inhibition	%	80.0	CHEMBL4454	Homo sapiens	INH	%	80.0
	13448546	CHEMBL2427788	Competitive binding affinity to FGR (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3ncc4ccccc43)n2)CC1		CHEMBL2425645	<	Inhibition	%	50.0	CHEMBL4454	Homo sapiens	INH	%	50.0
	13448682	CHEMBL2427788	Competitive binding affinity to FGR (unknown origin) at 10 uM in presence of ATP relative to control	B	O=C([C@H]1CC[C@H](Nc2nccc(-n3nnc4ccccc43)n2)CC1)N1CCOCC1		CHEMBL2425649	=	Inhibition	%	82.0	CHEMBL4454	Homo sapiens	INH	%	82.0
	13451477	CHEMBL2427788	Competitive binding affinity to FGR (unknown origin) at 10 uM in presence of ATP relative to control	B	N[C@H]1CC[C@H](Nc2nccc(-n3nnc4ccccc43)n2)CC1		CHEMBL2425652	=	Inhibition	%	80.0	CHEMBL4454	Homo sapiens	INH	%	80.0
	13454662	CHEMBL2427788	Competitive binding affinity to FGR (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3nnc4ccccc43)n2)CC1		CHEMBL2425654	=	Inhibition	%	75.0	CHEMBL4454	Homo sapiens	INH	%	75.0
	13872143	CHEMBL3101768	Inhibition of human Fgr assessed as residual activity at 1 uM relative to control	B	O=C1Nc2ncccc2/C1=C1/Nc2ncccc2C1=O		CHEMBL3099673	=	Activity	%	114.0	CHEMBL4454	Homo sapiens	Activity	%	114.0
	13872226	CHEMBL3102532	Inhibition of FGR (unknown origin) assessed as residual activity at 10 uM relative to control	B	O=C1Nc2ncccc2/C1=C1/Nc2ncccc2C1=O		CHEMBL3099673	=	Activity	%	93.0	CHEMBL4454	Homo sapiens	Activity	%	93.0
	13872256	CHEMBL3100332	Inhibition of FGR (unknown origin) assessed as residual activity at 1 uM relative to control	B	O=C1Nc2ncccc2/C1=C1/Nc2ncccc2C1=O		CHEMBL3099673	=	Activity	%	95.0	CHEMBL4454	Homo sapiens	Activity	%	95.0
	13918703	CHEMBL3118224	Inhibition of human Fgr	B	C[C@H](Nc1nc(Nc2cn(C)cn2)c2cc[nH]c2n1)c1ncc(F)cn1		CHEMBL3116050	=	IC50	nM	33.0	CHEMBL4454	Homo sapiens	IC50	uM	0.033
	14582503	CHEMBL3242355	Inhibition of human Fgr assessed as enzyme activity at 1 uM relative to control	B	CCCS(=O)(=O)Nc1cccc(Nc2ccc3ncn(C)c(=O)c3c2)c1C#N		CHEMBL3236464	=	Activity	%	105.0	CHEMBL4454	Homo sapiens	Activity	%	105.0
	14979420	CHEMBL3372978	Inhibition of Fgr (unknown origin) in presence of 1 mM ATP	B	CN(Cc1ccccc1)C(=O)c1ccc(S(=O)(=O)Nc2ccccc2)cc1		CHEMBL3355482	>	IC50	nM	100000.0	CHEMBL4454	Homo sapiens	IC50	uM	100.0
	15018596	CHEMBL3362260	Inhibition of Fgr (unknown origin) at 100 nM	B	O=C(N[C@H](CO)c1ccc(Cl)c(F)c1)N1CCc2cnc(NC3CCOCC3)nc2C1		CHEMBL3298678	=	Inhibition	%	0.4	CHEMBL4454	Homo sapiens	INH	%	0.4
	15058842	CHEMBL3371396	Inhibition of FGR (unknown origin) assessed as residual activity at 1 uM by radiometric protein kinase assay	B	COc1cc(-c2c[nH]c(=O)c(-c3cc(OC)c(OC)c(OC)c3)n2)ccc1O		CHEMBL3358999	=	Activity	%	36.0	CHEMBL4454	Homo sapiens	Activity	%	36.0
	15122480	CHEMBL3367686	Inhibition of human Fgr assessed as residual activity at 10 uM by KinaseProfiler assay	B	CCOC(=O)C1=C(C)N=c2s/c(=C\c3ccc(O)c(O)c3)c(=O)n2C1c1ccc(Cl)cc1		CHEMBL3331445	=	Activity	%	98.0	CHEMBL4454	Homo sapiens	Activity	%	98.0
	15126957	CHEMBL3367686	Inhibition of human Fgr assessed as residual activity at 10 uM by KinaseProfiler assay	B	CCOC(=O)C1=C(C)N=c2s/c(=C\c3cc(O)c(O)c(O)c3)c(=O)n2C1c1ccc(Cl)cc1		CHEMBL3331446	=	Activity	%	75.0	CHEMBL4454	Homo sapiens	Activity	%	75.0
	15126989	CHEMBL3367686	Inhibition of human Fgr assessed as residual activity at 10 uM by KinaseProfiler assay	B	Brc1c(Br)c(Br)c2[nH]nnc2c1Br		CHEMBL177820	=	Activity	%	102.0	CHEMBL4454	Homo sapiens	Activity	%	102.0
	15600500	CHEMBL3580032	Inhibition of human FGR assessed as residual activity at 10 uM relative to control	B	Nc1ncnc2c1c(-c1ccc(Cl)cc1)nn2CC(Cl)c1ccccc1		CHEMBL3578214	=	Activity	%	4.0	CHEMBL4454	Homo sapiens	Activity	%	4.0
	15616267	CHEMBL3583125	Inhibition of Tel-fused FGR (unknown origin) expressed in mouse BA/F3 cells after 48 hrs by luciferase reporter gene assay in absence of recombinant mouse IL3	B	OC1CCN(c2cc(-c3cnc4ccc(N5CCC[C@@H]5c5cccc(F)c5)nn34)ccn2)CC1		CHEMBL3582442	=	IC50	nM	5900.0	CHEMBL4454	Homo sapiens	IC50	uM	5.9
	15616268	CHEMBL3583125	Inhibition of Tel-fused FGR (unknown origin) expressed in mouse BA/F3 cells after 48 hrs by luciferase reporter gene assay in absence of recombinant mouse IL3	B	O=C(O)CN1CCN(c2cc(-c3cnc4ccc(N5CCC[C@@H]5c5cccc(F)c5)nn34)ccn2)CC1		CHEMBL3582441	=	IC50	nM	2800.0	CHEMBL4454	Homo sapiens	IC50	uM	2.8
	15616269	CHEMBL3583125	Inhibition of Tel-fused FGR (unknown origin) expressed in mouse BA/F3 cells after 48 hrs by luciferase reporter gene assay in absence of recombinant mouse IL3	B	Fc1cccc([C@H]2CCCN2c2ccc3ncc(-c4ccccn4)n3n2)c1		CHEMBL3582439	=	IC50	nM	8700.0	CHEMBL4454	Homo sapiens	IC50	uM	8.7
	15616270	CHEMBL3583125	Inhibition of Tel-fused FGR (unknown origin) expressed in mouse BA/F3 cells after 48 hrs by luciferase reporter gene assay in absence of recombinant mouse IL3	B	N#Cc1ccc(-c2cnc3ccc(NCc4ccccc4)nn23)cc1		CHEMBL3582427	=	IC50	nM	6400.0	CHEMBL4454	Homo sapiens	IC50	uM	6.4
	15622549	CHEMBL3588280	Inhibition of human recombinant Fgr	B	Cc1cc2cn[nH]c2cc1-c1cccc2c(N)c(C(N)=O)nnc12		CHEMBL3586447	=	IC50	nM	41.0	CHEMBL4454	Homo sapiens	IC50	nM	41.0
	15622562	CHEMBL3588267	Inhibition of human recombinant Fgr at 1 uM	B	Cc1cc2cn[nH]c2cc1-c1cccc2c(N)c(C(N)=O)nnc12		CHEMBL3586447	=	Inhibition	%	94.0	CHEMBL4454	Homo sapiens	INH	%	94.0
	15649714	CHEMBL3595391	Inhibition of human FGR at 0.1 uM relative to control	B	CCc1cc(NC(=O)Nc2ccc(-c3cnc(Nc4cc(N5CCN(CC)CC5)nc(C)n4)s3)cc2)no1		CHEMBL3593290	=	Inhibition	%	89.0	CHEMBL4454	Homo sapiens	INH	%	89.0
	15673247	CHEMBL3603403	Inhibition of human FGR at 1 uM	B	Nc1nc2ccc(-c3ccn(CC4CC4)c(=O)c3)cc2s1		CHEMBL3600779	=	Inhibition	%	98.0	CHEMBL4454	Homo sapiens	INH	%	98.0
	15736133	CHEMBL3627530	Inhibition of human Fgr at 0.1 uM	B	Cc1nn(-c2ccnc(Nc3ccc4c(c3)c(Cl)c(C)n4C)n2)cc1CN1CC(O)C1		CHEMBL3622956	<	Inhibition	%	25.0	CHEMBL4454	Homo sapiens	INH	%	25.0
	15756983	CHEMBL3630500	Inhibition of FGR (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccncc3)cc2)no1		CHEMBL166031	=	Inhibition	%	90.68	CHEMBL4454	Homo sapiens	INH	%	90.68
	15757740	CHEMBL3630500	Inhibition of FGR (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	CS(=O)(=O)c1cccc(Nc2nccc(-c3sc(N4CCOCC4)nc3-c3cccc(NS(=O)(=O)c4c(F)cccc4F)c3)n2)c1		CHEMBL3628627	=	Inhibition	%	99.98	CHEMBL4454	Homo sapiens	INH	%	99.98
	15758719	CHEMBL3630500	Inhibition of FGR (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	COCCNC(=O)c1ccc2c(c1)nc(-c1cnc(-c3ccc(Cl)cc3)[nH]1)n2CCOC		CHEMBL3628628	=	Inhibition	%	67.48	CHEMBL4454	Homo sapiens	INH	%	67.48
306886	16277933	CHEMBL3707718	Inhibition Assay: The inhibitory activity measurement against the kinases mentioned above was measured in the kinase inhibition reaction mixture containing 2 ul purified kinase protein (10-50 ng), 20 mM Tris-HCl, pH 8.0, 5 mM MgCl2, 0.5 mM dithiothreitol, 0.01 mM ATP, 4 ug of poly(D4Y)n peptide substrate (Promega), 0.2 uCi of 32P-ATP and the each compound shown in tablel. The mixture was incubated for 15 min at 30° C. and the reaction was then ended by adding a half volume of 30% phosphoric acid solution. Subsequently, the reaction mixture solution was spotted in avidin coated membrane (Promega). This membrane was washed using 50 mM phosphate, 0.1N NaCl buffer (pH 6.0) solution for 10 min 5 times and then the radioactivity of each spot was quantified by using a BAS image analyzer (Fuji).	B	Oc1cccc(Nc2ccnc3cc(-c4cccc(CN5CCOCC5)c4)sc23)c1		CHEMBL2336005	=	IC50	nM	3.7	CHEMBL4454	Homo sapiens	IC50	nM	3.7
281023	16331386	CHEMBL3707994	Millipore Kinase Panel Assay: Employing the Milipore panel of purified kinases EXAMPLE 87 (IC50=1 nM) inhibited 98% of purified Syk kinase activity at 50 nM. IC50 values were determined for those kinases that were inhibited by >80% at 300 nM in the Millipore kinase panel.	B	NC(=O)c1cnc(N[C@@H]2CCCC[C@@H]2N)nc1Nc1cccc(-n2nccn2)c1		CHEMBL2177736	=	IC50	nM	81.0	CHEMBL4454	Homo sapiens	IC50	nM	81.0
	16425432	CHEMBL3749827	Inhibition of FGR (unknown origin) at 1 uM	B	Cc1c(-c2cc(Nc3cc4n(n3)CCN(C)C4)c(=O)[nH]n2)ccc(F)c1NC(=O)c1cc2ccccc2s1		CHEMBL3746293	=	Inhibition	%	69.8	CHEMBL4454	Homo sapiens	INH	%	69.8
	16426147	CHEMBL3750474	Inhibition of FGR (unknown origin)	B	Cc1c(-c2cc(Nc3cc4n(n3)CCN(C)C4)c(=O)[nH]n2)ccc(F)c1NC(=O)c1cc2ccccc2s1		CHEMBL3746293	=	IC50	nM	1033.0	CHEMBL4454	Homo sapiens	IC50	nM	1033.0
	16431836	CHEMBL3748190	Inhibition of human FGR using poly[Glu:Tyr] (4:1) as substrate	B	Cn1c(=O)c(S(=O)(=O)c2ccc(F)cc2F)cc2cnc(Nc3ccc4[nH]ccc4c3)nc21		CHEMBL3745885	>	IC50	nM	10000.0	CHEMBL4454	Homo sapiens	IC50	uM	10.0
	16446723	CHEMBL3756084	Inhibition of recombinant human FGR assessed as residual activity at 1 uM by radiometric assay in presence of [gamma-33P]-ATP relative to control	B	CC(C)n1nc(-c2cc(C3CC3)on2)c2c(N)ncnc21		CHEMBL3753341	=	Activity	%	10.8	CHEMBL4454	Homo sapiens	Activity	%	10.8
	16446732	CHEMBL3757135	Inhibition of recombinant human FGR by radiometric assay in presence of [gamma-33P]-ATP	B	CC(C)n1nc(-c2cc(C3CC3)on2)c2c(N)ncnc21		CHEMBL3753341	=	IC50	nM	65.0	CHEMBL4454	Homo sapiens	IC50	nM	65.0
	16450848	CHEMBL3762704	Inhibition of FGR (unknown origin) at 100 nM	B	CC1(C)OCc2c(Nc3n[nH]c4ccccc34)nc(-c3cn[nH]c3)nc21		CHEMBL3758502	=	Inhibition	%	83.7	CHEMBL4454	Homo sapiens	INH	%	83.7
	16457722	CHEMBL3761572	Inhibition of FGR (unknown origin) at 500 nM	B	C[C@@H](Nc1ncnc2sc(-c3ccccc3C(N)=O)cc12)c1ccccc1		CHEMBL3759085	=	Inhibition	%	2.0	CHEMBL4454	Homo sapiens	INH	%	2.0
	16457723	CHEMBL3761572	Inhibition of FGR (unknown origin) at 500 nM	B	C[C@@H](Nc1ncnc2sc(-c3ccc(C(=O)NCCN(C)C)cc3)cc12)c1ccccc1		CHEMBL3758800	=	Inhibition	%	18.0	CHEMBL4454	Homo sapiens	INH	%	18.0
	16457724	CHEMBL3761572	Inhibition of FGR (unknown origin) at 500 nM	B	CN(C)CCNC(=O)c1ccc(-c2cc3c(N[C@H](CO)c4ccccc4)ncnc3s2)cc1		CHEMBL3758376	=	Inhibition	%	33.0	CHEMBL4454	Homo sapiens	INH	%	33.0
	16457725	CHEMBL3761572	Inhibition of FGR (unknown origin) at 500 nM	B	COc1cc(C(N)=O)ccc1-c1cc2c(N[C@H](CO)c3ccccc3)ncnc2s1		CHEMBL3759480	=	Inhibition	%	40.0	CHEMBL4454	Homo sapiens	INH	%	40.0
	16457726	CHEMBL3761572	Inhibition of FGR (unknown origin) at 500 nM	B	COc1ccc(C(=O)NCCN(C)C)cc1-c1cc2c(N[C@H](C)c3ccccc3)ncnc2s1		CHEMBL3758582	=	Inhibition	%	71.0	CHEMBL4454	Homo sapiens	INH	%	71.0
	16457727	CHEMBL3761572	Inhibition of FGR (unknown origin) at 500 nM	B	COc1cc(CO)ccc1-c1cc2c(N[C@H](C)c3ccccc3)ncnc2s1		CHEMBL3759559	=	Inhibition	%	40.0	CHEMBL4454	Homo sapiens	INH	%	40.0
	16457728	CHEMBL3761572	Inhibition of FGR (unknown origin) at 500 nM	B	COc1cc(CO)ccc1-c1cc2c(N[C@H](CO)c3ccccc3)ncnc2s1		CHEMBL3758682	=	Inhibition	%	58.0	CHEMBL4454	Homo sapiens	INH	%	58.0
	16457729	CHEMBL3761572	Inhibition of FGR (unknown origin) at 500 nM	B	COc1cc(CO)ccc1-c1cc2c(Nc3ccccc3)ncnc2s1		CHEMBL3758768	=	Inhibition	%	25.0	CHEMBL4454	Homo sapiens	INH	%	25.0
	16457730	CHEMBL3761572	Inhibition of FGR (unknown origin) at 500 nM	B	C#Cc1cccc(Nc2ncnc3sc(-c4ccc(CO)cc4OC)cc23)c1		CHEMBL3758802	=	Inhibition	%	11.0	CHEMBL4454	Homo sapiens	INH	%	11.0
	16457731	CHEMBL3761572	Inhibition of FGR (unknown origin) at 500 nM	B	COc1cc(CO)ccc1-c1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2s1		CHEMBL3758351	=	Inhibition	%	11.0	CHEMBL4454	Homo sapiens	INH	%	11.0
	16457732	CHEMBL3761572	Inhibition of FGR (unknown origin) at 500 nM	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	=	Inhibition	%	42.0	CHEMBL4454	Homo sapiens	INH	%	42.0
	16495997	CHEMBL3779692	Inhibition of N-terminal His6-tagged recombinant human FGR expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CCOCC5)cc34)cc2)cn1		CHEMBL3774885	=	Activity	%	-4.0	CHEMBL4454	Homo sapiens	Activity	%	-4.0
	16508184	CHEMBL3779692	Inhibition of N-terminal His6-tagged recombinant human FGR expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	CNC(=O)c1ccc2[nH]nc(Cc3ccc4c(cnn4C)c3)c2c1		CHEMBL3775576	=	Activity	%	21.0	CHEMBL4454	Homo sapiens	Activity	%	21.0
	16509161	CHEMBL3779692	Inhibition of N-terminal His6-tagged recombinant human FGR expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CC[C@@H](O)C5)cc34)cc2)cn1		CHEMBL3775317	=	Activity	%	11.0	CHEMBL4454	Homo sapiens	Activity	%	11.0
	16592320	CHEMBL3807326	Inhibition of full length human recombinant His-tagged FGR expressed in baculovirus expression system at 1 uM relative to control	B	NC(=O)c1cc2c(Oc3ccc(Cl)cc3)cncc2s1		CHEMBL118518	<	Inhibition	%	30.0	CHEMBL4454	Homo sapiens	INH	%	30.0
	16592321	CHEMBL3807326	Inhibition of full length human recombinant His-tagged FGR expressed in baculovirus expression system at 1 uM relative to control	B	NC(=O)c1cc2c(Oc3ccc(Cl)cc3)cnc(N)c2s1		CHEMBL3805194	>	Inhibition	%	50.0	CHEMBL4454	Homo sapiens	INH	%	50.0
	16593606	CHEMBL3811564	Inhibition of His-tagged full length human recombinant FGR expressed in baculovirus using Fluorescein-Poly GT as substrate at 100 nM	B	COC(=O)c1cc2cc(NCc3cc(NC(=O)c4cc(-n5cnc(C)c5)cc(C(F)(F)F)c4)ccc3C)cnc2[nH]1		CHEMBL3808884	>=	Inhibition	%	80.0	CHEMBL4454	Homo sapiens	INH	%	80.0
	16614479	CHEMBL3816609	Inhibition of human FGR at 1 uM using poly[Glu:Tyr] (4:1) as substrate	B	CNS(=O)(=O)c1ccc(N(C)C)c(Nc2ncnc3cc(OC)c(OC)cc23)c1		CHEMBL3815093	=	Inhibition	%	5.0	CHEMBL4454	Homo sapiens	INH	%	5.0
	16618214	CHEMBL3816340	Inhibition of full length recombinant human C-terminal His-tagged cytoplasmic FGR expressed in baculovirus expression system at 1 uM relative to control	B	CC1(C)OCCn2c1nc1c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12		CHEMBL3813842	<	Inhibition	%	50.0	CHEMBL4454	Homo sapiens	INH	%	50.0
	16739451	CHEMBL3857049	Inhibition of recombinant full length human C-terminal His-tagged FGR expressed in baculovirus at 500 nM by Z'-LYTE assay	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	=	Inhibition	%	42.0	CHEMBL4454	Homo sapiens	INH	%	42.0
	16739452	CHEMBL3857049	Inhibition of recombinant full length human C-terminal His-tagged FGR expressed in baculovirus at 500 nM by Z'-LYTE assay	B	C[C@@H](Nc1ncnc2oc(-c3ccc(NCCN4CCCCC4)cc3)cc12)c1ccccc1		CHEMBL3891846	=	Inhibition	%	56.0	CHEMBL4454	Homo sapiens	INH	%	56.0
	16739453	CHEMBL3857049	Inhibition of recombinant full length human C-terminal His-tagged FGR expressed in baculovirus at 500 nM by Z'-LYTE assay	B	C[C@@H](Nc1ncnc2oc(-c3ccc(NCCN(C)C)cc3)cc12)c1ccccc1		CHEMBL3901622	=	Inhibition	%	60.0	CHEMBL4454	Homo sapiens	INH	%	60.0
	16804205	CHEMBL3869793	Inhibition of human recombinant full length C-terminal His-tagged FGR cytoplasmic domain expressed in baculovirus expression system at 200 nM by Z'-LYTE assay	B	Cn1cc(-c2nc(N[C@@H]3CCCC[C@@H]3N)c(F)c3c2C(=O)NC3)cn1		CHEMBL3979920	=	Inhibition	%	62.0	CHEMBL4454	Homo sapiens	INH	%	62.0
342611	17720002	CHEMBL3887539	HotSpot kinase assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 μM ATP.). For enzyme inhibition assays, compounds were tested in range of ten concentrations from 10 uM to 0.0005 uM using purified enzymes and the Hotspot kinase assay. Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.	B	C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL1873475	=	IC50	nM	2.3	CHEMBL4454	Homo sapiens	IC50	nM	2.3
342632	17720023	CHEMBL3887539	HotSpot kinase assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 μM ATP.). For enzyme inhibition assays, compounds were tested in range of ten concentrations from 10 uM to 0.0005 uM using purified enzymes and the Hotspot kinase assay. Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.	B	C=CC(=O)N[C@H]1CC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)CC1		CHEMBL3647967	=	IC50	nM	0.4	CHEMBL4454	Homo sapiens	IC50	nM	0.4
385003	17758425	CHEMBL3888245	In Vitro HotSpot Kinase Assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 uM ATP.). Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.	B	C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL1873475	=	IC50	nM	2.3	CHEMBL4454	Homo sapiens	IC50	nM	2.3
385024	17758446	CHEMBL3888245	In Vitro HotSpot Kinase Assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 uM ATP.). Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.	B	C=CC(=O)N[C@H]1CC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)CC1		CHEMBL3647967	=	IC50	nM	0.4	CHEMBL4454	Homo sapiens	IC50	nM	0.4
Inactive	17903397	CHEMBL3991718	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1)C1CCCN1		CHEMBL3545328	>	Kd	nM	30000.0	CHEMBL4454	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903398	CHEMBL3991718	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	30000.0	CHEMBL4454	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903399	CHEMBL3991718	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21		CHEMBL494089	>	Kd	nM	30000.0	CHEMBL4454	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903400	CHEMBL3991718	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Cc1ccc(-c2ccc(OCCN3CCOCC3)cc2)cn1)NCc1ccccc1		CHEMBL571546	>	Kd	nM	30000.0	CHEMBL4454	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903401	CHEMBL3991718	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1		CHEMBL2216870	>	Kd	nM	30000.0	CHEMBL4454	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903402	CHEMBL3991718	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	>	Kd	nM	30000.0	CHEMBL4454	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903403	CHEMBL3991718	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc3nnc(C(F)(F)c4ccc5ncccc5c4)n3n2)cn1		CHEMBL2133806	>	Kd	nM	30000.0	CHEMBL4454	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903404	CHEMBL3991718	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	>	Kd	nM	30000.0	CHEMBL4454	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903405	CHEMBL3991718	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(C)c(-n2c(C)cc(OCc3ccc(F)cc3F)c(Br)c2=O)c1		CHEMBL1088751	>	Kd	nM	30000.0	CHEMBL4454	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903406	CHEMBL3991718	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	>	Kd	nM	30000.0	CHEMBL4454	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903407	CHEMBL3991718	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OCCO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL1908360	>	Kd	nM	30000.0	CHEMBL4454	Homo sapiens	Kd apparent	nM	30000.0
Active	17903408	CHEMBL3991718	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1nc(-c2cccc(NS(=O)(=O)c3c(F)cccc3F)c2F)c(-c2ccnc(N)n2)s1		CHEMBL2028663	=	Kd	nM	1549.0	CHEMBL4454	Homo sapiens	Kd apparent	nM	1549.0
Inactive	17903409	CHEMBL3991718	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(C2CCN(C(=O)Nc3cc(Oc4ccc(NC(=O)C5(C(=O)Nc6ccc(F)cc6)CC5)c(F)c4)ccn3)CC2)CC1		CHEMBL3039525	>	Kd	nM	30000.0	CHEMBL4454	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903410	CHEMBL3991718	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	30000.0	CHEMBL4454	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903411	CHEMBL3991718	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	30000.0	CHEMBL4454	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903412	CHEMBL3991718	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)c(F)c2)ccn1		CHEMBL1946170	>	Kd	nM	30000.0	CHEMBL4454	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903413	CHEMBL3991718	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	30000.0	CHEMBL4454	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903414	CHEMBL3991718	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	>	Kd	nM	30000.0	CHEMBL4454	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903415	CHEMBL3991718	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(C2=Nc3cc(NC(=O)C(N)C4CCCCC4)cc4c3C2=CNNC4=O)cn1		CHEMBL3545137	>	Kd	nM	30000.0	CHEMBL4454	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903416	CHEMBL3991718	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(-c4ccc(Cl)cc4)cc23)c1F		CHEMBL1229517	>	Kd	nM	30000.0	CHEMBL4454	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903417	CHEMBL3991718	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)CC(=O)Nc1n[nH]c2c1CN(C(=O)C1CCN(C)CC1)C2(C)C		CHEMBL1230607	>	Kd	nM	30000.0	CHEMBL4454	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903418	CHEMBL3991718	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	>	Kd	nM	30000.0	CHEMBL4454	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903419	CHEMBL3991718	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL507361	>	Kd	nM	30000.0	CHEMBL4454	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903420	CHEMBL3991718	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)C1(Cc2cccc(Nc3nccs3)n2)CCC(Oc2cccc(Cl)c2F)CC1		CHEMBL3182444	>	Kd	nM	30000.0	CHEMBL4454	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903421	CHEMBL3991718	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1		CHEMBL2103875	>	Kd	nM	30000.0	CHEMBL4454	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903422	CHEMBL3991718	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NC[C@H](O)CO)c1ccncc1Nc1ccc(I)cc1F		CHEMBL2107832	>	Kd	nM	30000.0	CHEMBL4454	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903423	CHEMBL3991718	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	30000.0	CHEMBL4454	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903424	CHEMBL3991718	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(OC)c(/C=C/S(=O)(=O)Cc2ccc(OC)c(NCC(=O)O)c2)c(OC)c1		CHEMBL1241855	>	Kd	nM	30000.0	CHEMBL4454	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903425	CHEMBL3991718	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	>	Kd	nM	30000.0	CHEMBL4454	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903426	CHEMBL3991718	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc4c(cc23)OCCOCCOCCO4)c1		CHEMBL2087361	>	Kd	nM	30000.0	CHEMBL4454	Homo sapiens	Kd apparent	nM	30000.0
Uncertain	17903427	CHEMBL3991718	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12		CHEMBL1171837	=	Kd	nM	38.0	CHEMBL4454	Homo sapiens	Kd apparent	nM	38.0
Inactive	17903428	CHEMBL3991718	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)c1		CHEMBL2336325	>	Kd	nM	30000.0	CHEMBL4454	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903429	CHEMBL3991718	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(S(=O)(=O)N(C(C)=O)c2ccccc2/C=C/c2cc[n+]([O-])cc2)cc1		CHEMBL3991927	>	Kd	nM	30000.0	CHEMBL4454	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903430	CHEMBL3991718	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	>	Kd	nM	30000.0	CHEMBL4454	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903431	CHEMBL3991718	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	>	Kd	nM	30000.0	CHEMBL4454	Homo sapiens	Kd apparent	nM	30000.0
Active	17903432	CHEMBL3991718	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1c[nH]nc1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)NC1CC1		CHEMBL495727	=	Kd	nM	1537.0	CHEMBL4454	Homo sapiens	Kd apparent	nM	1537.0
Inactive	17903433	CHEMBL3991718	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(N)sc1-c1ccnc(Nc2ccc(N3CCOCC3)cc2)n1		CHEMBL482967	>	Kd	nM	30000.0	CHEMBL4454	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903434	CHEMBL3991718	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2cnn3c(N)c(Br)c([C@@H]4CCCNC4)nc23)cn1		CHEMBL2386889	>	Kd	nM	30000.0	CHEMBL4454	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903435	CHEMBL3991718	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	>	Kd	nM	30000.0	CHEMBL4454	Homo sapiens	Kd apparent	nM	30000.0
Active	17903436	CHEMBL3991718	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Kd	nM	5.0	CHEMBL4454	Homo sapiens	Kd apparent	nM	5.0
Inactive	17903437	CHEMBL3991718	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1N=C(N)c2cn([C@@H]3O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL462018	>	Kd	nM	30000.0	CHEMBL4454	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903438	CHEMBL3991718	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)c1c(OCc2c(F)cc(Br)cc2F)nsc1NC(=O)NCCCCN1CCCC1		CHEMBL253969	>	Kd	nM	30000.0	CHEMBL4454	Homo sapiens	Kd apparent	nM	30000.0
Active	17903439	CHEMBL3991718	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1		CHEMBL217092	=	Kd	nM	956.0	CHEMBL4454	Homo sapiens	Kd apparent	nM	956.0
Inactive	17903440	CHEMBL3991718	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc2c(OCc3nnc4ccc(-c5ccccc5)nn34)ccnc2c1		CHEMBL496102	>	Kd	nM	30000.0	CHEMBL4454	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903441	CHEMBL3991718	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)N[C@H]4CC[C@H](N5CCN(CC6CC6)CC5)CC4)cc3OC)nc2N1C(C)C		CHEMBL1233528	>	Kd	nM	30000.0	CHEMBL4454	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903442	CHEMBL3991718	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	30000.0	CHEMBL4454	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903443	CHEMBL3991718	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3F)c(C(=O)NOCCO)cc21		CHEMBL3187723	>	Kd	nM	30000.0	CHEMBL4454	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903444	CHEMBL3991718	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(/C=C/c3ccccc3)n2)n[nH]1		CHEMBL482968	>	Kd	nM	30000.0	CHEMBL4454	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903445	CHEMBL3991718	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	>	Kd	nM	30000.0	CHEMBL4454	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903446	CHEMBL3991718	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	>	Kd	nM	30000.0	CHEMBL4454	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903447	CHEMBL3991718	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2ccc3ncc4c(c3c2)n(-c2ccc(N3CCNCC3)c(C(F)(F)F)c2)c(=O)n4C)cn1		CHEMBL3218578	>	Kd	nM	30000.0	CHEMBL4454	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903448	CHEMBL3991718	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OC(=O)C(C)(CO)CO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL1201182	>	Kd	nM	30000.0	CHEMBL4454	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903449	CHEMBL3991718	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc2cc(-c3nn(C(C)C)c4ncnc(N)c34)ccc2o1		CHEMBL3991933	>	Kd	nM	30000.0	CHEMBL4454	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903450	CHEMBL3991718	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	>	Kd	nM	30000.0	CHEMBL4454	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903451	CHEMBL3991718	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1ccc(OC(F)(F)F)cc1)c1sccc1NCc1ccnc2ccccc12		CHEMBL1614710	>	Kd	nM	30000.0	CHEMBL4454	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903452	CHEMBL3991718	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	30000.0	CHEMBL4454	Homo sapiens	Kd apparent	nM	30000.0
Uncertain	17903453	CHEMBL3991718	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	1518.0	CHEMBL4454	Homo sapiens	Kd apparent	nM	1518.0
Inactive	17903454	CHEMBL3991718	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	>	Kd	nM	30000.0	CHEMBL4454	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903455	CHEMBL3991718	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(-c2cc(O)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL400402	>	Kd	nM	30000.0	CHEMBL4454	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903456	CHEMBL3991718	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC[C@@](O)(c1ccc(Cl)cc1)c1ccc(-c2cn[nH]c2)cc1		CHEMBL3544960	>	Kd	nM	30000.0	CHEMBL4454	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903457	CHEMBL3991718	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc2ccc(-n3ncc(C(=O)c4cc5ccccc5[nH]4)c3N)cc2[nH]1		CHEMBL3907479	>	Kd	nM	30000.0	CHEMBL4454	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903458	CHEMBL3991718	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1cc(-c2ccnc3[nH]c(-c4cccc(CN(C)C)c4)cc23)c(-c2ccc(NC(=O)N(C)C)cc2)n1		CHEMBL1090479	>	Kd	nM	30000.0	CHEMBL4454	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903459	CHEMBL3991718	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccccc32)c(C)c1CCC(=O)O		CHEMBL274654	>	Kd	nM	30000.0	CHEMBL4454	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903460	CHEMBL3991718	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	30000.0	CHEMBL4454	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903461	CHEMBL3991718	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(C(=O)NOCCO)c(Nc2ccc(I)cc2F)n(C)c1=O		CHEMBL3182621	>	Kd	nM	30000.0	CHEMBL4454	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903462	CHEMBL3991718	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	OCCn1cc(-c2cnc3nnn(Cc4ccc5ncccc5c4)c3n2)cn1		CHEMBL2001019	>	Kd	nM	30000.0	CHEMBL4454	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903463	CHEMBL3991718	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1cc2c(cc1N1CCC(N3CCOCC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL1738797	>	Kd	nM	30000.0	CHEMBL4454	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903464	CHEMBL3991718	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc(OC)c(OCCCCCCC(=O)NO)cc23)c1		CHEMBL598797	>	Kd	nM	30000.0	CHEMBL4454	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903465	CHEMBL3991718	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	30000.0	CHEMBL4454	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903466	CHEMBL3991718	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	>	Kd	nM	30000.0	CHEMBL4454	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903467	CHEMBL3991718	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3cc(C(C)(C)C)nn3-c3ccc4ncccc4c3)c(F)c2)ccn1		CHEMBL1738757	>	Kd	nM	30000.0	CHEMBL4454	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903468	CHEMBL3991718	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	>	Kd	nM	30000.0	CHEMBL4454	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903469	CHEMBL3991718	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	>	Kd	nM	30000.0	CHEMBL4454	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903470	CHEMBL3991718	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	>	Kd	nM	30000.0	CHEMBL4454	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903471	CHEMBL3991718	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	30000.0	CHEMBL4454	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903472	CHEMBL3991718	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	>	Kd	nM	30000.0	CHEMBL4454	Homo sapiens	Kd apparent	nM	30000.0
Active	17903473	CHEMBL3991718	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	=	Kd	nM	642.0	CHEMBL4454	Homo sapiens	Kd apparent	nM	642.0
	18053016	CHEMBL4011863	Inhibition of FGR (unknown origin) at 0.1 uM pretreated for 30 mins followed by substrate addition measured after 5 hrs in presence of 1 mM ATP relative to control	B	COC(=O)C1=C(Nc2ccccc2Cl)O/C(=C\c2c[nH]c3ncccc23)C1=O		CHEMBL4089159	=	Inhibition	%	-0.6	CHEMBL4454	Homo sapiens	INH	%	-0.6
	18064132	CHEMBL4013823	Inhibition of human FGR at 10 uM preincubated for 15 mins followed by peptide substrate addition measured after 3 hrs by caliper capillary electrophoresis method relative to control	B	C=CC(=O)Nc1ccc(CCn2c(=O)c(-c3ccccc3Cl)cc3cnc(NCCCCN(CC)CC)nc32)cc1		CHEMBL4103536	<	Inhibition	%	85.0	CHEMBL4454	Homo sapiens	INH	%	85.0
	18114350	CHEMBL4025144	Inhibition of wild-type human partial length FGR (L233 to T529 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2cc(-c3cccc(NC(=O)c4ccc(C(C)(C)C)cc4)c3C)cn(C)c2=O)ccc1C(=O)N1CCOCC1		CHEMBL4077123	=	Activity	%	77.0	CHEMBL4454	Homo sapiens	Activity	%	77.0
	18203668	CHEMBL4043955	Inhibition of wild-type human partial length FGR (L233 to T529 residues) expressed in Escherichia coli BL21 assessed as residual activity at 1000 nM after 30 mins by Kinomescan method relative to control	B	COc1cc(OC)c(Cl)c(N2Cc3cnc(Nc4ccc(F)cc4)nc3N(C3CCN(C(=O)/C=C/CN(C)C)CC3)C2=O)c1Cl		CHEMBL4092508	=	Activity	%	19.0	CHEMBL4454	Homo sapiens	Activity	%	19.0
	18211638	CHEMBL4045679	Inhibition of FGR conserved Lys1 (LIKDDEYNPCQGSKFPIK) in human PBMC at 1 uM	B	CC(C)n1cc(-c2cc(-c3ccc(CN4CCOCC4)cc3)cnc2N)nn1		CHEMBL3971067	=	Inhibition	%	-8.4	CHEMBL4454	Homo sapiens	INH	%	-8.4
	18211826	CHEMBL4045922	Inhibition of FGR conserved Lys1 (LIKDDEYNPCQGSKFPIK) in human PBMC at 0.1 uM	B	CC(C)n1cc(-c2cc(-c3ccc(CN4CCOCC4)cc3)cnc2N)nn1		CHEMBL3971067	=	Inhibition	%	9.6	CHEMBL4454	Homo sapiens	INH	%	9.6
	18225378	CHEMBL4048704	Inhibition of FGR (unknown origin) at 1 uM relative to control	B	Nc1cc(Nc2cc(Cl)c3n(c2=O)C2(CCCC2)NC3=O)ncn1		CHEMBL4094975	=	Inhibition	%	60.0	CHEMBL4454	Homo sapiens	INH	%	60.0
	18253511	CHEMBL4055039	Inhibition of wild-type human partial length FGR (L233 to T529 residues) expressed in bacterial expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(-c4ccccc4)cc23)CC[C@]1(C)N		CHEMBL4096145	=	Activity	%	85.0	CHEMBL4454	Homo sapiens	Activity	%	85.0
	18253512	CHEMBL4055039	Inhibition of wild-type human partial length FGR (L233 to T529 residues) expressed in bacterial expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	COc1ccc(-c2cc3c(N[C@@H]4CC[C@](C)(N)C4(C)C)c(C(N)=O)cnn3c2)cn1		CHEMBL4080797	=	Activity	%	99.0	CHEMBL4454	Homo sapiens	Activity	%	99.0
	18265862	CHEMBL4057312	Inhibition of FGR (unknown origin) at 0.45 uM relative to control	B	Cc1n[nH]c(C)c1-c1ccc2c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)n[nH]c2c1		CHEMBL4095072	=	Inhibition	%	13.0	CHEMBL4454	Homo sapiens	INH	%	13.0
	18266056	CHEMBL4057506	Inhibition of FGR (unknown origin) at 0.49 uM relative to control	B	Cc1[nH]nc(C2CC2)c1-c1ccc2c(NC(=O)C3CC3)noc2c1		CHEMBL4088455	=	Inhibition	%	-4.0	CHEMBL4454	Homo sapiens	INH	%	-4.0
	18268023	CHEMBL4057958	Inhibition of FGR (unknown origin)	B	CC(C)C(=O)N1CCC[C@@H](c2nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3F)c3c(N)nccn23)C1		CHEMBL4069387	=	IC50	nM	203.0	CHEMBL4454	Homo sapiens	IC50	nM	203.0
	18268024	CHEMBL4057958	Inhibition of FGR (unknown origin)	B	CC(C)C(=O)N1CCO[C@@H](c2nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3F)c3c(N)nccn23)C1		CHEMBL4075954	=	IC50	nM	268.0	CHEMBL4454	Homo sapiens	IC50	nM	268.0
	18268025	CHEMBL4057958	Inhibition of FGR (unknown origin)	B	COCC(=O)N1CCC[C@@H](c2nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3F)c3c(N)nccn23)C1		CHEMBL4076024	=	IC50	nM	28.0	CHEMBL4454	Homo sapiens	IC50	nM	28.0
	18268026	CHEMBL4057958	Inhibition of FGR (unknown origin)	B	COCC(=O)N1CCO[C@@H](c2nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3F)c3c(N)nccn23)C1		CHEMBL4062498	=	IC50	nM	69.0	CHEMBL4454	Homo sapiens	IC50	nM	69.0
	18268027	CHEMBL4057958	Inhibition of FGR (unknown origin)	B	Nc1nccn2c([C@@H]3CCCN(C4CCOCC4)C3)nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3F)c12		CHEMBL4077588	=	IC50	nM	22.0	CHEMBL4454	Homo sapiens	IC50	nM	22.0
	18268028	CHEMBL4057958	Inhibition of FGR (unknown origin)	B	Nc1nccn2c([C@H]3CN(C4CCOCC4)CCO3)nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3F)c12		CHEMBL4060757	=	IC50	nM	39.0	CHEMBL4454	Homo sapiens	IC50	nM	39.0
	18269000	CHEMBL4058131	Inhibition of recombinant human N-terminal His6-tagged FGR (2 to end residues) expressed in baculovirus Sf21 insect cells preincubated for 5 mins followed by substrate addition after 30 to 60 mins in presence of ATP by fluorescence assay	B	C=CS(=O)(=O)N1CCC[C@@H]1Cn1cc(-c2ccc3c(c2)OCO3)c2c(N)ncnc21		CHEMBL4095253	=	IC50	nM	133.3	CHEMBL4454	Homo sapiens	IC50	nM	133.3
	18282094	CHEMBL4120049	Inhibition of recombinant full length His-tagged human FGR expressed in baculovirus expression system at 1 uM by FRET assay relative to control	B	CC(C)n1nc(-c2cnc(N)c(OC(F)(F)F)c2)cc1[C@@H]1[C@H]2CN(C3COC3)C[C@H]21		CHEMBL3719135	=	Inhibition	%	31.9	CHEMBL4454	Homo sapiens	INH	%	31.9
	18282413	CHEMBL4120049	Inhibition of recombinant full length His-tagged human FGR expressed in baculovirus expression system at 1 uM by FRET assay relative to control	B	Nc1ncc(-c2cc([C@@H]3[C@H]4CN(C5COC5)C[C@H]43)n(CC3CC3)n2)cc1C(F)(F)F		CHEMBL3715238	=	Inhibition	%	32.2	CHEMBL4454	Homo sapiens	INH	%	32.2
	18282759	CHEMBL4120344	Inhibition of FGR (unknown origin) at 0.45 uM relative to control	B	Cc1n[nH]c(C)c1-c1ccc2c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)n[nH]c2c1		CHEMBL4095072	=	Inhibition	%	13.0	CHEMBL4454	Homo sapiens	INH	%	13.0
	18282986	CHEMBL4120571	Inhibition of FGR (unknown origin) at 0.19 uM relative to control	B	Cc1[nH]nc(C2CC2)c1-c1ccc2c(-c3ccc(N4CCN(C)CC4)nc3)n[nH]c2c1		CHEMBL4125807	=	Inhibition	%	-3.0	CHEMBL4454	Homo sapiens	INH	%	-3.0
	18283210	CHEMBL4120795	Inhibition of FGR (unknown origin) at 0.164 uM relative to control	B	COC(=O)Nc1cc(-c2c(C3CC3)n[nH]c2C)cc2[nH]ncc12		CHEMBL4129737	=	Inhibition	%	-4.3	CHEMBL4454	Homo sapiens	INH	%	-4.3
	18330825	CHEMBL4136276	Inhibition of recombinant FGR (unknown origin) at 1 uM by off-chip mobility shift assay	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	=	Inhibition	%	96.0	CHEMBL4454	Homo sapiens	INH	%	96.0
	18431341	CHEMBL4155793	Inhibition of FGR (unknown origin) at 1 uM relative to control	B	Cn1ncc2c(Oc3ccc4c(c3)nc(Nc3ccc(OC(F)(F)F)cc3)n4C)ncnc21		CHEMBL4170025	=	Inhibition	%	-6.9	CHEMBL4454	Homo sapiens	INH	%	-6.9
	18440210	CHEMBL4157034	Binding affinity to wild-type human partial length FGR (L233 to T529 residues) expressed in bacterial expression system assessed as residual binding at 1 uM by Kinomescan method relative to control	B	Cc1cccc(S(=O)(=O)Nc2cc(-c3sc(NC(=O)[C@@H](N)C(C)C)nc3C)cnc2Cl)c1		CHEMBL4174988	=	Activity	%	89.0	CHEMBL4454	Homo sapiens	Activity	%	89.0
	18484650	CHEMBL4185813	Binding affinity to wild-type human partial length FGR (L233 to T529 residues) expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control	B	CCC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL4206831	=	Activity	%	96.0	CHEMBL4454	Homo sapiens	Activity	%	96.0
	18484987	CHEMBL4185813	Binding affinity to wild-type human partial length FGR (L233 to T529 residues) expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL3969370	=	Activity	%	93.0	CHEMBL4454	Homo sapiens	Activity	%	93.0
	18507786	CHEMBL4190976	Inhibition of recombinant human FGR (2 to end residues) at 1 uM using poly(Glu,Tyr) 4:1 as substrate after 40 mins in presence of [gamma-33P]ATP by scintillation counting method	B	CS(=O)(=O)c1ccc(-n2nc(-c3cnc4[nH]ccc4c3)c3c(N)ncnc32)cc1		CHEMBL4207014	=	Inhibition	%	69.0	CHEMBL4454	Homo sapiens	INH	%	69.0
	18558656	CHEMBL4201062	Inhibition of human FGR at 1 uM relative to control	B	Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1N1Cc2cnc(N)nc2N(C)C1=O		CHEMBL459850	=	Inhibition	%	99.1	CHEMBL4454	Homo sapiens	INH	%	99.1
	18653629	CHEMBL4230089	Inhibition of FGR (unknown origin) at 1 uM by mobility shift microfluidics platform based assay relative to control	B	CC(C)n1nc(C#Cc2cccc(NC(=O)c3cccc(C(F)(F)F)c3)c2)c2c(N)ncnc21		CHEMBL3736320	=	Inhibition	%	99.0	CHEMBL4454	Homo sapiens	INH	%	99.0
	18653630	CHEMBL4230089	Inhibition of FGR (unknown origin) at 1 uM by mobility shift microfluidics platform based assay relative to control	B	CC(C)n1nc(C#Cc2cccc3cc(-c4cccc(C(F)(F)F)c4)ncc23)c2c(N)ncnc21		CHEMBL4247506	=	Inhibition	%	71.0	CHEMBL4454	Homo sapiens	INH	%	71.0
	18655522	CHEMBL4230713	Binding affinity to wild-type human partial length FGR (L233 to T529 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	Cc1ccc(NC(=O)c2ccc(CN(CCN(C)C)C(=O)c3cccnc3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL4247298	=	Activity	%	91.0	CHEMBL4454	Homo sapiens	Activity	%	91.0
	18737910	CHEMBL4261444	Inhibition of recombinant human Fgr (2 to end residues) using poly(Glu, Tyr) 4:1 as substrate after 40 mins in presence of [gamma-33P]-ATP by scintillation counting analysis	B	CCn1cc(-c2ccc3c(c2)CCN3C(=O)Cc2cccc(OC(F)(F)F)c2)c2c(N)ncnc21		CHEMBL4281823	=	IC50	nM	470.0	CHEMBL4454	Homo sapiens	IC50	nM	470.0
	18751107	CHEMBL4263807	Inhibition of FGR (unknown origin) at 1 uM relative to control	B	NC1(c2ccc(-c3cnc4c(-c5ccc(S(N)(=O)=O)c6ccccc56)cnn4c3)cc2)CCC1		CHEMBL4278763	=	Inhibition	%	13.0	CHEMBL4454	Homo sapiens	INH	%	13.0
	18751601	CHEMBL4264302	Binding affinity to wild-type human partial length FGR (L233 to T529 residues) expressed in bacterial expression system assessed as remaining unbound target protein level at 1000 nM by Kinomescan method relative to control	B	COCCN[C@H]1CC[C@H](Nc2cc(-c3csc(NCC4(C#N)CCOCC4)n3)c(Cl)cn2)CC1		CHEMBL4281048	=	Activity	%	90.0	CHEMBL4454	Homo sapiens	Activity	%	90.0
	18857971	CHEMBL4307817	Binding affinity to wild-type human partial length FGR (L233 to T529 residues) expressed in bacterial expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	CC(C)N1C(=O)C(NCCCN(C)C)=C(c2cn(C)c3ccccc23)C1=O.Cl		CHEMBL4533018	=	Activity	%	82.0	CHEMBL4454	Homo sapiens	Activity	%	82.0
	18892621	CHEMBL4314681	Inhibition of recombinant human FGR (2 to end residues) assessed as residual activity at 10 uM using poly(Glu, Tyr) 4:1 as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	Cc1cc(C)c(CNc2nc(Cl)nc3c2ncn3C2CCCC2)c(=O)[nH]1		CHEMBL4557538	=	Activity	%	94.5	CHEMBL4454	Homo sapiens	Activity	%	94.5
	18919458	CHEMBL4322815	Binding affinity to recombinant full-length N-terminal His-FLAG-tagged FGR (unknown origin) expressed in baculovirus infected Sf9 insect cells incubated for 1 hr by TR-FRET assay	B	CO[C@@H]1[C@H](NCCOCCOCCOCCNC(=O)CCC2=[N+]3C(=Cc4c(C)cc(C)n4[B-]3(F)F)C=C2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL4465866	=	Kd	nM	101.0	CHEMBL4454	Homo sapiens	Kd	nM	101.0
	18919646	CHEMBL4322815	Binding affinity to recombinant full-length N-terminal His-FLAG-tagged FGR (unknown origin) expressed in baculovirus infected Sf9 insect cells incubated for 1 hr by TR-FRET assay	B	CO[C@@H]1[C@H](N(C)CCOCCOCCOCCNC(=O)CCC2=[N+]3C(=Cc4c(C)cc(C)n4[B-]3(F)F)C=C2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL4576489	=	Kd	nM	119.0	CHEMBL4454	Homo sapiens	Kd	nM	119.0
	18934097	CHEMBL4326629	Inhibition of human FGR at 10 uM using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay relative to control	B	CC(=O)N1CCN(c2ccc(Nc3ncc(C(F)(F)F)c(N4Cc5cccc(N(C)S(C)(=O)=O)c5C4)n3)cc2)CC1		CHEMBL4476226	=	Inhibition	%	80.6	CHEMBL4454	Homo sapiens	INH	%	80.6
	18937937	CHEMBL4327699	Inhibition of human FGR assessed as residual activity at 1 uM using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay relative to control	B	ClC/C=C/C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]		CHEMBL4438024	=	Activity	%	102.26	CHEMBL4454	Homo sapiens	Activity	%	102.26
	18937938	CHEMBL4327699	Inhibition of human FGR assessed as residual activity at 1 uM using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay relative to control	B	C(=C/c1ccccc1)\C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]		CHEMBL4446405	=	Activity	%	97.26	CHEMBL4454	Homo sapiens	Activity	%	97.26
	18938539	CHEMBL4328059	Inhibition of human FGR assessed as residual activity at 100 uM using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay relative to control	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	<	Activity	%	65.0	CHEMBL4454	Homo sapiens	Activity	%	65.0
	18938917	CHEMBL4328423	Inhibition of human FGR using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	1.15	CHEMBL4454	Homo sapiens	IC50	10'-9M	1.15
	18958888	CHEMBL4333407	Binding affinity to wild-type human partial length FGR (L233 to T529 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	CC(C)Nc1sc(C(=O)c2ccc(Cl)s2)c(N)c1C#N		CHEMBL4563315	=	Activity	%	97.0	CHEMBL4454	Homo sapiens	Activity	%	97.0
	18964301	CHEMBL4335088	Inhibition of recombinant human FGR (2 to end residues) assessed as residual activity at 1 uM using poly(Glu, Tyr) 4:1 as substrate at 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	N=C1NC(=O)/C(=C\c2ccc(-c3cccc([N+](=O)[O-])c3)o2)S1		CHEMBL4455512	=	Activity	%	81.0	CHEMBL4454	Homo sapiens	Activity	%	81.0
	18964302	CHEMBL4335088	Inhibition of recombinant human FGR (2 to end residues) assessed as residual activity at 1 uM using poly(Glu, Tyr) 4:1 as substrate at 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	C=CCOC(=O)c1cc(-c2ccc(/C=C3/NC(=S)NC3=O)o2)ccc1Cl		CHEMBL4568120	=	Activity	%	90.0	CHEMBL4454	Homo sapiens	Activity	%	90.0
	18971905	CHEMBL4336915	Inhibition of recombinant human FGR (2 to end residues) assessed as residual activity at 10 uM using poly(Glu, Tyr) 4:1 as substrate at 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	C[C@@H](c1ccccc1)n1nnc2cnc3ccc(-c4cnc5[nH]ccc5c4)cc3c21		CHEMBL4472294	=	Activity	%	5.0	CHEMBL4454	Homo sapiens	Activity	%	5.0
	18972855	CHEMBL4337354	Inhibition of full-length N-terminal GST-tagged human FGR (1 to 529 residues) expressed in baculovirus expression system at 10 uM using propeptide-27 as substrate after 30 mins by electrophoretic mobility shift assay relative to control	B	Cc1ccc(C(=O)NC2CC2)cc1NC(=O)c1ccc2c(c1)OCCO2		CHEMBL4580637	=	Inhibition	%	1.0	CHEMBL4454	Homo sapiens	INH	%	1.0
	19018949	CHEMBL4347060	Inhibition of human recombinant FGR using Ulight-TK peptide as substrate measured after 60 mins in the presence of ATP by LANCE method	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C[C@H]1CCCN1C[C@@H]1CO1		CHEMBL4525187	=	IC50	nM	28.0	CHEMBL4454	Homo sapiens	IC50	nM	28.0
Not Active	19039776	CHEMBL4351866	Inhibition of recombinant human FGR (2 to end residues) at 10 uM using poly(Glu, Tyr) 4:1 as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	CN1C[C@H](Nc2nc3cc[nH]c3c(=O)n2C)C[C@H](c2ccc3c(c2)OCCO3)C1		CHEMBL4574669		Inhibition	%		CHEMBL4454	Homo sapiens	INH		
Active	19041115	CHEMBL4352376	Inhibition of human FGR at 10 uM using poly[Glu:Tyr] (4:1) as substrate in presence of [gamma-33P]-ATP	B	CC(C)(C)C(=O)N1N=CC[C@H]1c1ccccc1		CHEMBL4521353		Inhibition	%		CHEMBL4454	Homo sapiens	INH		
	19059590	CHEMBL4357891	Binding affinity to wild-type human partial length FGR (L233 to T529 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1C(=O)Nc1c(C)cccc1Cl		CHEMBL4515441	=	Activity	%	30.0	CHEMBL4454	Homo sapiens	Activity	%	30.0
	19072924	CHEMBL4362099	Effect on FGR at Y412 phosphorylation level in human NCI-H1975 incubated for 12 hrs by human phosphokinase proteome profiler array relative to control	B	CCOc1ccc(-c2nc(C(=O)NO)c3[nH]c(=O)n(-c4ccccc4OC)c3n2)cc1		CHEMBL4443725	=	FC		0.32	CHEMBL4454	Homo sapiens	FC		0.32
	19072963	CHEMBL4362138	Effect on FGR at Y412 phosphorylation level in human NCI-H1975 incubated for 12 hrs by human phosphokinase proteome profiler array relative to beta-catenin	B	CCOc1ccc(-c2nc(C(=O)NO)c3[nH]c(=O)n(-c4ccccc4OC)c3n2)cc1		CHEMBL4443725	=	FC		0.36	CHEMBL4454	Homo sapiens	FC		0.36
	19073002	CHEMBL4362099	Effect on FGR at Y412 phosphorylation level in human NCI-H1975 incubated for 12 hrs by human phosphokinase proteome profiler array relative to control	B	CCOc1ccc(-c2nc(C(=O)NO)c3[nH]c(=O)n(-c4ccccc4OC)c3n2)cc1		CHEMBL4443725	=	log2FC		-1.65	CHEMBL4454	Homo sapiens	log2FC		-1.65
	19073041	CHEMBL4362138	Effect on FGR at Y412 phosphorylation level in human NCI-H1975 incubated for 12 hrs by human phosphokinase proteome profiler array relative to beta-catenin	B	CCOc1ccc(-c2nc(C(=O)NO)c3[nH]c(=O)n(-c4ccccc4OC)c3n2)cc1		CHEMBL4443725	=	log2FC		-1.48	CHEMBL4454	Homo sapiens	log2FC		-1.48
	19073103	CHEMBL4362099	Effect on FGR at Y412 phosphorylation level in human NCI-H1975 incubated for 12 hrs by human phosphokinase proteome profiler array relative to control	B	CCOc1ccc(-c2nc(/C(N)=N/O)c3[nH]c(=O)n(-c4ccccc4OC)c3n2)cc1		CHEMBL4515196	=	FC		1.01	CHEMBL4454	Homo sapiens	FC		1.01
	19073142	CHEMBL4362138	Effect on FGR at Y412 phosphorylation level in human NCI-H1975 incubated for 12 hrs by human phosphokinase proteome profiler array relative to beta-catenin	B	CCOc1ccc(-c2nc(/C(N)=N/O)c3[nH]c(=O)n(-c4ccccc4OC)c3n2)cc1		CHEMBL4515196	=	FC		1.18	CHEMBL4454	Homo sapiens	FC		1.18
	19073181	CHEMBL4362099	Effect on FGR at Y412 phosphorylation level in human NCI-H1975 incubated for 12 hrs by human phosphokinase proteome profiler array relative to control	B	CCOc1ccc(-c2nc(/C(N)=N/O)c3[nH]c(=O)n(-c4ccccc4OC)c3n2)cc1		CHEMBL4515196	=	log2FC		0.02	CHEMBL4454	Homo sapiens	log2FC		0.02
	19073220	CHEMBL4362138	Effect on FGR at Y412 phosphorylation level in human NCI-H1975 incubated for 12 hrs by human phosphokinase proteome profiler array relative to beta-catenin	B	CCOc1ccc(-c2nc(/C(N)=N/O)c3[nH]c(=O)n(-c4ccccc4OC)c3n2)cc1		CHEMBL4515196	=	log2FC		0.24	CHEMBL4454	Homo sapiens	log2FC		0.24
	19090161	CHEMBL4365735	Inhibition of wild-type human partial length FGR (L233 to T529 residues) expressed in bacterial expression system assessed as residual activity at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccnc1)c1cc(C(=O)c2c(F)cccc2Br)c[nH]1		CHEMBL4436895	=	Activity	%	100.0	CHEMBL4454	Homo sapiens	Activity	%	100.0
	19091932	CHEMBL4366406	Inhibition of human FGR at 100 nM using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay	B	COc1ccc(N2C(=O)COc3ccc(-c4cnc(OC)c(NS(=O)(=O)c5ccc(F)cc5)c4)cc32)cc1		CHEMBL4528675	=	Inhibition	%	5.02	CHEMBL4454	Homo sapiens	INH	%	5.02
	19092271	CHEMBL4366691	Inhibition of FGR (unknown origin) at 1 uM relative to control	B	Nc1nccc(Oc2ccc(Nc3nccc4ccn(-c5ccc(F)cc5)c(=O)c34)cc2F)c1Cl		CHEMBL4474232	=	Inhibition	%	62.0	CHEMBL4454	Homo sapiens	INH	%	62.0
	19140792	CHEMBL4376556	Inhibition of recombinant full length human His-tagged FGR expressed in baculovirus expression system at 1 uM using biotin as substrate preincubated for 5 mins followed by substrate addition and measured after 30 to 60 mins in presence of ATP by HTRF assay relative to control	B	Cn1cc(-c2ccc(F)cc2)c(=O)c2c(Nc3ccc(Oc4ccnc(NC(=O)C5CC5)c4)c(F)c3)nccc21		CHEMBL4584949	>	Inhibition	%	80.0	CHEMBL4454	Homo sapiens	INH	%	80.0
	19144847	CHEMBL4377863	Inhibition of recombinant human FGR (2 to end residues) at 1 uM using poly(Glu, Tyr) 4:1 as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(NC(=O)CCCCCCCN=C=S)cc3)nc2n1C1CCCC1		CHEMBL4548580	=	Inhibition	%	66.0	CHEMBL4454	Homo sapiens	INH	%	66.0
	19146937	CHEMBL4378855	Inhibition of recombinant human FGR (2 to end residues) at 10 uM using poly(Glu, Tyr) 4:1 as substrate after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	C=CS(=O)(=O)Nc1ccc(Cc2ccc3ccccc3c2)cc1		CHEMBL4459587	=	Inhibition	%	15.0	CHEMBL4454	Homo sapiens	INH	%	15.0
	19147856	CHEMBL4379330	Inhibition of recombinant human FGR (2 to end residues) using poly(Glu, Tyr) 4:1 as substrate after 40 mins in presence of [gamma-33ATP] by radiometric scintillation counting analysis	B	CN(C)c1ccc(C(=O)Nc2cccc(NC(=O)COc3ccc4c(=O)ccoc4c3)c2)cc1		CHEMBL4438748	>	IC50	nM	10000.0	CHEMBL4454	Homo sapiens	IC50	uM	10.0
	19159418	CHEMBL4382522	Binding affinity to wild-type human partial length FGR (L233 to T529 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL4473365	=	Activity	%	57.0	CHEMBL4454	Homo sapiens	Activity	%	57.0
	19181034	CHEMBL4387245	Inhibition of recombinant full length human His-tagged FGR expressed in baculovirus expression system at 0.1 uM using tyrosine-2 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control	B	CCN1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1		CHEMBL3301610	=	Inhibition	%	8.5	CHEMBL4454	Homo sapiens	INH	%	8.5
	19181260	CHEMBL4387245	Inhibition of recombinant full length human His-tagged FGR expressed in baculovirus expression system at 0.1 uM using tyrosine-2 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control	B	CCN1CC2(C1)CN(c1ccc(Nc3ncc(F)c(-c4cnn5c4[C@H](C)CCCC5)n3)nc1)C2		CHEMBL4545456	=	Inhibition	%	7.0	CHEMBL4454	Homo sapiens	INH	%	7.0
	19191589	CHEMBL4389241	Inhibition of wild-type human partial length FGR (L233 to T529 residues) expressed in bacterial expression system at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@H]2CCCN(c3ncnc4[nH]ccc34)C2)c1)Nc1ccccc1N1CCCC1		CHEMBL4555459	=	Inhibition	%	62.0	CHEMBL4454	Homo sapiens	INH	%	62.0
	19191904	CHEMBL4389718	Inhibition of wild-type human partial length FGR (L233 to T529 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@@H]2CN(c3ncnc4[nH]ccc34)CCN2CCO)c1)Nc1c(F)cccc1N1CCCC1		CHEMBL4564973	=	Inhibition	%	77.0	CHEMBL4454	Homo sapiens	INH	%	77.0
	19199878	CHEMBL4391344	Binding affinity to wild-type human partial length FGR (L233 to T529 residues) expressed in bacterial expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cc(-c2cn(CCNc3c4c(nc5ccccc35)CCCC4)nn2)ccn1)Nc1cccc2c1C1CCCCN1C2=O		CHEMBL4559936	=	Activity	%	97.0	CHEMBL4454	Homo sapiens	Activity	%	97.0
	19266428	CHEMBL4405378	Inhibition of wild-type human partial length FGR (L233 to T529 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control	B	CC[C@H](Nc1nc(N)nc(C)c1C#N)c1nc2cccc(NCc3ccc(C(=O)NO)cc3)c2c(=O)n1-c1ccccc1		CHEMBL4455923	<	Inhibition	%	50.0	CHEMBL4454	Homo sapiens	INH	%	50.0
	19275996	CHEMBL4407999	Inhibition of recombinant human FGR (2 to end residues) at 1 uM using poly(Glu, Tyr) 4:1 as substrate incubated for 40 mins in presence of [gamma-33P]-ATP by scintillation counting method relative to control	B	Cc1ccc(NC(=O)C2(C(=O)Nc3ccc(Nc4ncc(F)c(-c5cc(F)c6nc(C)n(C(C)C)c6c5)n4)cc3)CC2)cc1		CHEMBL4445335	=	Inhibition	%	55.0	CHEMBL4454	Homo sapiens	INH	%	55.0
	19306068	CHEMBL4414921	Inhibition of human FGR using poly[Glu:Tyr] (4:1) as substrate preincubated for 60 mins followed by [gamma-33P]-ATP addition and measured after 120 mins by filter binding method	A	C=CC(=O)N1CCC([C@@H]2CCNc3c(C(N)=O)c(-c4ccc(Oc5ccccc5)cc4)nn32)CC1		CHEMBL3936761	=	IC50	nM	155.0	CHEMBL4454	Homo sapiens	IC50	nM	155.0
	19306069	CHEMBL4414921	Inhibition of human FGR using poly[Glu:Tyr] (4:1) as substrate preincubated for 60 mins followed by [gamma-33P]-ATP addition and measured after 120 mins by filter binding method	A	C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL1873475	=	IC50	nM	1.82	CHEMBL4454	Homo sapiens	IC50	nM	1.82
	19312948	CHEMBL4416503	Inhibition of recombinant human N-terminal His6-tagged FGR (2 to end residues) expressed in baculovirus infected Sf21 insect cells at 10 uM using poly (Glu4-Tyr) (4:1) as substrate relative to control	B	N#CC[C@H]1CC[C@H](n2c(=O)[nH]c3cnc(Nc4ccc[nH]c4=O)nc32)CC1		CHEMBL4463007	<	Inhibition	%	50.0	CHEMBL4454	Homo sapiens	INH	%	50.0
	20600436	CHEMBL4603313	Inhibition of recombinant full length human C-terminal His-tagged FGR expressed in baculovirus expression system using tyrosine-2 peptide as substrate incubated for 60 mins in presence of ATP by Z'-LYTE assay	B	C[C@@H]1C[C@H]1C(=O)N1CCN(c2cnc(C#N)c(-c3cnn(C)c3)n2)C[C@H]1C		CHEMBL4634634	=	IC50	nM	25390.0	CHEMBL4454	Homo sapiens	IC50	uM	25.39
	20609543	CHEMBL4605800	Inhibition of FGR (unknown origin) transfected in mouse Ba/F3 cells assessed as reduction in cell viability incubated for 48 hrs by brightglo-luciferase reporter gene assay	B	COc1ccc(-c2cnn3c(N)c(-c4ccccc4)c(OC4CCN(C)CC4)nc23)cc1OC		CHEMBL4640601	=	IC50	nM	98.0	CHEMBL4454	Homo sapiens	IC50	uM	0.098
	20609544	CHEMBL4605800	Inhibition of FGR (unknown origin) transfected in mouse Ba/F3 cells assessed as reduction in cell viability incubated for 48 hrs by brightglo-luciferase reporter gene assay	B	COC(=O)Nc1ccc(-c2c(OC3CCN(C)CC3)nc3c(-c4ccc(OC)c(OC)c4)cnn3c2N)cc1		CHEMBL4634073	=	IC50	nM	440.0	CHEMBL4454	Homo sapiens	IC50	uM	0.44
	20609545	CHEMBL4605800	Inhibition of FGR (unknown origin) transfected in mouse Ba/F3 cells assessed as reduction in cell viability incubated for 48 hrs by brightglo-luciferase reporter gene assay	B	COc1ccc(-c2cnn3c(N)c(-c4nccs4)c(OC4CCN(C)CC4)nc23)cc1OC		CHEMBL4636995	=	IC50	nM	4100.0	CHEMBL4454	Homo sapiens	IC50	uM	4.1
	20654889	CHEMBL4616955	Inhibition of FGR (unknown origin)	B	ClC(Cn1ncc2c(NCc3ccccc3)ncnc21)c1ccccc1		CHEMBL411043	=	Ki	nM	3467.37	CHEMBL4454	Homo sapiens	pKi		5.46
Active	20680041	CHEMBL4622601	Inhibition of recombinant human C-terminal His-tagged FGR expressed in baculovirus expression system using Fluorescein-polyGT as substrate incubated for 1 hr by Lanthascreen assay	B	C[C@H]1CN(C2COC2)CCN1c1ccc(Nc2cc(-c3ccnc(N4CCn5c(cc6c5CC(C)(C)C6)C4=O)c3CO)cn(C)c2=O)nc1		CHEMBL4065122		Inhibition	%		CHEMBL4454	Homo sapiens	INH		
	22392058	CHEMBL4667153	Inhibition of recombinant human C-terminal His-tagged full length FGR expressed in baculovirus expression system using Tyr 02 as substrate at 10 uM incubated for 60 mins by Z'-Lyte assay relative to control	B	CN1C(=O)[C@@H](NC(=O)c2n[nH]c3ncc(C(F)(F)C(F)(F)F)cc23)COc2ccccc21		CHEMBL4785812	=	Inhibition	%	1.5	CHEMBL4454	Homo sapiens	INH	%	1.5
	22418503	CHEMBL4672812	Inhibition of FGR (unknown origin)	B	Cc1c(-c2c(Cl)cc(C(N)=O)c3[nH]c4cc(C(C)(C)O)ccc4c23)cccc1-n1c(=O)cc2c(Cl)cccn2c1=O		CHEMBL3928976	=	IC50	nM	15.0	CHEMBL4454	Homo sapiens	IC50	nM	15.0
	22423099	CHEMBL4674114	Inhibition of human FGR using poly[Glu:Tyr] (4:1) as substrate at 0.5 uM by [gamma-33P]-ATP assay relative to control	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	>	Inhibition	%	80.0	CHEMBL4454	Homo sapiens	INH	%	80.0
	22423609	CHEMBL4674380	Inhibition of human FGR using poly[Glu:Tyr] (4:1) as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OC1CCCCC1		CHEMBL4785602	=	Activity	%	50.25	CHEMBL4454	Homo sapiens	Activity	%	50.25
	22423610	CHEMBL4674380	Inhibition of human FGR using poly[Glu:Tyr] (4:1) as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OCc1ccncc1		CHEMBL4749141	=	Activity	%	73.31	CHEMBL4454	Homo sapiens	Activity	%	73.31
	22823734	CHEMBL4717041	Inhibition of human FGR	B	C[C@H]1CC[C@@H](c2nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3F)c3c(N)nccn23)CN1C(=O)C1CC1		CHEMBL4103954	=	IC50	nM	37.0	CHEMBL4454	Homo sapiens	IC50	nM	37.0
	22823735	CHEMBL4717041	Inhibition of human FGR	B	CC1(C(=O)N2CCC[C@@H](c3nc(-c4ccc(C(=O)Nc5cc(C(F)(F)F)ccn5)cc4F)c4c(N)nccn34)C2)COC1		CHEMBL4799627	=	IC50	nM	55.0	CHEMBL4454	Homo sapiens	IC50	nM	55.0
	22836216	CHEMBL4718858	Inhibition of recombinant full length human C-terminal His-tagged FGR expressed in baculovirus expression system at 500 nM using Tyr 02 peptide as substrate incubated for 1 hr in presence of ATP at its Km concentration by Z'-LYTE assay relative to control	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	=	Inhibition	%	42.0	CHEMBL4454	Homo sapiens	INH	%	42.0
	22836217	CHEMBL4718858	Inhibition of recombinant full length human C-terminal His-tagged FGR expressed in baculovirus expression system at 500 nM using Tyr 02 peptide as substrate incubated for 1 hr in presence of ATP at its Km concentration by Z'-LYTE assay relative to control	B	OCC[C@@H](Nc1ncnc2[nH]c(-c3ccccc3)cc12)c1ccccc1		CHEMBL4786776	=	Inhibition	%	67.0	CHEMBL4454	Homo sapiens	INH	%	67.0
	22836218	CHEMBL4718858	Inhibition of recombinant full length human C-terminal His-tagged FGR expressed in baculovirus expression system at 500 nM using Tyr 02 peptide as substrate incubated for 1 hr in presence of ATP at its Km concentration by Z'-LYTE assay relative to control	B	CN(C)CCNCc1ccc(-c2cc3c(N[C@H](CO)c4ccccc4)ncnc3[nH]2)cc1F		CHEMBL4748367	=	Inhibition	%	83.0	CHEMBL4454	Homo sapiens	INH	%	83.0
	22836219	CHEMBL4718858	Inhibition of recombinant full length human C-terminal His-tagged FGR expressed in baculovirus expression system at 500 nM using Tyr 02 peptide as substrate incubated for 1 hr in presence of ATP at its Km concentration by Z'-LYTE assay relative to control	B	CCOc1ccccc1-c1cc2c(N[C@H](CO)c3ccccc3)ncnc2[nH]1		CHEMBL4776396	=	Inhibition	%	73.0	CHEMBL4454	Homo sapiens	INH	%	73.0
	22836220	CHEMBL4718858	Inhibition of recombinant full length human C-terminal His-tagged FGR expressed in baculovirus expression system at 500 nM using Tyr 02 peptide as substrate incubated for 1 hr in presence of ATP at its Km concentration by Z'-LYTE assay relative to control	B	COc1ccccc1-c1cc2c(N[C@H](CO)c3ccccc3)ncnc2[nH]1		CHEMBL4783569	=	Inhibition	%	74.0	CHEMBL4454	Homo sapiens	INH	%	74.0
	22836221	CHEMBL4718858	Inhibition of recombinant full length human C-terminal His-tagged FGR expressed in baculovirus expression system at 500 nM using Tyr 02 peptide as substrate incubated for 1 hr in presence of ATP at its Km concentration by Z'-LYTE assay relative to control	B	OC[C@@H](Nc1ncnc2[nH]c(-c3ccccc3)cc12)c1ccccc1		CHEMBL4780286	=	Inhibition	%	73.0	CHEMBL4454	Homo sapiens	INH	%	73.0
	22843223	CHEMBL4720247	Inhibition of FGR (unknown origin)	B	C=CC(=O)N1CCC(Cn2cc(-c3ccc4c(c3)OCO4)c3c(N)ncnc32)CC1		CHEMBL4755698	=	IC50	nM	657.4	CHEMBL4454	Homo sapiens	IC50	nM	657.4
	22843224	CHEMBL4720247	Inhibition of FGR (unknown origin)	B	C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL1873475	=	IC50	nM	2.3	CHEMBL4454	Homo sapiens	IC50	nM	2.3
	22843741	CHEMBL4720727	Inhibition of human FGR using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	0.658	CHEMBL4454	Homo sapiens	IC50	10^-10M	6.58
	22844093	CHEMBL4721079	Inhibition of human FGR assessed as residual activity using poly[Glu:Tyr] (4:1) as substrate at 1 uM by [gamma-33P]-ATP assay relative to control	B	O=C(Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1)c1cc([N+](=O)[O-])ccc1F		CHEMBL4750196	=	Activity	%	81.05	CHEMBL4454	Homo sapiens	Activity	%	81.05
	22844713	CHEMBL4721388	Inhibition of wild-type human partial length FGR (L233 to T529 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	CCOc1nc(Nc2ccc(C(=O)N3CCOCC3)cc2OC)nc2[nH]ccc12		CHEMBL4794578	=	Activity	%	103.81	CHEMBL4454	Homo sapiens	Activity	%	103.81
	22882838	CHEMBL4727422	Inhibition of FGR (unknown origin)	B	Nc1nccn2c([C@@H]3CC[C@H]4COC(=O)N4C3)nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3)c12		CHEMBL4749037	=	IC50	nM	26.0	CHEMBL4454	Homo sapiens	IC50	nM	26.0
Not Determined	22882839	CHEMBL4727422	Inhibition of FGR (unknown origin)	B	Nc1nccn2c([C@@H]3CC[C@H]4CCC(=O)N4C3)nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3)c12		CHEMBL4106978		IC50			CHEMBL4454	Homo sapiens	IC50		
	22882840	CHEMBL4727422	Inhibition of FGR (unknown origin)	B	CC1(C)OC(=O)N2C[C@H](c3nc(-c4ccc(C(=O)Nc5cc(C(F)(F)F)ccn5)cc4)c4c(N)nccn34)CC[C@H]21		CHEMBL4108687	=	IC50	nM	34.0	CHEMBL4454	Homo sapiens	IC50	nM	34.0
	22882841	CHEMBL4727422	Inhibition of FGR (unknown origin)	B	COc1cc(C(=O)Nc2cc(C(F)(F)F)ccn2)ccc1-c1nc([C@@H]2CC[C@H]3CCC(=O)N3C2)n2ccnc(N)c12		CHEMBL4114929	=	IC50	nM	64.0	CHEMBL4454	Homo sapiens	IC50	nM	64.0
	22882842	CHEMBL4727422	Inhibition of FGR (unknown origin)	B	Nc1nccn2c([C@@H]3CC[C@H]4CCC(=O)N4C3)nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3OC3CC3)c12		CHEMBL4107779	=	IC50	nM	263.0	CHEMBL4454	Homo sapiens	IC50	nM	263.0
	22952842	CHEMBL4766779	Inhibition of recombinant human FGR (2 to end residues) assessed as residual activity at 10 uM using poly(Glu, Tyr) 4:1 as substrate incubated for 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Nc3ncnc4c3OCCCN4)cc2)no1		CHEMBL4793380	=	Activity	%	20.0	CHEMBL4454	Homo sapiens	Activity	%	20.0
	23122576	CHEMBL4804927	Inhibition of human FGR assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN1CCN(C(=O)c2ccc3cc(CCNc4ccnc5ccc(C#N)cc45)ccc3c2)CC1		CHEMBL4878072	=	Activity	%	90.0	CHEMBL4454	Homo sapiens	Activity	%	90.0
	23123271	CHEMBL4805515	Inhibition of human FGR assessed as percent of control at 1000 nM by KINOMEscan assay relative to control	B	COc1cc2nc(NC3CC3)nc(NC3CCN(C(C)C)CC3)c2cc1OC.O=C(O)C(F)(F)F		CHEMBL4870304	=	Activity	%	100.0	CHEMBL4454	Homo sapiens	Activity	%	100.0
	23123620	CHEMBL4805864	Inhibition of DNA-tagged human FGR assessed as percent of control at 50000 nM by qPCR analysis relative to control	B	CN1C(=O)/C(=C2/C(=O)Nc3ccccc32)c2ccccc21		CHEMBL607535	=	Activity	%	95.0	CHEMBL4454	Homo sapiens	Activity	%	95.0
	23124632	CHEMBL4806532	Inhibition of human FGR assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	100.0	CHEMBL4454	Homo sapiens	Activity	%	100.0
	23124633	CHEMBL4806532	Inhibition of human FGR assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	100.0	CHEMBL4454	Homo sapiens	Activity	%	100.0
	23128116	CHEMBL4807847	Inhibition of FGR (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)csc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL4867844	<	Activity	%	25.0	CHEMBL4454	Homo sapiens	Activity	%	25.0
	23128117	CHEMBL4807847	Inhibition of FGR (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(Cl)ccnc3C)s2)cc(NN2CCN(CCO)CC2)n1		CHEMBL4855726	<	Activity	%	25.0	CHEMBL4454	Homo sapiens	Activity	%	25.0
	23128118	CHEMBL4807847	Inhibition of FGR (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	<	Activity	%	25.0	CHEMBL4454	Homo sapiens	Activity	%	25.0
	23192956	CHEMBL4818917	Inhibition of recombinant human FGR (2 to end residues) using poly(Glu, Tyr) 4:1 as substrate incubated for 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	C=CC(=O)N1CC[C@@H](NC(=O)c2sc3nccc4c3c2NC(=O)N4c2ccc(Oc3ccccc3)cc2C)C1		CHEMBL4851021	=	IC50	nM	4760.0	CHEMBL4454	Homo sapiens	IC50	uM	4.76
	23209858	CHEMBL4822467	Inhibition of human FGR at 1 uM	B	Cc1nn(C(C)C)c(C)c1-c1nc2c(-c3ccc4c(c3)CCCC[C@H]4NC(=O)c3nc(C(C)(C)C)no3)ccnc2[nH]1		CHEMBL4877846	>	Inhibition	%	80.0	CHEMBL4454	Homo sapiens	INH	%	80.0
	23209892	CHEMBL4822490	Inhibition of human FGR	B	CN1CCN(c2ccc(Nc3cc(-c4cccc(-n5ccc6cc(C7CC7)cc(F)c6c5=O)c4CO)cn(C)c3=O)nc2)CC1		CHEMBL2057918	=	IC50	nM	180.0	CHEMBL4454	Homo sapiens	IC50	nM	180.0
	23209893	CHEMBL4822490	Inhibition of human FGR	B	Cc1nn(C(C)C)c(C)c1-c1nc2c(-c3ccc4c(c3)CCCC[C@H]4NC(=O)c3nc(C(C)(C)C)no3)ccnc2[nH]1		CHEMBL4877846	=	IC50	nM	5.36	CHEMBL4454	Homo sapiens	IC50	nM	5.36
	23291249	CHEMBL4839532	Inhibition of human recombinant FGR (456 to 770) at 5 nM by radiometric scintillation counting analysis relative to control	B	Cc1ccc(C(=O)Nc2ccc(Cl)cc2Cl)cc1C#Cc1cc(-c2cnn(C)c2)cnc1N		CHEMBL4467948	=	Inhibition	%	4.0	CHEMBL4454	Homo sapiens	INH	%	4.0
	23291250	CHEMBL4839532	Inhibition of human recombinant FGR (456 to 770) at 5 nM by radiometric scintillation counting analysis relative to control	B	Cc1ccc(C(=O)Nc2ccc(OC(F)(F)F)cc2)cc1C#Cc1cc(-c2cnn(C)c2)cnc1N		CHEMBL4850154	=	Inhibition	%	9.0	CHEMBL4454	Homo sapiens	INH	%	9.0
	23291251	CHEMBL4839532	Inhibition of human recombinant FGR (456 to 770) at 5 nM by radiometric scintillation counting analysis relative to control	B	Cc1ccc(C(=O)Nc2cc(C(F)(F)F)cc(C(F)(F)F)c2)cc1C#Cc1cc(-c2cnn(C)c2)cnc1N		CHEMBL4862806	=	Inhibition	%	27.0	CHEMBL4454	Homo sapiens	INH	%	27.0
	23291321	CHEMBL4839556	Inhibition of human recombinant FGR (456 to 770) at 50 nM by radiometric scintillation counting analysis relative to control	B	Cc1ccc(C(=O)Nc2ccc(Cl)cc2Cl)cc1C#Cc1cc(-c2cnn(C)c2)cnc1N		CHEMBL4467948	=	Inhibition	%	20.0	CHEMBL4454	Homo sapiens	INH	%	20.0
	23291322	CHEMBL4839556	Inhibition of human recombinant FGR (456 to 770) at 50 nM by radiometric scintillation counting analysis relative to control	B	Cc1ccc(C(=O)Nc2ccc(OC(F)(F)F)cc2)cc1C#Cc1cc(-c2cnn(C)c2)cnc1N		CHEMBL4850154	=	Inhibition	%	34.0	CHEMBL4454	Homo sapiens	INH	%	34.0
	23291323	CHEMBL4839556	Inhibition of human recombinant FGR (456 to 770) at 50 nM by radiometric scintillation counting analysis relative to control	B	Cc1ccc(C(=O)Nc2cc(C(F)(F)F)cc(C(F)(F)F)c2)cc1C#Cc1cc(-c2cnn(C)c2)cnc1N		CHEMBL4862806	=	Inhibition	%	71.0	CHEMBL4454	Homo sapiens	INH	%	71.0
	23291393	CHEMBL4839580	Inhibition of human recombinant FGR (456 to 770) at 500 nM by radiometric scintillation counting analysis relative to control	B	Cc1ccc(C(=O)Nc2ccc(Cl)cc2Cl)cc1C#Cc1cc(-c2cnn(C)c2)cnc1N		CHEMBL4467948	=	Inhibition	%	46.0	CHEMBL4454	Homo sapiens	INH	%	46.0
	23291394	CHEMBL4839580	Inhibition of human recombinant FGR (456 to 770) at 500 nM by radiometric scintillation counting analysis relative to control	B	Cc1ccc(C(=O)Nc2ccc(OC(F)(F)F)cc2)cc1C#Cc1cc(-c2cnn(C)c2)cnc1N		CHEMBL4850154	=	Inhibition	%	77.0	CHEMBL4454	Homo sapiens	INH	%	77.0
	23291395	CHEMBL4839580	Inhibition of human recombinant FGR (456 to 770) at 500 nM by radiometric scintillation counting analysis relative to control	B	Cc1ccc(C(=O)Nc2cc(C(F)(F)F)cc(C(F)(F)F)c2)cc1C#Cc1cc(-c2cnn(C)c2)cnc1N		CHEMBL4862806	=	Inhibition	%	101.0	CHEMBL4454	Homo sapiens	INH	%	101.0
	23291446	CHEMBL4839598	Inhibition of human recombinant FGR (456 to 770) radiometric scintillation counting analysis	B	Cc1ccc(C(=O)Nc2ccc(Cl)cc2Cl)cc1C#Cc1cc(-c2cnn(C)c2)cnc1N		CHEMBL4467948	>	IC50	nM	1000.0	CHEMBL4454	Homo sapiens	IC50	nM	1000.0
	23291447	CHEMBL4839598	Inhibition of human recombinant FGR (456 to 770) radiometric scintillation counting analysis	B	Cc1ccc(C(=O)Nc2cc(C(F)(F)F)cc(C(F)(F)F)c2)cc1C#Cc1cc(-c2cnn(C)c2)cnc1N		CHEMBL4862806	=	IC50	nM	41.0	CHEMBL4454	Homo sapiens	IC50	nM	41.0
Not Active	23317411	CHEMBL4879717	KinomeScan assay: inhibition of FGR	B	CCC(=N\O)/C(C)=C/c1ccc(F)cc1		CHEMBL3697701		% Control	%	67.0	CHEMBL4454	Homo sapiens	% Control	%	67.0
Not Active	23317879	CHEMBL4879717	KinomeScan assay: inhibition of FGR	B	CCC(=N\O)/C(C)=C/c1ccc(F)c(C)c1		CHEMBL3701197		% Control	%	86.0	CHEMBL4454	Homo sapiens	% Control	%	86.0
Not Active	23318548	CHEMBL4879717	KinomeScan assay: inhibition of FGR	B	Cn1cncc1[C@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4586794		% Control	%	100.0	CHEMBL4454	Homo sapiens	% Control	%	100.0
Not Active	23319029	CHEMBL4879717	KinomeScan assay: inhibition of FGR	B	Cn1cncc1[C@@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4526341		% Control	%	100.0	CHEMBL4454	Homo sapiens	% Control	%	100.0
Not Active	23319666	CHEMBL4879717	KinomeScan assay: inhibition of FGR	B	CCCCN(CCCC)C(=O)CN1C[C@H](c2cc(OC)c3c(c2)OCO3)[C@@H](C(=O)O)[C@@H]1CC(C)(C)CCC		CHEMBL111612		% Control	%	100.0	CHEMBL4454	Homo sapiens	% Control	%	100.0
Not Active	23320141	CHEMBL4879717	KinomeScan assay: inhibition of FGR	B	CCCCN(CCCC)C(=O)CN1C[C@@H](c2cc(OC)c3c(c2)OCO3)[C@H](C(=O)O)[C@H]1CC(C)(C)CCC		CHEMBL4513786		% Control	%	92.4	CHEMBL4454	Homo sapiens	% Control	%	92.4
Not Active	23320819	CHEMBL4879717	KinomeScan assay: inhibition of FGR	B	c1ccc(N2CCN(Cc3nc4ccccc4[nH]3)CC2)nc1		CHEMBL440687		% Control	%	100.0	CHEMBL4454	Homo sapiens	% Control	%	100.0
Not Active	23321287	CHEMBL4879717	KinomeScan assay: inhibition of FGR	B	CSc1cccnc1N1CCN(Cc2nc3ccccc3[nH]2)CC1		CHEMBL4630641		% Control	%	100.0	CHEMBL4454	Homo sapiens	% Control	%	100.0
Not Active	23321917	CHEMBL4879717	KinomeScan assay: inhibition of FGR	B	CCCOc1ccc([C@H]2[C@H](C(=O)O)[C@@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL332794		% Control	%	98.0	CHEMBL4454	Homo sapiens	% Control	%	98.0
Not Active	23322385	CHEMBL4879717	KinomeScan assay: inhibition of FGR	B	CCCOc1ccc([C@@H]2[C@@H](C(=O)O)[C@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL4533479		% Control	%	93.0	CHEMBL4454	Homo sapiens	% Control	%	93.0
Not Active	23323074	CHEMBL4879717	KinomeScan assay: inhibition of FGR	B	COc1ccc2c(c1)O[C@@H](c1ccc(OC)c(OC)c1)C[C@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4093612		% Control	%	94.0	CHEMBL4454	Homo sapiens	% Control	%	94.0
Not Active	23323542	CHEMBL4879717	KinomeScan assay: inhibition of FGR	B	COc1ccc2c(c1)O[C@H](c1ccc(OC)c(OC)c1)C[C@@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4066040		% Control	%	87.0	CHEMBL4454	Homo sapiens	% Control	%	87.0
Not Active	23324013	CHEMBL4880632	Fgr (h) Millipore kinase activity assay	B	CC1=C(C#N)C(c2ccc3[nH]nc(C)c3c2)C(C#N)=C(C)N1		CHEMBL4593677		Inhibition	%	14.0	CHEMBL4454	Homo sapiens	% inhibition	%	14.0
Not Active	23324396	CHEMBL4879717	KinomeScan assay: inhibition of FGR	B	CC1=C(C#N)[C@@H](c2ccc3[nH]nc(C)c3c2)C(C#N)=C(c2ccc(Cl)cc2)N1		CHEMBL4522773		% Control	%	100.0	CHEMBL4454	Homo sapiens	% Control	%	100.0
Not Active	23325031	CHEMBL4879717	KinomeScan assay: inhibition of FGR	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@H]1CC[C@@H](Cn2nnc3ccccc3c2=O)[C@@H]1C(=O)O		CHEMBL4585243		% Control	%	86.0	CHEMBL4454	Homo sapiens	% Control	%	86.0
Not Active	23325499	CHEMBL4879717	KinomeScan assay: inhibition of FGR	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@@H]1CC[C@H](Cn2nnc3ccccc3c2=O)[C@H]1C(=O)O		CHEMBL4539943		% Control	%	100.0	CHEMBL4454	Homo sapiens	% Control	%	100.0
Not Active	23326146	CHEMBL4879717	KinomeScan assay: inhibition of FGR	B	NS(=O)(=O)c1cc(NC(=O)Cc2ccccc2)ccc1Oc1cccc(Cl)c1		CHEMBL4521594		% Control	%	100.0	CHEMBL4454	Homo sapiens	% Control	%	100.0
Not Active	23326614	CHEMBL4879717	KinomeScan assay: inhibition of FGR	B	NS(=O)(=O)c1cc(NC(=O)C2(c3ccccc3Cl)CC2)ccc1Oc1cccc(Cl)c1		CHEMBL4516843		% Control	%	54.0	CHEMBL4454	Homo sapiens	% Control	%	54.0
Not Active	23327314	CHEMBL4879717	KinomeScan assay: inhibition of FGR	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4537788		% Control	%	100.0	CHEMBL4454	Homo sapiens	% Control	%	100.0
Not Active	23327782	CHEMBL4879717	KinomeScan assay: inhibition of FGR	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4564312		% Control	%	93.0	CHEMBL4454	Homo sapiens	% Control	%	93.0
Not Active	23328369	CHEMBL4879717	KinomeScan assay: inhibition of FGR	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C#N)cc1		CHEMBL4448899		% Control	%	93.0	CHEMBL4454	Homo sapiens	% Control	%	93.0
Not Active	23328837	CHEMBL4879717	KinomeScan assay: inhibition of FGR	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C(C)(C)C)cc1		CHEMBL4552180		% Control	%	96.0	CHEMBL4454	Homo sapiens	% Control	%	96.0
Not Active	23329347	CHEMBL4881054	Fgr(h) Eurofins Kinase panel	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% residual kinase activity	%	98.0	CHEMBL4454	Homo sapiens	% residual kinase activity	%	98.0
Not Active	23329783	CHEMBL4879717	KinomeScan assay: inhibition of FGR	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% Control	%	100.0	CHEMBL4454	Homo sapiens	% Control	%	100.0
Not Active	23330251	CHEMBL4879717	KinomeScan assay: inhibition of FGR	B	Cc1nc(C2CCN(C(=O)c3ccc(OC(F)(F)F)cc3N)CC2)c2ncc(N3CCN(C)CC3)cc2n1		CHEMBL4455582		% Control	%	100.0	CHEMBL4454	Homo sapiens	% Control	%	100.0
Not Active	23331007	CHEMBL4879717	KinomeScan assay: inhibition of FGR	B	O=C(N1CCS(=O)(=O)CC1)N1C[C@H](c2ccc(OC(F)(F)F)cc2)C[C@H](c2nc(C3CC3)no2)C1		CHEMBL4630644		% Control	%	100.0	CHEMBL4454	Homo sapiens	% Control	%	100.0
Not Active	23331475	CHEMBL4879717	KinomeScan assay: inhibition of FGR	B	Cc1noc([C@H]2C[C@@H](c3ccc(C(F)(F)F)cc3)CN(C(=O)N3CCS(=O)(=O)C3)C2)n1		CHEMBL4630643		% Control	%	100.0	CHEMBL4454	Homo sapiens	% Control	%	100.0
Not Active	23332062	CHEMBL4879717	KinomeScan assay: inhibition of FGR	B	Cc1cc(C)c(-n2ccn3nc(-c4cccnc4)cc23)cc1NC(=O)c1cc(C#N)cc(S(F)(F)(F)(F)F)c1		CHEMBL3907057		% Control	%	84.9	CHEMBL4454	Homo sapiens	% Control	%	84.9
Not Active	23332528	CHEMBL4879717	KinomeScan assay: inhibition of FGR	B	Cc1cc(NC(=O)c2cccc(S(F)(F)(F)(F)F)c2)cc(-n2ccn3nc(-c4cccnc4)cc23)c1		CHEMBL4526351		% Control	%	100.0	CHEMBL4454	Homo sapiens	% Control	%	100.0
Not Active	23333246	CHEMBL4879717	KinomeScan assay: inhibition of FGR	B	CC(=O)C1=C(C)N(c2cccc(C(F)(F)F)c2)C(=O)N[C@@H]1c1ccc(C#N)nc1		CHEMBL3617968		% Control	%	86.7	CHEMBL4454	Homo sapiens	% Control	%	86.7
Not Active	23333885	CHEMBL4879717	KinomeScan assay: inhibition of FGR	B	CNCc1ccccc1-c1csc([C@@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4535474		% Control	%	100.0	CHEMBL4454	Homo sapiens	% Control	%	100.0
Not Active	23334353	CHEMBL4879717	KinomeScan assay: inhibition of FGR	B	CNCc1ccccc1-c1csc([C@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4520788		% Control	%	100.0	CHEMBL4454	Homo sapiens	% Control	%	100.0
Not Active	23334895	CHEMBL4881519	Fgr (h) Upstate kinase activity assay	B	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12		CHEMBL1971943		Inhibition	%	27.0	CHEMBL4454	Homo sapiens	% inhibition	%	27.0
Not Active	23335332	CHEMBL4879717	KinomeScan assay: inhibition of FGR	B	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12		CHEMBL1971943		% Control	%	100.0	CHEMBL4454	Homo sapiens	% Control	%	100.0
Not Active	23335800	CHEMBL4879717	KinomeScan assay: inhibition of FGR	B	Cn1cc(Cl)c2c(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)ccnc21		CHEMBL4546802		% Control	%	100.0	CHEMBL4454	Homo sapiens	% Control	%	100.0
Not Active	23336427	CHEMBL4879717	KinomeScan assay: inhibition of FGR	B	O=C(NC[C@H]1[C@@H]2CN(C(=O)OCc3cc(C(F)(F)F)cc(C(F)(F)F)c3)C[C@H]12)c1ccc2[nH]nnc2c1		CHEMBL4165749		% Control	%	88.0	CHEMBL4454	Homo sapiens	% Control	%	88.0
Not Active	23336895	CHEMBL4879717	KinomeScan assay: inhibition of FGR	B	Cc1nccc(COC(=O)N2C[C@H]3[C@H](CNC(=O)c4ccc5[nH]nnc5c4)[C@H]3C2)n1		CHEMBL4552354		% Control	%	100.0	CHEMBL4454	Homo sapiens	% Control	%	100.0
Not Active	23337599	CHEMBL4881970	FGR Invitrogen selectivity data (BI)	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Ctrl	%	90.5	CHEMBL4454	Homo sapiens	% Ctrl	%	90.5
Not Active	23337976	CHEMBL4879717	KinomeScan assay: inhibition of FGR	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Control	%	100.0	CHEMBL4454	Homo sapiens	% Control	%	100.0
Not Active	23338444	CHEMBL4879717	KinomeScan assay: inhibition of FGR	B	CN(C)C(=O)Cn1cc(-c2nc(C3(c4ccc(-c5cnc(N)nc5)cc4)CC3)no2)cn1		CHEMBL4560241		% Control	%	100.0	CHEMBL4454	Homo sapiens	% Control	%	100.0
Not Active	23339056	CHEMBL4879717	KinomeScan assay: inhibition of FGR	B	CCS(=O)(=O)c1cc2cc(C[C@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL3358954		% Control	%	100.0	CHEMBL4454	Homo sapiens	% Control	%	100.0
Not Active	23339524	CHEMBL4879717	KinomeScan assay: inhibition of FGR	B	CCS(=O)(=O)c1cc2cc(C[C@@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL4531220		% Control	%	88.0	CHEMBL4454	Homo sapiens	% Control	%	88.0
Not Active	23340161	CHEMBL4879717	KinomeScan assay: inhibition of FGR	B	CS(=O)(=O)c1cc(C2(NC(=O)c3cncc4c3cnn4-c3ccc(F)cc3)CC2)ccn1		CHEMBL4456123		% Control	%	100.0	CHEMBL4454	Homo sapiens	% Control	%	100.0
Not Active	23340629	CHEMBL4879717	KinomeScan assay: inhibition of FGR	B	CS(=O)(=O)NCC[C@H](NC(=O)c1cncc2c1cnn2-c1ccc(F)cc1)c1ccnc(S(C)(=O)=O)c1		CHEMBL4539555		% Control	%	100.0	CHEMBL4454	Homo sapiens	% Control	%	100.0
Not Active	23341286	CHEMBL4879717	KinomeScan assay: inhibition of FGR	B	CC(=O)N1CCC(c2ccc(C(=O)NC(=N)N)cc2C(F)(F)F)CC1		CHEMBL2170610		% Control	%	91.0	CHEMBL4454	Homo sapiens	% Control	%	91.0
Not Active	23341754	CHEMBL4879717	KinomeScan assay: inhibition of FGR	B	CC(=O)N1CCC(c2ccc(C(=O)NC3=NCCN3)cc2C(F)(F)F)CC1		CHEMBL4540759		% Control	%	100.0	CHEMBL4454	Homo sapiens	% Control	%	100.0
Not Active	23342370	CHEMBL4879717	KinomeScan assay: inhibition of FGR	B	CCC(=O)N[C@H]1CC[C@@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834184		% Control	%	81.0	CHEMBL4454	Homo sapiens	% Control	%	81.0
Not Active	23342838	CHEMBL4879717	KinomeScan assay: inhibition of FGR	B	CCC(=O)N[C@@H]1CC[C@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834199		% Control	%	100.0	CHEMBL4454	Homo sapiens	% Control	%	100.0
Not Active	23343468	CHEMBL4879717	KinomeScan assay: inhibition of FGR	B	CCOC(=O)c1cc2cc(-c3cc(C(=O)NCc4ccc(C(=O)O)cc4)nn3C)ccc2[nH]1		CHEMBL1939876		% Control	%	94.0	CHEMBL4454	Homo sapiens	% Control	%	94.0
Not Active	23343936	CHEMBL4879717	KinomeScan assay: inhibition of FGR	B	Cn1nc(C(=O)NCc2ccc(C(=O)O)cc2)cc1-c1ccc2[nH]ccc2c1		CHEMBL1939880		% Control	%	87.0	CHEMBL4454	Homo sapiens	% Control	%	87.0
Not Active	23344574	CHEMBL4879717	KinomeScan assay: inhibition of FGR	B	CCOCCn1cc(C(=O)Nc2ccc(-n3nc(-c4cccnc4)cc3C(F)(F)F)cn2)ccc1=O		CHEMBL4516982		% Control	%	100.0	CHEMBL4454	Homo sapiens	% Control	%	100.0
Not Active	23345147	CHEMBL4879717	KinomeScan assay: inhibition of FGR	B	COc1ccc2c(O[C@@H]3C[C@H]4C(=O)N[C@]5(C(=O)O)CC5/C=C\CCCCC[C@H](NC(=O)OC5CCCC5)C(=O)N4C3)cc(-c3csc(NC(=O)C(C)C)n3)nc2c1C		CHEMBL4588900		% Control	%	100.0	CHEMBL4454	Homo sapiens	% Control	%	100.0
Not Active	23345615	CHEMBL4879717	KinomeScan assay: inhibition of FGR	B	O=C(N[C@H]1CCCCC/C=C\C2C[C@@]2(C(=O)O)NC(=O)[C@@H]2C[C@@H](Oc3ccncc3)CN2C1=O)OC1CCCC1		CHEMBL4516471		% Control	%	100.0	CHEMBL4454	Homo sapiens	% Control	%	100.0
Not Active	23346022	CHEMBL4882589	Invitrogen kinase assay (FGR)	B	Cc1cc(Nc2nccc(C)n2)cc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)c1		CHEMBL3685796		IC50	nM	185.0	CHEMBL4454	Homo sapiens	IC50	nM	185.0
Not Active	23346192	CHEMBL4879717	KinomeScan assay: inhibition of FGR	B	Cc1cc(Nc2nccc(C)n2)cc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)c1		CHEMBL3685796		% Control	%	100.0	CHEMBL4454	Homo sapiens	% Control	%	100.0
Not Active	23346661	CHEMBL4879717	KinomeScan assay: inhibition of FGR	B	Cc1ccc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)cc1Nc1cccc(C(F)(F)F)n1		CHEMBL4530401		% Control	%	100.0	CHEMBL4454	Homo sapiens	% Control	%	100.0
Not Active	23347266	CHEMBL4879717	KinomeScan assay: inhibition of FGR	B	C[C@@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccc1		CHEMBL4538174		% Control	%	100.0	CHEMBL4454	Homo sapiens	% Control	%	100.0
Not Active	23347752	CHEMBL4879717	KinomeScan assay: inhibition of FGR	B	C[C@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccn1		CHEMBL4557026		% Control	%	100.0	CHEMBL4454	Homo sapiens	% Control	%	100.0
Not Active	23348331	CHEMBL4879717	KinomeScan assay: inhibition of FGR	B	CC(=O)Nc1c(C(C)=O)c(=O)n(C)c2nc(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)cc12		CHEMBL204232		% Control	%	100.0	CHEMBL4454	Homo sapiens	% Control	%	100.0
Not Active	23348799	CHEMBL4879717	KinomeScan assay: inhibition of FGR	B	CC(=O)c1c(NS(C)(=O)=O)c2cc(-c3ccc(Cl)cc3)c(-c3ccc(Cl)cc3Cl)nc2n(C)c1=O		CHEMBL4578164		% Control	%	100.0	CHEMBL4454	Homo sapiens	% Control	%	100.0
Not Active	23349386	CHEMBL4879717	KinomeScan assay: inhibition of FGR	B	O=S(=O)(NC1CCC(c2cc(F)ccc2F)(S(=O)(=O)c2ccc(Cl)cc2)CC1)C(F)(F)F		CHEMBL1091513		% Control	%	99.0	CHEMBL4454	Homo sapiens	% Control	%	99.0
Not Active	23350004	CHEMBL4879717	KinomeScan assay: inhibition of FGR	B	COc1cc(-c2cn(C3CCc4c(F)cccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1cnc(C)c1		CHEMBL3609637		% Control	%	100.0	CHEMBL4454	Homo sapiens	% Control	%	100.0
Not Active	23350472	CHEMBL4879717	KinomeScan assay: inhibition of FGR	B	COc1cc(-c2cn(C3CCc4ccccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1ccc(C)n1		CHEMBL4534005		% Control	%	90.0	CHEMBL4454	Homo sapiens	% Control	%	90.0
Not Active	23351077	CHEMBL4879717	KinomeScan assay: inhibition of FGR	B	CN([C@@H]1CCc2c(CC(=O)O)c3ccccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL561132		% Control	%	93.0	CHEMBL4454	Homo sapiens	% Control	%	93.0
Not Active	23351545	CHEMBL4879717	KinomeScan assay: inhibition of FGR	B	CN([C@@H]1CCc2c(CC(=O)O)c3cc(S(C)(=O)=O)ccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL1643772		% Control	%	84.0	CHEMBL4454	Homo sapiens	% Control	%	84.0
Not Active	23352050	CHEMBL4882741	FGR Kinase screen	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		Inhibition	%	-2.243	CHEMBL4454	Homo sapiens	% Inhibition	%	-2.2432
Not Active	23352569	CHEMBL4879717	KinomeScan assay: inhibition of FGR	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		% Control	%	89.0	CHEMBL4454	Homo sapiens	% Control	%	89.0
Not Active	23353037	CHEMBL4879717	KinomeScan assay: inhibition of FGR	B	C[C@H]1CN(c2cc(-c3nn(C)c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4560589		% Control	%	90.0	CHEMBL4454	Homo sapiens	% Control	%	90.0
Not Active	23353919	CHEMBL4879717	KinomeScan assay: inhibition of FGR	B	O=C(O)c1cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc2c1		CHEMBL1800685		% Control	%	100.0	CHEMBL4454	Homo sapiens	% Control	%	100.0
Not Active	23354387	CHEMBL4879717	KinomeScan assay: inhibition of FGR	B	Cc1c(C(=O)O)cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc12		CHEMBL4566600		% Control	%	100.0	CHEMBL4454	Homo sapiens	% Control	%	100.0
Not Active	23355119	CHEMBL4879717	KinomeScan assay: inhibition of FGR	B	COCCOc1nc(-c2ccc(Cl)nc2)nc2c1CN(C(=O)c1ncn3ccccc13)CC2		CHEMBL2204538		% Control	%	100.0	CHEMBL4454	Homo sapiens	% Control	%	100.0
Not Active	23355587	CHEMBL4879717	KinomeScan assay: inhibition of FGR	B	CC(C)CC(=O)N1CCc2nc(-c3ccc(Br)cc3)nc(N(C)Cc3ccccc3)c2C1		CHEMBL4518342		% Control	%	99.0	CHEMBL4454	Homo sapiens	% Control	%	99.0
Not Active	23356223	CHEMBL4879717	KinomeScan assay: inhibition of FGR	B	CC(C)(O)c1cncc(-c2nc3ccc(F)cc3n2C2CC2)c1		CHEMBL3582478		% Control	%	100.0	CHEMBL4454	Homo sapiens	% Control	%	100.0
Not Active	23356691	CHEMBL4879717	KinomeScan assay: inhibition of FGR	B	FC(F)(F)c1ccc2c(c1)nc(-c1cccnc1)n2C1CC1		CHEMBL3582461		% Control	%	100.0	CHEMBL4454	Homo sapiens	% Control	%	100.0
Not Active	23357300	CHEMBL4879717	KinomeScan assay: inhibition of FGR	B	C[C@H](c1ccc(F)cc1)N(Cc1cccc(C(=O)O)c1)C(=O)c1cnc2ccccc2c1		CHEMBL3577885		% Control	%	100.0	CHEMBL4454	Homo sapiens	% Control	%	100.0
Not Active	23357947	CHEMBL4879717	KinomeScan assay: inhibition of FGR	B	O=C(Nc1cccnn1)N1CCC(=Cc2cccc(Oc3ccc(C(F)(F)F)cn3)c2)CC1		CHEMBL1651534		% Control	%	63.0	CHEMBL4454	Homo sapiens	% Control	%	63.0
Not Active	23358415	CHEMBL4879717	KinomeScan assay: inhibition of FGR	B	O=C(Nc1cccnn1)N1CC(C/C=C/c2cncc(Oc3ccc(C(F)(F)F)cn3)n2)C1		CHEMBL4780458		% Control	%	100.0	CHEMBL4454	Homo sapiens	% Control	%	100.0
Not Active	23359001	CHEMBL4879717	KinomeScan assay: inhibition of FGR	B	COc1cccc(CNC(=O)c2nc3scc(COCc4ccc(C(=O)O)cc4)c3c(=O)[nH]2)c1		CHEMBL3337894		% Control	%	90.0	CHEMBL4454	Homo sapiens	% Control	%	90.0
Not Active	23359599	CHEMBL4879717	KinomeScan assay: inhibition of FGR	B	C[C@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3799292		% Control	%	80.0	CHEMBL4454	Homo sapiens	% Control	%	80.0
Not Active	23360067	CHEMBL4879717	KinomeScan assay: inhibition of FGR	B	C[C@@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3797887		% Control	%	87.0	CHEMBL4454	Homo sapiens	% Control	%	87.0
Not Active	23360652	CHEMBL4879717	KinomeScan assay: inhibition of FGR	B	Cn1nc(C(F)(F)F)cc1-c1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4455357		% Control	%	90.0	CHEMBL4454	Homo sapiens	% Control	%	90.0
Not Active	23361120	CHEMBL4879717	KinomeScan assay: inhibition of FGR	B	Nc1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4585920		% Control	%	100.0	CHEMBL4454	Homo sapiens	% Control	%	100.0
Not Active	23361693	CHEMBL4879717	KinomeScan assay: inhibition of FGR	B	Cc1nc(N2CC[C@@H](O)C2)ncc1-c1cc(C(F)(F)F)cc2[nH]ncc12		CHEMBL3799512		% Control	%	100.0	CHEMBL4454	Homo sapiens	% Control	%	100.0
Not Active	23362229	CHEMBL4879717	KinomeScan assay: inhibition of FGR	B	Cc1cc(-n2nc(Cc3cc(F)cc(C(F)(F)F)c3)nc2C)ccc1C(N)=O		CHEMBL4082756		% Control	%	94.0	CHEMBL4454	Homo sapiens	% Control	%	94.0
Not Active	23362697	CHEMBL4879717	KinomeScan assay: inhibition of FGR	B	Cc1nc(Cc2cccc(C(F)(F)F)c2)sc1-c1ccc(C(N)=O)nc1		CHEMBL4100408		% Control	%	100.0	CHEMBL4454	Homo sapiens	% Control	%	100.0
Not Active	23364339	CHEMBL4879717	KinomeScan assay: inhibition of FGR	B	CO[C@H]1CC[C@H](CNc2ccc(S(=O)(=O)NC(=O)c3ccc(N4CCN(CC5=C(c6ccc(Cl)cc6)CC(C)(C)CC5)CC4)cc3Oc3cnc4[nH]ccc4c3)cc2[N+](=O)[O-])CC1		CHEMBL4228713		% Control	%	100.0	CHEMBL4454	Homo sapiens	% Control	%	100.0
Not Active	23364807	CHEMBL4879717	KinomeScan assay: inhibition of FGR	B	O=C(NS(=O)(=O)c1ccc(NCC2CCOCC2)c([N+](=O)[O-])c1)c1ccc(N2CCN(Cc3ccc(C(F)(F)F)cc3-c3ccc(Cl)cc3)CC2)cc1Oc1cnc2[nH]ccc2c1		CHEMBL4551344		% Control	%	100.0	CHEMBL4454	Homo sapiens	% Control	%	100.0
Not Active	23365546	CHEMBL4879717	KinomeScan assay: inhibition of FGR	B	CN(C)CC#Cc1ccc(OCCCc2sc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)c(F)c1		CHEMBL3342332		% Control	%	100.0	CHEMBL4454	Homo sapiens	% Control	%	100.0
Not Active	23366089	CHEMBL4879717	KinomeScan assay: inhibition of FGR	B	Cc1c(Oc2c(F)cccc2F)c(OC(C)C)nn1-c1ncc(C2CC2)cc1F		CHEMBL3589752		% Control	%	85.0	CHEMBL4454	Homo sapiens	% Control	%	85.0
Not Active	23366679	CHEMBL4879717	KinomeScan assay: inhibition of FGR	B	Nc1c(C(=O)NCc2ccc(C(=O)NCCCC3CCCCC3)cc2)cnn1-c1ccccc1		CHEMBL4436748		% Control	%	100.0	CHEMBL4454	Homo sapiens	% Control	%	100.0
Not Active	23367147	CHEMBL4879717	KinomeScan assay: inhibition of FGR	B	O=C(NCCCC1CCCCC1)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2C(F)(F)F)cc1		CHEMBL4531775		% Control	%	95.0	CHEMBL4454	Homo sapiens	% Control	%	95.0
Not Active	23367576	CHEMBL4883929	FGR ProQinase selectivity panel	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2ccc(OC[C@H](O)CO)cc21		CHEMBL2152944		% Residual activity with Skepinone-L	%	100.0	CHEMBL4454	Homo sapiens	% Residual activity with Skepinone-L	%	100.0
Not Active	23368025	CHEMBL4879717	KinomeScan assay: inhibition of FGR	B	O=C(Nc1cnc(Oc2ccc(F)cc2)nc1)N1CCc2ncccc2[C@@H]1c1ccc(F)cc1		CHEMBL4458424		% Control	%	100.0	CHEMBL4454	Homo sapiens	% Control	%	100.0
Not Active	23368493	CHEMBL4879717	KinomeScan assay: inhibition of FGR	B	O=C(Nc1ccc(Oc2ccc(F)cc2)cc1)N1CCc2ncccc2[C@H]1c1ccc(F)cc1		CHEMBL4592872		% Control	%	100.0	CHEMBL4454	Homo sapiens	% Control	%	100.0
Not Active	23369092	CHEMBL4879717	KinomeScan assay: inhibition of FGR	B	C[C@H](c1ccnc(Nc2nc3ccc(-c4cc(N(C)C)ncn4)cc3[nH]2)c1)N1CCN(C(=O)CC(F)(F)F)CC1		CHEMBL4537673		% Control	%	85.0	CHEMBL4454	Homo sapiens	% Control	%	85.0
Not Active	23369560	CHEMBL4879717	KinomeScan assay: inhibition of FGR	B	CN(C)c1ncnc(-c2ccc3nc(Nc4cc(CN5CCN(C(=O)CC(F)(F)F)CC5)ccn4)[nH]c3c2)c1Cl		CHEMBL4538591		% Control	%	98.0	CHEMBL4454	Homo sapiens	% Control	%	98.0
Not Active	23370069	CHEMBL4884313	Fgr(h) Eurofins kinase panel	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% residual kinase activity	%	93.0	CHEMBL4454	Homo sapiens	% residual kinase activity	%	93.0
Not Active	23370528	CHEMBL4879717	KinomeScan assay: inhibition of FGR	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% Control	%	51.0	CHEMBL4454	Homo sapiens	% Control	%	51.0
Not Active	23370996	CHEMBL4879717	KinomeScan assay: inhibition of FGR	B	CC1=C(C#N)C(c2ccc3c(c2)c(NC(=O)c2ccccc2C)nn3C)C(C#N)=C(C)N1		CHEMBL4630642		% Control	%	92.0	CHEMBL4454	Homo sapiens	% Control	%	92.0
Not Active	23371805	CHEMBL4879717	KinomeScan assay: inhibition of FGR	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNC(=O)c3cnc4ccccn34)cc2)C1		CHEMBL4591082		% Control	%	87.0	CHEMBL4454	Homo sapiens	% Control	%	87.0
Not Active	23372273	CHEMBL4879717	KinomeScan assay: inhibition of FGR	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNc3ncnc4c3nnn4-c3ccccc3)cc2)C1		CHEMBL4568183		% Control	%	88.0	CHEMBL4454	Homo sapiens	% Control	%	88.0
	23372747	CHEMBL4884712	Fgr(FGR1LGF1) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3cn(Cc4ccccc4)nc3C2=O)COc2ccccc21		CHEMBL4088216		IC50	nM	1000.0	CHEMBL4454	Homo sapiens	pIC50		6.0
	23373156	CHEMBL4885003	Fgr(FGR1LGF1) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3c(nn(Cc4ccccc4)c3Br)C2=O)COc2ccccc21		CHEMBL4549667		IC50	nM	1000.0	CHEMBL4454	Homo sapiens	pIC50		6.0
	23373517	CHEMBL4885294	Fgr(FGR1LGF1) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3cn(CC4CCS(=O)(=O)CC4)nc3C2=O)COc2ccccc21		CHEMBL4097778		IC50	nM	1000.0	CHEMBL4454	Homo sapiens	pIC50		6.0
Not Active	23374981	CHEMBL4885975	Fgr Kinase panel	B	CC(C)(O)[C@H](F)CN1Cc2cc(NC(=O)c3cnn4cccnc34)c(N3CCOCC3)cc2C1=O		CHEMBL4475494		Inhibition	%	53.0	CHEMBL4454	Homo sapiens	% Inhibition	%	53.0
Not Active	23375261	CHEMBL4886243	Gardner-Rasheed feline sarcoma viral (v-fgr) oncogene homolog Millipore kinase panel	B	COCCc1ccc(-c2c(C)nc3c(N4CCOCC4)ccnn23)cn1		CHEMBL2180408		Inhibition	%	7.0	CHEMBL4454	Homo sapiens	% inhibition	%	7.0
Not Active	23375700	CHEMBL4879717	KinomeScan assay: inhibition of FGR	B	O=C1CCc2cc(Nc3cc(OC4CCOCC4)c([N+](=O)[O-])cc3Cl)ccc2N1		CHEMBL4075278		% Control	%	100.0	CHEMBL4454	Homo sapiens	% Control	%	100.0
Not Active	23376168	CHEMBL4879717	KinomeScan assay: inhibition of FGR	B	N#Cc1ccc(Nc2ccc3[nH]c(=O)[nH]c3c2)c(Cl)c1		CHEMBL4063249		% Control	%	100.0	CHEMBL4454	Homo sapiens	% Control	%	100.0
Not Active	23376745	CHEMBL4879717	KinomeScan assay: inhibition of FGR	B	O=c1nc(-c2ccccn2)sc2ccccc12		CHEMBL4516611		% Control	%	100.0	CHEMBL4454	Homo sapiens	% Control	%	100.0
Not Active	23377214	CHEMBL4879717	KinomeScan assay: inhibition of FGR	B	O=C1NC(c2ccccn2)Sc2ccccc21		CHEMBL4561806		% Control	%	100.0	CHEMBL4454	Homo sapiens	% Control	%	100.0
Not Active	23378073	CHEMBL4879717	KinomeScan assay: inhibition of FGR	B	CNC(=O)Nc1ccc2c(c1)CC[C@@]21OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4282264		% Control	%	75.0	CHEMBL4454	Homo sapiens	% Control	%	75.0
Not Active	23378541	CHEMBL4879717	KinomeScan assay: inhibition of FGR	B	CNC(=O)Nc1ccc2c(c1)[C@@]1(CC2)OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4536197		% Control	%	88.0	CHEMBL4454	Homo sapiens	% Control	%	88.0
Not Active	23379708	CHEMBL4879717	KinomeScan assay: inhibition of FGR	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)O)c(=O)n3ccccc23)CC1		CHEMBL1800285		% Control	%	94.0	CHEMBL4454	Homo sapiens	% Control	%	94.0
Not Active	23380176	CHEMBL4879717	KinomeScan assay: inhibition of FGR	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)N3CCCC3)c(=O)n3ccccc23)CC1		CHEMBL2204283		% Control	%	100.0	CHEMBL4454	Homo sapiens	% Control	%	100.0
Not Active	23380870	CHEMBL4879717	KinomeScan assay: inhibition of FGR	B	COc1ccc2cc(OCC3(C(=O)O)CN(C(=O)c4ccc(F)cc4)C3)ccc2c1		CHEMBL3286797		% Control	%	96.0	CHEMBL4454	Homo sapiens	% Control	%	96.0
Not Active	23381518	CHEMBL4879717	KinomeScan assay: inhibition of FGR	B	C[C@H](NC(=O)c1cnc2n1[C@](C)(Cc1ccc(C#N)cc1)C(=O)N2c1cc(Cl)c(F)c(Cl)c1)C(=O)NC1(c2ccccn2)CC1		CHEMBL4530740		% Control	%	100.0	CHEMBL4454	Homo sapiens	% Control	%	100.0
Not Active	23381986	CHEMBL4879717	KinomeScan assay: inhibition of FGR	B	C[C@@]1(Cc2ccc(C#N)cc2)C(=O)N(c2cc(Cl)cc(Cl)c2)c2ncc(C(=O)NC3(c4nc(C5CCC5)no4)CC3)n21		CHEMBL4577237		% Control	%	100.0	CHEMBL4454	Homo sapiens	% Control	%	100.0
Not Active	23382610	CHEMBL4879717	KinomeScan assay: inhibition of FGR	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331		% Control	%	81.0	CHEMBL4454	Homo sapiens	% Control	%	81.0
Not Active	23383078	CHEMBL4879717	KinomeScan assay: inhibition of FGR	B	CN(c1ccnc(CNc2nc(Nc3ccc4c(c3)CC(=O)N4)ncc2C(F)(F)F)n1)S(C)(=O)=O		CHEMBL4518706		% Control	%	58.0	CHEMBL4454	Homo sapiens	% Control	%	58.0
Not Active	23383794	CHEMBL4887431	FGR Invitrogen Lab (UK) kinase screen (BI)	B	CCC(F)(F)c1cc(N2CCC(S(C)(=O)=O)CC2)nc2sc(C(N)=O)c(N)c12		CHEMBL4522930		% Ctrl	%	78.0	CHEMBL4454	Homo sapiens	% Ctrl	%	78.0
Not Active	23384278	CHEMBL4887873	Fgr(h) Millipore kinase panel	B	CC[C@@H](Nc1c(C#N)c(-c2ccc(-c3cccc(C)c3F)cc2)nc2cnccc12)C(=O)O		CHEMBL4802045		Inhibition	%	5.05	CHEMBL4454	Homo sapiens	% inhibition	%	5.05
Not Active	23384993	CHEMBL4879717	KinomeScan assay: inhibition of FGR	B	CO[C@@H](C)c1c(Nc2ccc([C@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4568735		% Control	%	100.0	CHEMBL4454	Homo sapiens	% Control	%	100.0
Not Active	23385460	CHEMBL4879717	KinomeScan assay: inhibition of FGR	B	CO[C@@H](C)c1c(Nc2ccc([C@@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4584981		% Control	%	100.0	CHEMBL4454	Homo sapiens	% Control	%	100.0
